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Summary 
    To date, eight different mcr-variants have been identified encoding phosphoethanolamine 
transferases contributing to phosphoethanolamine addition to lipid A and thereby conferring 
colistin resistance. This novel mechanism of plasmid-mediated colistin resistance provides an 
efficient way in distributing colistin resistance. This thesis aims to further our understanding 
of the multifaceted aspects of mcr-like genes using detailed molecular analysis including 
whole-genome sequencing (WGS) for 17 mcr-positive Klebsiella pneumoniae (MCRPKP) 
and 219 mcr-positive Escherichia coli (MCRPEC) from Thailand and Vietnam. 
    Fitness is an important factor to predict the spread and development of antibiotic resistance. 
In chapter 3, the data show that over-producing MCR-1 in E. coli imposes a great fitness loss, 
observed by slow growth rates, impaired membrane integrity and decreased competitiveness. 
The fitness burden conferred by mcr-3 seems to be more moderate and mcr-3-positive 
plasmids are more stable and competitive, than that of mcr-1-carrying plasmids.  
    In addition, I provided evidence that blowflies serve as reservoirs of mcr-genes and 48 
mcr-1-positive strains recovered from blowflies have been characterized. In particular, the 
clonal relationship among 17 MCRPKP strains obtained from blowflies was observed by 
indistinguishable PFGE patterns and an identical phylogenetic tree. The virulence potential of 
this MCRPKP clone was measured in the Galleria mellonella model.  
    Furthermore, 219 MCRPEC isolates were characterized using WGS and bioinformatics 
analysis. WGS analysis shows that MCRPEC isolates are highly diverse, with distinct 
phylogenetic groups and various accessory genes including heavy-metal/antibiotic resistance 
determinants, virulence factors and toxin-antitoxin systems. The genetic context analysis on 
the origin and spread of gene mcr-1 and mcr-3, provides important knowledge of 
understanding on the movement and dissemination of mcr-like genes bacterial population. 
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Chapter 1    
General Introduction 
 
1. 1 The end of antibiotics against Gram-negative bacteria?  
As the discovered antibiotic in 1928 by Sir Alexander Fleming (FLEMING, 1944), 
penicillin has been described as a wonder drug which transformed medical treatment in 1941 
and saved millions of lives during World War II. Penicillin’s discovery was exemplary of 
many pioneering researchers, and the period between 1950s and 1970s was considered as ‘the 
golden era of antibiotic discovery’. By the 1970s many of history’s endemic and almost 
incurable human infections including tuberculosis, cholera and malaria, were no longer fatal. 
Unfortunately, even before the first medical use of penicillin in 1941, penicillin resistance 
had been reported in 1940 (Ventola, 2015). But at that time most doctors remained optimistic 
and hopeful for the success of this new drug, which had defeated diseases such as syphilis 
and cholera, so the first emergence of possible penicillin resistance was overlooked. The 
conclusion from an early report for acquired penicillin resistance in 1952 was (Rollo et al., 
1952): ‘Syphilis has now been treated with arsenicals for about 40 years without any 
indications of an increased incidence of arsenic-resistance infections, and this work gives 
grounds for the hoping that the widespread use of penicillin will equally not result in an 
increasing incidence of infections resistance to penicillin’. Antibiotic treatments have two 
conflicting consequences: in the short-term, antibiotics can effectively block bacterial growth 
and cure bacterial infections; but in the long-term, the use of antibiotics promotes the 
evolution of resistance. History has shown that shortly after the introduction of a new 
antibiotic, it is usually followed by the emergence and development of resistance, and 
resistance has been seen to almost all current available antibiotics (Fig.1.1). Today, there is 
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considerable concern with the mounting prevalence of pan-drug resistant Gram-negative 
Bacteria (GNB) in clinical and environmental settings, in particular Enterobacteriaceae, 
Acinetobacter baumannii, and Pseudomonas aeruginosa. Worse still, the discovery and 
development of novel antibiotics have declined considerably in the last two decades   
(Livermore, 2004, Brown & Wright, 2016).  The U.S. CDC has estimated that each year at 
least 2 million people suffer from infectious illnesses and 23,000 deaths are directly linked to 
antibiotic-resistant bacteria (https://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-
threats-2013-508.pdf#page=6).  
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Fig.1.1 key dates in the history of antibiotic discovery and subsequent resistance development. -R: resistance; XDR: extended-drug resistance; PDR: Pan-drug 
resistance. *Teixobactin is not in clinical use yet. (updated from (Bbosa et al., 2014, Ventola, 2015) 
!
 
4!
    Currently, the main treatment options for Gram-negative infection are β-lactams, which 
consist of three subclasses, namely, narrow-spectrum (penicillins and early generations of 
cephalosporins), extended-spectrum (cephalosporins) and broad-spectrum (carbapenems) 
(Table 1.1). However, bacteria have rapidly developed several strategies to counter the 
effects of β-lactams, one of the most effective mechanisms is the production of β-lactamases, 
enzymes that hydrolyse β-lactams. High levels of extended-spectrum β-lactamases (ESBLs), 
which can inactivate the majority of β-lactams including celphalosporins but not 
carbapenems, have been reported globally (Bonnet, 2004, Arcilla et al., 2017). One of the 
most prevalent ESBLs, CTX-M-15, is associated with the widespread pathogenic E. coli 
clone, ST131. With the occurrence of ESBLs, carbapenems were one of a few remaining β-
lactam agents left for the treatment of Gram-negative infections. However, after the first 
report of the K. pneumoniae carbapenemase (KPC), several novel carbapenemases have been 
subsequently found in GNB, including OXA-types and the NDM-β-lactamases (Walsh et al., 
2005, Queenan & Bush, 2007, Doi & Paterson, 2015).  Carbapenemase-producing GNB thus 
can inactivate virtually all β-lactams including carbapenems, regarded as the last resort 
against Gram-negative infections. Considerably high resistance rates (>50%) to carbapenems 
have now been reported in K. pneumoniae in some European countries (Canton et al., 2012). 
In 2013, the U.S. CDC classified carbapenem-resistant Enterobacteriaceae (CRE) as first-
line ‘urgently treated’ (https://www.cdc.gov/narms/resources/threats.html), and high burdens 
of CRE strains have also been reported globally (Munoz-Price et al., 2013, Nordmann, 2014). 
Successful spread of β-lactam-resistance in the hospitals and communities, have forced 
clinicians to explore combination therapies. Fluoroquinolones, aminoglycosides and 
polymixins are often used in combination with β-lactams for the treatment of serious Gram-
negative infections. Frequent exposure to mixed antibiotics, ultimately pave the way for 
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bacteria to develop more complex mechanisms of resistance conferring protection against 
more than one group of antibiotics. We now are facing more complex and chronic situations 
of multi-drug resistant GNB (MDR-GNB), for instance, resistance genes encoding β-
lactamases often co-exist with other antibiotic resistance genes conferring resistance to 
quinolones, aminoglycoside or tetracyclines (Crofts et al., 2017). According to latest NARS-
Net surveillance data in 2017 (https://ecdc.europa.eu/en/antimicrobial-
resistance/surveillance-and-disease-data/report), the high prevalence of MDR phenotypes 
(resistance to fluoroquinolones, aminoglycosides and carbapenems) in Acinetobacter species, 
has been frequently reported in southern and south-eastern Europe (EARS-Net, 2017), which 
makes therapeutic options for Acinetobacter infections even more limited. Moreover, over 
one-third of K. pneumoniae were resistant to more than one of the antibiotic classes and 
combined resistance to multiple antibiotics were common, according to 2017 EARS-Net 
surveillance. There is increasing evidence that MDR (and increasing reports of pan-drug 
resistance [PDR]) in GNB, have spread globally (Crofts et al., 2017, Logan & Weinstein, 
2017, Navon-Venezia et al., 2017), such that if we do not act promptly to preserve the 
activity of current available antibiotics and focus on the development of new antimicrobial 
agents, we will soon return to an equivalent of the ‘pre-antibiotic era’.  
The situation of antibiotic resistance in animals is equally worrisome. Since the first 
industrial production of low-dose tetracycline to enhance chicken growth and boost poultry 
profits in 1948, the process of routinely feeding antibiotics to food-producing animals has 
been implemented in the majority of countries (Popescu, 2018). All major species of food 
animals, including fish, sheep, cattle and pigs, derive some benefit from the use of antibiotics 
as prophylaxis, chemotherapy and/or growth promotion. In the United States, food-producing 
animals consume approximately 70% of the nation’s annual antibiotic consumption, and a 
significant fraction (62%) are medically important antimicrobials including tetracycline, 
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aminoglycosides, cephalosporins and fluoroquinolones (FDA, 2016). A recent study has 
estimated that the global consumption of antibiotics in livestock will rise by 67% by 2030, 
from approx. 63,151 tons in 2010 to approx. 105,596 tons, and nearly double in Brazil, China, 
Russia, India and South Africa (Van Boeckel et al., 2015). The intensive use of antibiotics, 
especially in low- or middle-income countries, where most of those counties have no standard 
guidelines on antibiotic use in animal production, potentially increase selective pressure on 
bacteria and aid the emergence of antibiotic resistances (Founou et al., 2016). There is a 
proven relationship between the consumption of antibiotics and the prevalence of antibiotic-
resistance in commensal E. coli from pigs, cattle and poultry. It is therefore not surprising 
that the high prevalence of MDR pathogens has been identified from food products, posing a 
significant public health threat through food consumption (Founou et al., 2016). There are 
numerous transmission pathway for MDR bacteria from animals to human. For instance, the 
resistance genes can be transferred horizontally between commensal species like E. coli and 
Enterococci, and then to pathogens, aided and abetted by exposure through food or contact 
with animals. Direct spread of livestock-associated methicillin-resistant Staphylococcus 
aureus (MRSA) to people exposed to pigs, cattle or poultry have been well studied 
(Graveland et al., 2011, Alba et al., 2015, Goerge et al., 2017). The occurrence of ESBL-
producing E. coli with MDR phenotypes from animals and food products is also increasing 
(Ewers et al., 2012, Vitas et al., 2018). The potential effects of antibiotic use in animals on 
human health has attracted public attention and resulted in those antibiotics used for growth 
promotion in animals, being banned in some countries (Walsh & Wu, 2016). In 1985, 
Sweden was the first country to regulate a ban on the use of antibiotic as growth promoters in 
food animal production (Wierup, 2001, Maron et al., 2013). It was followed by Norway 
(1995) and Denmark (1998-1999) with the withdrawal of antimicrobials used as routine 
preventative use in food-producing animals (Grave et al., 2006). In 2006, the European 
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Union declared a ban on the use of all antibiotic growth promoters in food animals; however, 
this did not cover antibiotics used for metaphylaxis treatment in large flocks, and they are still 
in use in non-EU countries. In 2013, the Indian government changed antibiotic regulation 
laws aiming to end the sale of over-the-counter antibiotics (Kakkar et al., 2017); however due 
to lack of regulatory scrutiny in India, their increasing sales of unapproved antibiotics made 
this initiative soon nullified (https://theconversation.com/the-indian-government-is-not-
doing-enough-to-tackle-the-sale-of-unapproved-antibiotics-85432). There are no geographic 
boundaries to impede the global spread of AMR-humans move and therefore so do bacteria.  
If preventive and containment efforts can be made locally, nationally and regionally, and 
apply the One Health approach to ensure food safety and security, we will be in a better 
position to combat infectious diseases and potentially curb the spread of AMR (Founou et al., 
2016).
!
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Table 1.1 Currently available antibiotics for the treatment of GNB infections  
 
Antibiotic classes Some important 
antibiotics 
Infections and drug-resistant 
pathogens 
Major resistance 
mechanisms and comments 
narrow-spectrum 
β-lactams:  
penicillis and 
early generation 
cephalosporins 
penicillin, cephalothin, 
cefazolin, cephaprilin, 
cephalexin 
In the absence of resistance, 
these drugs are still active 
against a wide range of 
bacterial pathogens. But 
resistance is widespread, it is 
not recommended for serious 
infections  
The production of β-
lactamases: such as 
penicillinase 
extended-
spectrum β-
lactams: 
celphalosporins  
ceftriaxone, ampicillin, 
cefepime, ceftazidime 
for pneumonia bloodstream 
infections and UTI#  
 
ESBLs, mainly CTX-M-
types, they can hydrolyze 
most of β-lactams expect 
carbapenems.  
broad-spectrum β-
lactams:  
carbapenems 
 
meropenem, imipenem, 
ertapenem, doripenem 
(considered as the last-line 
antibiotic against serious 
infections) 
for ESBLs-producing 
Enterobacteriaceae, 
pneumonia, bloodstream 
infections and UTI. 
A variety of potent 
carbapenemases (such as 
NDM, OXA, KPC) that are 
effective against all β-
lactams.  
β-lactamase 
inhibitors 
clavulanic acid, 
sulbactam, tazobactam 
combined with other β-
lactams such as ampicilin, 
these drugs are important for 
serious infections caused by 
GNB that have β-lactamases 
with limited activities 
potent β-lactamases 
including ESBLs and 
carbapenemases 
Aminoglycosides amikacin, gentamicin, 
tobramycin 
for pneumonia, bloodstream 
infections and UTI. 
16S rRNA methylases that 
confer a high level of 
resistance to all 
aminoglycosides, often co-
produce with ESBLs and 
carbapenemases(Doi & 
Arakawa, 2007) 
Fluoroquinolones ciprofloxacin, 
levofloxacin, 
moxifloxacin 
for pneumonia bloodstream 
infections and UTI 
target-site mutations like 
gyrA, efflux pumps, qnr 
genes (Jacoby, 2005, 
Redgrave et al., 2014) 
Tetracyclines and 
Glycyclines 
Tigecycline+, 
(*tetracyclines serve as 
secon-or third line 
therapy) 
for CRE, CRA 
 
resistance to tigecycline has 
been identified but it is still 
rare.  
Polymyxins colistin+ for CRE, CRA, CRP plasmid-borne mcr-genes, 
chromosomal pmrAB and 
phoPQ systems 
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Footnotes: * tetracyclines are not fist-line treatment options, but increasing resistance to other classes, 
it is considered as a therapeutic option). + tigecycline and colistin are last-line antibiotics for the 
treatment of serious infections caused by CRE (Carbapenem-Resistance Enterobacteriaceae), CRA 
(Carbapenem-Resistance A. baumannii) and CRP (Carbapenem-Resistance P. aeruginosa). # UTI: 
urinary tract infection. This detail was updated from (Peleg & Hooper, 2010) and U.S. CDC 2013 
report (https://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf#page=6). 
 
1.2 Re-introduction of the old antibiotic colistin for multidrug resistant Gram-negative 
bacterial infections 
     As seen in Table 1.1, Gram-negative pathogens (A. baumannii, P. aeruginosa, 
and Enterobacteriaceae) that cause the majority of hospital infections, have evolved a variety 
of strategies to escape the action of antibiotics. The increasing gulf between the escalation of  
carbapenem-resistance and the shortage of novel antibiotic entering clinical trials has aroused 
renewed interest in older antimicrobial agents to be redeployed in the battle against MDR 
bacteria (Li et al., 2006). One of these old antibiotics are polymyxins, which were first 
obtained from the soil bacterium Paenibacillus polymyxa (previously Bacillus polymyxa) in 
1947 (Ainsworth et al., 1947, Benedict & Langlykke, 1947, Stansly et al., 1947). Polymyxins 
are a group of antimicrobial polypeptides (AMPs), they are bactericidal and mainly active 
against GNB (Storm et al., 1977). Polymyxins include five different chemical compounds 
(polymyxin A, B, C, D and E), each consisting of a cyclic heptapeptide, a linear tripeptide 
and a long hydrophobic tail which are integrated into the bacterial membrane inflicting 
damage (Fig.1.2). There are only one amino acid difference at position 6’ between polymyxin 
B and polymyxin E (colistin), where D-Phe (D-phenylalanine) in polymyxin B is replaced by 
D-Leu (D-leucine) in colistin,  as shown in Fig.1.2 (Falagas et al., 2005). Colistin was first 
discovered from soil bacterium Aerobacillus polyaerogenes in 1949 (Koyama, 1950), and it 
was not correctly classified as belonging to the polymyxin group until 1963 (Wilkinson, 
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1963). Colistin was comprised mainly of colistin A and B, varying slightly by different 
attachment of fatty acids (‘R2’), where colistin A was MOA and colistin B was IOA (Suzuki 
et al., 1965) (Fig.1.2). Therefore, the chemical structure of polymyxins are a mixture of 
lipophilic, such as cationic L-Dab (α,γ-diaminobutyric acid) residues and hydrophobic groups 
(N-terminal fatty acid chain and D-Leu/Phe6-L-Leu7 segment), and this amphipathic structure 
is essential for antibacterial activity (Velkov et al., 2010, Yu et al., 2015). 
 
 
Fig.1.2 Chemical structure of colistin and polymyxin. Dab:α,γ-diaminobutyric acid; Phe: 
phenylalanine; Leu: leucine; Thr: threonine. Roman numbers mean the position of amino acid 
residues in polymyxins. 
 
1.2.1 Antibacterial Mechanism of polymyxins 
It is well-established that the broad-spectrum bactericidal activity of polymyxins is 
mediated by altering GNB membrane structure/topology. A prerequisite for antibiotic activity 
against GNB is to overcome the outer membrane permeability barrier and reach the inner 
membrane, which is the primary target of polymyxins. Lipopolysaccharides (LPS) is the 
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major component of the outer membrane in GNB and consists of a lipid and 
a polysaccharide composed O-antigen, an outer core and inner core joined by a covalent bond. 
LPS contributes greatly to the structural integrity of the bacteria, and protecting the other cell 
structures from harmful substances (Ruiz et al., 2009). The lipid component of LPS, lipid A, 
which is responsible for the toxic stimulus in sepsis, consists of two glucosamine-base 
disaccharides attached to six fatty acid chains (Fig.1.3). The lipid A disaccharide contains 
two phosphoryl groups at the 1’ and 4’-position, both phosphates can be further modified by 
the addition of groups inducing ethanolamine, glucose, mannose or 4-amino-4-deoxy-L-
arabinose (Erridge et al., 2002, Needham & Trent, 2013). It has been proposed that lipid A 
can increase the negative charge of the cell membrane and help stabilize the overall 
membrane topology. It is generally believed that the antibacterial activity of polymyxins 
depends on electrostatic attraction between cationic residue of polymyxin and the anionic 
phosphate head-groups of lipid A in the outer membrane of GNB, resulting in disarrangement 
of the bacterial cell membrane (Newton, 1956, Falagas et al., 2005). A classic model of 
polymyxin B binding to lipid A, which is based on the three-dimensional nuclear magnetic 
resonance (NMR) structure of polymyxin in complex with lipid A (Pristovsek & Kidric, 1999, 
Velkov et al., 2010) is: the positively-charged Dab residues closely interact with the 
negatively-charged 1’- and  4’-phosphate groups of lipid A, reducing the net-negative charge 
of lipid A. The hydrophobic leucine residues and tail of polymyxin interact with the fatty acid 
tails of lipid A. This initial electrostatic interaction between polymyxin and to LPS molecules 
in the outer membrane of the GNB leads to the displacement of the divalent cations, 
magnesium (Mg+2) and calcium (Ca+2), which normally act as a bridge to stabilize the LPS 
molecules. (Storm et al., 1977, Yu et al., 2015). As a result, this insertion of hydrophobic 
residues [(D-Phe6 -L-Leu7 (polymyxin) or D-Leu6 -L-Leu7 (colistin)) and the fatty acyl chain 
acts to disrupt and destabilize the monolayer of outer-membrane, and eventually the 
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permeability of the cell wall to polymyxins is increased, that ultimately causes cell death 
(Fig.1.3).  
 
 
Fig. 1.3. A schematic of putative antimicrobial action of colistin on the outer membrane of Gram-
negative bacteria (modified from (Velkov et al., 2010). The activity of colistin on bacterial cells are 
usually divided into three steps: firstly, disruption of outer-membrane through colistin-lipid A 
interaction; self-promoted uptake into inner membrane and finally lysis of cell through disruption of 
the stability of bacterial inner membrane.  
 
1.2.2 Antimicrobial activity of polymyxins 
    Due to the high toxicity of polymyxin A, C and D, only polymyxin B and E (colistin) have 
been used in clinical practice. Colistin has excellent antibacterial activity against most GNB, 
including E.coli, Acinetobacter species, P. aeruginosa, Salmonella species, Enterobacter 
species, Citrobacter species and Shigella species, with minimum inhibitory concentrations 
less than 2 mg/l (Storm et al., 1977, Falagas et al., 2005). Generally, polymyxins are less 
active against Gram-positive bacteria though there are polymyxin sensitive strains including 
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Staphylococcus, Bacillus and Corynebacterium with MIC less than 2 mg/l (Storm et al., 
1977). In Edgar’s report, colistin was described as a successful antibiotic to cure infections 
caused by Pseudomonas, which is resistant to almost all chemotherapeutic agents, but most 
of the organisms remain susceptible to colistin (Edgar & Dickinson, 1962). It has been 
demonstrated that colistin possesses the same level of bactericidal activity as polymyxin B, 
but is less toxic than polymyxins, which is commonly associated with serious adverse effects 
(Hall, 1960, Reed et al., 2001). Subsequently, this led to the development and clinical 
availability of colisin in Japan and Europe during the 1950s. Soon after, significant colistin-
associated renal and neurological toxicity was also reported and the intravenous use of 
colistin and polymyxin B were gradually abandoned in the early 1980s (Yu et al., 2015). 
    Until the last decade, colistin has been shelved for over 30 years in most countries and 
replaced by the less toxic aminoglycosides and beta-lactams. However, outbreaks of MDR  
superbugs, such as NDM-1-producing bacteria that are resistant to most classes of  
antimicrobial agents (Yong et al., 2009, Kumarasamy et al., 2010), has led to the 
reintroduction of colistin, in particular, as a valuable clinical drug. Furthermore, the 
reassessments of the efficacy and safety of colistin in the treatment of serious infections 
suggests that colistin is less nephrotoxic than previously believed, and revised dosing 
regimens can minimize its toxicity (Reed et al., 2001, Li et al., 2006, Falagas et al., 2010, 
Honore et al., 2013). According to Matthew et al study in 2010, 258 patients with MDR 
bacterial infections received intravenous colistin therapy for at least 72 hours with no adverse 
effects (including nephrotoxicity) observed (Falagas et al., 2010). More importantly, due to 
its significant activity against MDR Gram-negative pathogens, including A. baumannii, P. 
aeruginosa and carbapenem-resistant K. pneumoniae, colistin has been revived as a ‘salvaged’ 
antibiotic employed against MDR bacterial infections (Table 1.1) (Linden et al., 2003, 
Falagas et al., 2010, Biswas et al., 2012).  
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    Another encouraging outcome of colstin’s reemergence is its synergistic effects when 
conbined with other antibiotics . The synergistic effect of colistin with rifampicin has also 
been reported in vitro against carbapenem-resistant A.baumannii (Song et al., 2007), the 
amount of colistin-rifapicin combination to achieve bactericidal activity was 4-8 fold lower 
when compared monotherapy with colistin. However, the efficacy to the combination therapy 
is still poorly undestood because of the sparisity of clinical outcome data. With the 
emergence of increasing colistin resistance, more clinical studies for colistin combination 
regimens is warranted. The recent results show that several antibiotics including 
clarithromycin, in combination with colistin, display stronger antimicrobial effecacy than the 
mono-treatment, suggesting a viable therapeutic alternative for highly antibiotic resistant 
GNB (MacNair et al., 2018). 
 
1.3 The acquired resistance mechanisms of polymyxins  
    Since the target of antimicrobial polypeptides (AMPs)  is the bacterial membrane, which is 
a fundamental structure and critical to  bacterial survival, it has been long thought that the 
acquisition of resistance by significantly altering the outer-membrane is improbable (Zasloff, 
2002). However, there are many reports showing that lipid A can undergo extensive re-
modelling that allow bacteria to adapt to their rapidly changing and often hostile environment. 
For instance, modification of lipid A by adding a phosphate group, results in a change in the 
outer-membrane permeability and can promote bacterial resistance to AMPs (Erridge et al., 
2002). The diversity of lipid A modification has been identified previously and has provided 
a deep insights into the interaction between lipid A modification, AMPs and bacterial 
resistance.   
    The World Health Organization (WHO) has classified polymyxins as ‘critically important’ 
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antibiotics for human medicine to treat serious infections caused by MDR Enterobacteriaceae 
(http://www.who.int/foodsafety/publications/antimicrobials-third/en/). Resistance to colistin 
is a great challenge to global health as it means virtually no remaining antibiotics are 
available to fight against colistin-resistant ‘superbugs’. Unfortunately, the reintroduction of 
polymyxins, colistin in particular, for last-line therapy will provide some selective pressure 
and potentially facilitate the outbreak of ‘superbugs’ and increase their global numbers 
(Moffatt et al., 2010). However, certain bacterial species are known to have natural or 
intrinsic resistance to colistin, such as Neisseria spp., Moraxella catarrhalis, Helicobacter 
pylori, Proteus mirabilis, Serratia marcescens, Morganella morganii, Chromobacterium and 
Brucella species, with MICs greater than 128 mg/l (Velkov et al., 2010, Biswas et al., 2012). 
Polymyxin resistance is most often mediated by a variety of LPS modifications, including 
changing the length of O-Antigen, lipidA modifications with phosphoethanolamine (PEtN) 
and 4-amino-4-deoxy-L-arabinose (L-Ara4N), and deacylation (Gunn, 2001, Olaitan et al., 
2014). Polymyxins are positively charged peptides, which are proposed to kill bacteria by 
compromising the integrity of the bacterial outer-membrane. The LPS modifications, which 
alters the net negative charge of the outer-membrane, will reduce the avidity between the 
AMPs and their target resulting in polymyxin  resistance (Olaitan et al., 2014) (Fig.1.4). 
Other strategies, such as overexpression of outer-membrane protein OprH or the use of efflux 
pumps, have also evolved in GNB to protect themselves from AMPs.  
 
1.3.1 Chromosomal-dependent colistin resistance 
1.3.1.1 The two-component systems govern LPS with PEtN/L-Ara4N additions in 
Enterobacteriaceae 
    Because the outer membrane is the initial site of interaction with colistin, the most efficient 
colistin resistance mechanisms are those directly connected to LPS modification as they 
!
 
16!
protect the peptide from entering the cell by decreasing colistin affinity. The most common 
LPS modifications are the cationic substitution of the phosphate groups by L-Ara4N and 
PEtN: the resulting positively charged LPS reduces the binding of colistin, leading to 
resistance. LPS modifications are induced by the two-component regulators, phoP/phoQ 
(phosphorylated, pho) and pmrA-pmrB (polymyxin resistance, pmr), which can be found in a 
wide variety of bacterial species, including E. coli, Salmonella Typhimurium, A. baumannii, 
P. aeruginosa, K. pneumoniae and Citrobacter rodenium (Chen & Groisman, 2013). As 
described below, it is now recognized  that specific mutations in both pmrAB and phoPQ 
systems contribute to constitutively activated pmrA and phoP, resulting in the upregulation of 
arnBCADTEF and pmrCAB, and a high level of LPS modification with PEtA and Ara4N, 
mediating polymyxin resistance (Olaitan et al., 2014, Poirel et al., 2017)(Fig. 1.4). 
     (i) pmrA-pmrB system: The two-component system pmrA-pmrB, first identified in S. 
Typhimurim, consists of the response regulator PmrA and its cognate sensor PmrB. The 
mechanism of polymyxin resistance mediated by the pmrA-pmrB system, is to modify the 
LPS core and lipid A region with L-Ara4N and PEtN addition (Gunn et al., 1998, Gunn, 2001, 
Zhou et al., 2001, Lee et al., 2004). Two loci arnBCADTEF (also known as pmrHFIJKLM) 
and pmrE (previously identified as pagA or ugd, encoding a UDP-glucose dehydrogenase) 
(Gunn et al., 1998),  are responsible for the biosynthesis and transportation of L-Ara4N to the 
lipid A, and deletion of these genes can cause 60 plus-fold decrease in resistance to 
polymyxin (Gunn, 2001, Falagas et al., 2010). The activation of this system is triggered by 
high concentrations of polymyxins, Fe3+ or low pH, which are sensed by PmrB. In response 
to high Fe3+, PmrB autophosphorylates by binding Fe3+ in an iron-binding motif and then 
activates the expression of pmrA, a regulator of arn operon. Once activated, phosphorylated 
PmrA triggers the activation of the arnBCADTEF, resulting in the addition of L-Ara4N to the 
1’- or 4’-phosphate group to lipid A (Mitrophanov et al., 2008). This modification decreases 
!
 
17!
the net charge from about -1.5 to 0. The pmrAB system can also enhance the addition of PEtN 
to lipid A by activating the pmrCAB operon (Fig.1.4), which consists of three proteins: 1). 
PEtN phospotransferase, PmrC (often referred as EptA), 2). A regulator, PmrA; and 3). A 
sensor kinase, PmrB. The addition of cationic PEtN decreases the net charge from -1.5 to -1 
(Nikaido, 2003). Because of the nature of charge alteration, the efficiency of L-Ara4N 
addition probably is higher than that of PEtN addition (Nikaido, 2003, Olaitan et al., 2014).   
In addition, pmrA-regulated genes including eptB, eptC (Salazar et al., 2017), pmrR 
(Nowicki et al., 2014) and lpxR (which deacylates lipid A)(Reynolds et al., 2006, Olaitan et 
al., 2014), have been identified as modifying the structure of LPS and thus altering the levels 
of  bacterial resistance to AMPs (Fig.1.4). For example, EptB and EptC belong to the PEA 
transferase family identified in E. coli, EptB catalyzes the addition of PEtN to the kdo 
(Olaitan et al., 2014), while EptC promotes resistance to polymyxin by decoration of PEtN of 
the LPS inner core (Salazar et al., 2017). A pmrA-activated membrane peptide, PmrR, has 
been reported to inhibit the activity of LpxT (Kato et al., 2012), a kinase responsible for the 
transfer of a phosphate group (Und-PP, undecaprenyl pyrophosphate) to the 1’-phosphate 
group of lipid A (Touze et al., 2008). The inhibition of LpxT leads to regeneration of the 
undecaprenyl phosphate (Und-P) which forms a phosphorylated lipid A, thereby decreasing 
the negative charge of bacterial surface and ultimately reducing the affinity to polymyxins 
(Herrera et al., 2010, Kato et al., 2012). 
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Fig. 1.4 Diagram of the regulations of three putative two-component systems, phoPQ, pmrAB and crrAB, responsible for polymyxin resistance in Gram-
negative bacteria (updated from (Chen & Groisman, 2013, Olaitan et al., 2014)).
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Fig.1.4 (legend continued) Environmental stress signals such as high concentrations of polymyxins 
and low Mg2+ can trigger the phosphorylation of the sensor PmrB and PhoQ, respectively. The former 
can activate its cognate PmrA, once induced, several lipopolysaccharide-modifying genes including 
arn operon and pmrABC operon are activated by phosphorylated pmrA (see main text). The activation 
of the latter phoQ-phoP system can trigger arn operon directly in some K. pneumoniae or indirectly 
via the activation of PmrD, which in turn activates pmrA. In addition, the activated PhoP in 
Salmonellae can trigger other gene such as pagL, pagP, and lpxO, which can further modify lipid A 
through the removal of a 3-hydroxymistate, the addition of palmitate and 2-hydroxymyristate, 
respectively (Miller & Mekalanos, 1990). The mgrB exerts negative feedback on the phoQ-phoP 
system. Therefore, mutations in mgrB lead to constitutive induction of the phoQ-phoP system.  
Finally, the third two-component system, CrrAB, consists of a regulator CrrA and its activator CrrB. 
It has been proposed that the crrB can repress the expression of crrC, acting as a connector between 
crrAB system and arn operon. The mutations in crrB lead to the over-expression of crrC, which in 
turn up-regulates both arn and pmrABC operons and eventually modifications of lipid A.  Black 
arrows indicate positive regulation of LPS-modifying genes. In addition, the mechanism of mcr-like 
genes is also added in this figure, MCR proteins catalyse the transfer of PEtN to the phosphate group 
of lipid A (Liu et al., 2015). 
 
  (ii) phoP-phoQ system: In the PhoP-PhoQ system, PhoQ is a sensor kinase that 
phosphorylates its cognate regulator, PhoP. The activation of PhoQ is initiated during growth 
in limited Mg2+, and an array of genes such as pmrD and pmrAB-regulated genes encode gens 
that are involved in modifying the structure of LPS (Nikaido, 2003). Upon activation, the 
phosphorylated PhoP directly activates the arnBCADTEF operon by binding its promoter, or 
indirectly via activating expression of PmrD protein (Mitrophanov et al., 2008). PhoP-
activated pmrD gene acts as a connector by creating regulatory links between the two-
component systems: one is downstream of the phoP-pmrQ system, and the other is upstream 
of the pmrA-pmrB system. PmrD stabilizes the phosphorylated state of PmrA by binding 
phosphorylated PmrA at the N-terminal domain, preventing PmrA de-phosphorylation by its 
cognate sensor PmrB (Gunn, 2001, Kato & Groisman, 2004, Falagas et al., 2010). As a result, 
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phosphorylated PmrA promotes the transcription of the arn operon that mediates the 
synthesis and addition of L-AraN4 to lipid A. 
Additionally, the PhoP-PhoQ system is the major mechanism for polymyxin resistance in 
Salmonellae (Ernst et al., 2001), the expression of phoP can simultaneously change the 
activation of more than 40 genes, termed PhoP-activated genes (pag) or PhoP-repressed 
genes (prg), respectively (Miller & Mekalanos, 1990, Guo et al., 1997). The pagL gene 
encoding a lipid A 3-o-deacylase (Trent et al., 2001), has been found to promote resistance to 
polymyxin B in Salmonellae via catalyzing 3-o-deacylation of lipid precursors (Guo et al., 
1997, Kawasaki et al., 2007). Another pag gene, pagP, has been showed to increase lipid A 
acylation, leading to AMPs resistance in Salmonellae. This observation has been further 
confirmed by mutations in pagP, resulting in increased outer membrane permeability in 
response to several AMPs in Salmonellae (Guo et al., 1998, Ernst et al., 2001). Taken 
together, these results further suggest the important role of PhoP-activation in LPS 
modifications and polymyxin resistance. 
    (iii)The regulation of phoP-phoQ system:  mgrB gene, which encodes a 47 amino acid 
peptide and plays an important role in regulating the transcription of the PhoP-PhoQ system 
(Lippa & Goulian, 2009). MgrB is a membrane protein with its N-terminus in the cytoplasm 
and C-terminus in the periplasm, which interacts directly with the periplasmic sensor domain 
of PhoQ. mgrB acts as a mediator in the negative feedback loop of the PhoP-PhoQ circuit that 
is prepressed by mgrB overexpression, and PhoQ inhibits PhoP phosphorylation (Lippa & 
Goulian, 2009). Inactivation or down-regulation of MgrB has been reported to be associated 
with colistin resistance in K. pneumoniae (Cannatelli et al., 2013, Cannatelli et al., 2014, 
Poirel et al., 2015). mgrB alterations, can occur either by mutations resulting in amino acid 
substitutions (Olaitan et al., 2014, Cheng et al., 2015, Poirel et al., 2017), importation of 
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insertion sequences (Cannatelli et al., 2014, Cannatelli et al., 2015, Jayol et al., 2015, Poirel 
et al., 2015), or insertion or deletion of small nucleotide sequences in the mrgB gene (Giani et 
al., 2015). Such inactivation of mgrB facilitates the up-regulation of the phoP-phoQ operon, 
subsequently activating the arnBCADTEF operon and leading to the LPS modification with 
L-Ara4N responsible for colistin resistance. mgrB-mediated colistin resistant bacteria had 
fully restored susceptibility to colistin, once acquired a functional mgrB gene (Fig.1.4) 
(Poirel et al., 2015). mgrB mutations appear to be the most common colistin resistance 
mechanism found in Klebsiella, and this mgr-mediated colistin mechanism so far has not 
been found in other bacteria (Poirel et al., 2017). 
    (iv) crrAB system:  A third two-component system, crrAB (Colistin Resistance Regulation, 
crr), has been reported to be associated with colistin resistance in K. pneumoniae. The crrAB 
system is present in most K. pneumoniae, but not in E. coli (Wright et al., 2015, Jayol et al., 
2017). The CrrAB system consists of a histidine kinase CrrB and an adjacent response 
regulator CrrA. Six specific amino acid substitutions (Q10L, Y31H, N141I, P51S, L94M and 
S195N) in CrrB have shown to be responsible for mediating high-level colistin resistance by 
inducing the expression of crrC, which acts as a connector between arnBCADTEF operon 
and the  crrAB system (Wright et al., 2015, Cheng et al., 2016). Inactivation of the ccrB gene 
elevates the expression of connector gene ccrC, followed by the up-regulation of 
arnBCADTEF operon and pmrC. This leads to the production of L-Ara4N and PEtN, 
consequently, mediating an increased colistin resistance. 
1.3.1.2 Other species-specific colistin resistance mechanisms 
    (i) The loss of LPS: The disruption of LPS biosynthesis is known to play a significant role 
in colistin resistant A. baumannii. Mutations or insertional inactivation of the first essential 
genes for lipid A biosynthesis, lpxA, lpxC, or lpxD, leads to loss of the ability to produce lipid 
!
 
22!
A (Moffatt et al., 2010, Moffatt et al., 2011). Because the initial target of colistin is lipid A, 
LPS deficient A. baumannii results in loss of colistin binding ability to its bacterial outer 
membrane, and consequently yields high-level colistin resistance (MIC>128 mg/l). pmrAB 
mutation is another colistin mechanism found in A. baumannii (Arroyo et al., 2011). Both 
these colistin resistance mechanisms confer a noticeable biological cost observed by striking 
reduction of bacterial fitness and virulence in murine infection models (Beceiro et al., 2014, 
Wand et al., 2015). Unsurprisingly, the fitness burden of lpx mutant strains are significantly 
higher than that of pmrB mutant strains. 
    (ii) Efflux pumps: Colistin was primarily used to treat lung infections caused by P. 
aeruginosa in patients afflicted with cystic fibrosis (Littlewood et al., 1985, Valerius et al., 
1991). The efflux pumps, mexAB-oprM are involved in developing tolerance to colistin in P. 
aeruginosa (Pamp et al., 2008). P. aeruginosa mexAB-oprM knock-out mutants have restored 
colistin sensitivity and its complementary strain exhibited a significant increase in colistin 
tolerance. (Breidenstein et al., 2011). 
    (iii) Production of the capsule polysaccharide (CPS) in K .pneumoniae:  K .pneumoniae 
is able to release anionic CPSs, which is a crucial pathogenic factor for K. pneumoniae, and a 
variety of chemical compositions of CPSs have been identified in K .pneumoniae (Cortes et 
al., 2002). It has been shown that CPS is associated with LPS by an ionic interaction (Fresno 
et al., 2006). In Llobet’s study in 2008, purified CPS from K .pneumoniae increased the 
bacteria survival and MIC of polymyxin B for an unencapsulated K. pneumoniae mutant. It 
has been speculated that CPS would act as a protective shield on the bacterial surface by 
trapping cationic polymyxins, resulting in reducing the amount of free polymyxins reaching 
the bacterial outer membrane and ultimately mediating resistance to polymyxins (Campos et 
al., 2004, Llobet et al., 2008).   
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    (iv) Role of porins: OmpD/NmpC, which belong to a member of the trimeric β-barrel 
outer membrane general porin family, has been shown to contribute to polymyxin B 
resistance in S. enterica (Pilonieta et al., 2009). In this study, the authors data showed that the 
gene, ydeI, which encodes an oligosaccharide/oligonucleotide binding-fold (OB-fold) 
periplasmic protein has an interaction with OmpD/NmpC and thus mediates colistin 
resistance. This suggests that the OB-fold protein, YedI, can protect bacteria from cationic 
polymyxins in connection with the general porin, OmpD. In addition, a second OB-folding 
protein, YgiM, and the porin, OmpF, also have been confirmed to confer to resistance to 
polymyxin B.  
 
1.3.2 Plasmid-mediated colistin resistance 
In November 2015, the first discovery of a mobile colistin resistance gene (mcr-1) was 
reported in food animals, food and humans from China (Liu et al., 2015), shortly after, mcr-1 
was identified in more than 40 countries across five continents (Fig.1.5). The discovery of 
mcr-1 attracted worldwide attention, due to it further limiting treatment options in humans. A 
recent study indicated that the emergence of mcr-1 is likely to be linked with antibiotic 
exposure, suggesting that the reduction of colistin use in food-producing animals would, 
potentially, be an effective way to minimize the further emergence and spread of colistin 
resistant E. coli (Wang et al., 2017). In order to control colistin consumption in agriculture, 
the Chinese government has banned colistin as an animal food additive and switched colistin 
to human therapy in 2017 (Walsh & Wu, 2016). Subsequently, the European Medicine 
Agency re-evaluated their advice on the use of colistin products in animals in the European 
Union, and aims to reduce the use in animal by 65% in next few years (EMA, 2016). 
!
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Fig.1.5 Global distribution of mcr-like genes (mcr-1, -2, -3, -4, -5, -6, -7 and mcr-8). This map shows the countries (n=43) that have reported 
plasmid-mediated colistin resistance conferred by mcr- genes, updated from (Giamarellou, 2016, Al-Tawfiq et al., 2017, Ellem et al., 2017, Yin 
et al., 2017, AbuOun et al., 2018, Alba et al., 2018, Eichhorn et al., 2018, Garcia et al., 2018, Wang et al., 2018, Wang et al., 2018, Wise et al., 
2018, Yamaguchi et al., 2018, Yang et al., 2018).
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A retrospective study indicated that the mcr-1 gene was circulating in the 1980s, when 
colistin was firstly introduced in veterinary medicine as a food additive and curative 
treatment in food-producing animals in China (Shen et al., 2016). mcr-1 has been identified 
both in strains obtained from livestock and clinical human patients, but the detection rates of 
mcr-1 in livestock is markedly higher than that in human patients (Gao et al., 2016, Health, 
2016, Quan et al., 2017). Worryingly, mcr-1 (and other variants) have been shown to coexist 
with other MDR genes, including genes encoding NDM-1 (Wang et al., 2017) and  ESBLs 
(Kluytmans, 2017), highlighting the possibility that pan-drug resistance is now emerging. 
Following the detection of mcr-1, a number of distantly related mcr-variants, mcr-2 (Xavier 
et al., 2016), mcr-3 (Yin et al., 2017), mcr-4 (Carattoli et al., 2017) and mcr-5 (Borowiak et 
al., 2017) genes were detected and added to the list of mobile PEA transferases conferring 
colistin resistance in Enterobacteriaceae. The amino acid sequence identity among these 
MRC-variants are distinct from each other (33.71%-44%), except for MCR-1 and MCR-2, 
which show an 81.23% amino acid sequence identity. Nevertheless five residues (E246, T285, 
H395, D465 and H478) that are hypothesized to be critical for substrate binding and MCR-
mediated colistin resistance, are conserved in all MCR-variants (Borowiak et al., 2017, 
Coates et al., 2017, Hinchliffe et al., 2017). It is believed that Moraxella species has acted as 
a potential reservoir of mcr-1 and mcr-2 (Gao et al., 2016, Kieffer et al., 2017), while mcr-3 
and mcr-4 align closely to PEA transferases originating from Aeromonas species (Yin et al., 
2017) and Shewanella frigidimarina (Carattoli et al., 2017), respectively. While the new mcr-
5, first discovered in Salmonella enterica, shows high similarity to PEA transferases from 
Proteobacteria and Pigmentiphaga species (Borowiak et al., 2017). Most recently, three new 
MCR homologs, MCR-6 (AbuOun et al., 2017), MCR-7 (Yang et al., 2018) and MCR-8 
(Wang et al., 2018), were detected on the chromosome of Moraxella pluranimalium, in an 
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IncI2 plasmid recovered from K. pneumoniae, and an IncFII plasmid from K. pneumoniae, 
respectively. 
 
1.3.2.1 Global spread of mcr-like genes 
Colistin resistance serves as an interface between human and animal health, because 
colistin has been used in both human and veterinary medicine for more than 50 years, 
although their usage in human patients had been limited due to its nephrotoxicity and 
neurotoxicity (Falagas et al., 2010). Whereas, colistin is widely used in veterinary medicine 
(particularly in China and SE Asia), especially for therapeutic treatment of gastrointestinal 
infections caused by GNB in pig and poultry populations. Polymyxins, mainly colistin, were 
the 5th highest group of antimicrobials sold for agriculture use in Europe in 2013, and the 
level of colistin usage ranged from below 1 mg/PCU such as in Denmark and the UK, up to 
20-25mg/PCU in Italy and Spain (Health, 2016). As noted by Liu and colleagues, China was 
one of the world’s highest users of colistin in agriculture, and eight out of top ten largest 
colistin producers are Chinese, the remaining two colistin producers are Indian and Danish. 
Until recently, China produces 71.1% of the world’s colistin exporting 28.7% including to 
Europe. The heavy use of colistin in food-producing animals in Asia have resulted in a 
selective pressure in the farming sector and environment, and ultimately an outbreak of mcr-1 
positive E.coli (MCRPEC). Unlike chromosomal-mediated colistin resistance, mcr genes are 
located on plasmids, which are efficient vehicles for the dissemination of antibiotic resistance 
and virulence genes among Enterobacteriaceae. The initial description of mcr-1-bearing 
plasmids had the IncI2 exclusion determinant, subsequently, genetic and sequencing revealed 
that plasmid-borne mcr-genes have been observed in at least 14 different plasmid backbones 
possessing different replicon incompatibilities, including IncFII, IncX4, IncX3, IncX1-X2, 
IncHI2, IncHI1 and IncP plasmids (Matamoros et al., 2017, Wang et al., 2017, Sun et al., 
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2018). It has been estimated that mcr-1-harbouring plasmids is highly transferrable with an in 
vitro transfer frequency as high as 10-1-10-4. A continuously increasing trend of mcr-1 gene 
positive strains isolated from chicken samples has been found in China, with positive rates 
rising from 5.2% in 2009 to 30% in 2014 (Shen et al., 2016).  Besides China, a high 
prevalence of mcr-1 has been circulated in Vietnam, where nine MCRPEC were identified 
from 24 (37.5%) blaCTX-M containing E.coli isolated from food animals (Malhotra-Kumar et 
al., 2016). In France, the dissemination of mcr-1 in commensal E. coli isolated from livestock 
were detected, with a prevalence rate ranging from 0.5% found in pig samples to 5.9% from 
turkeys.  However, it is difficult to estimate the exact prevalence of mcr-1 genes, as mcr-1 
screening from most of the current studies are from colistin resistant isolates, and the 
prevalence of mcr-1 has almost certainly been underestimated. Interestingly, from the study 
by Thanh et al., an inactive form of mcr-1 gene blocked by a 22-bp tandem repeat has been 
identified in the human pathogen Shigella sonnei under antibiotic-free selection (Thanh et al., 
2016). However, upon colistin exposure, the mcr-1 gene could restore its activity via deletion 
of one copy of the 22-bp repeat, resulting a high-level colistin resistance (32 mg/l). This 
inactivated form of MCR-1 may explain the reason that some isolates are positive by PCR 
but not phenotypically resistant to colistin.  
Unlike the worldwide spread of mcr-1-producing Enterobacteriaceae in food animal 
samples (Malhotra-Kumar et al., 2016, Schrauwen et al., 2017, Wang et al., 2017), the 
prevalence of other mcr-like genes, mcr-2, -3, -4, -5, -6, -7 and mcr-8, is sporadic and low 
(Fig. 1.5). mcr-2 has been firstly identified in E.coli (Xavier et al., 2016) and Salmonella 
isolates (Garcia-Graells et al., 2018) from European countries,  but recently, it has been found 
in human vaginal swabs in from China (Zhang et al., 2018). In Xavier and colleagues study, 
the prevalence of mcr-2 in porcine colistin resistant E.coli (11/53) in Belgium was higher 
than that of mcr-1 (7/53) (Xavier et al., 2016). In Belgium,  mcr-2 has also been found in 
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Salmonella isolated from food at retailers but its occurrence is very low (1/105) (Garcia-
Graells et al., 2017). Variants (mcr-2.2) with 87.9% nucleotide identity with mcr-2 were 
detected in Moraxella species isolated from healthy pigs at slaughter in the UK. The 
downstream genetic context of mcr-2.2-pap2 was conserved with eptA and mcr-1-like genes 
in Moraxella species, further suggesting that Moraxella species may act as a reservoir of mcr-
1 and mcr-2 genes (AbuOun et al., 2017, Poirel et al., 2017). This phenomenon is consistent 
with a new mcr-variant, mcr-4, which was first identified in Salmonella enterica and E. coli 
obtained from pigs in Europe (Carattoli et al., 2017). Surprisingly, mcr-3 and mcr-5 have 
been reported in E. coli obtained from pigs in Japan, with detection rates of 8.3% (10/120) 
and 28.3% (34/120), respectively (Fukuda et al., 2017). In this study, it stated that the co-
occurrence of mcr-1 and mcr-5 has an addictive effect with higher level of colistin resistance 
(MIC>16 mg/l), compared to strains carrying single mcr-genes (MIC 2mg/l or 4mg/l). The 
prevalence of mcr-3 gene has been determined in Asia, including China, (Yin et al., 2017), 
Japan (Fukuda et al., 2017) and Thailand (Wise et al., 2018); Europe including Denmark 
(Roer et al., 2017), Spain (Hernandez et al., 2017) and France (Perrin-Guyomard et al., 2016). 
mcr-4 (Carattoli et al., 2017) and mcr-5 (Borowiak et al., 2017) are first found in E.coli and 
Salmonella isolates from Europe, respectively, and further detected in Asia, including 
Thailand (Wise et al., 2018), Singapore (Teo et al., 2018) and Japan (Fukuda et al., 2017) 
(Fig.1.5). 
   In contrast with a much higher prevalence of mcr-1 detected in animal samples, especially 
in Asia, it has been shown that mcr-1 has so far only been found sporadically in humans with 
low detection rate (<1%) in both Asia and Europe (EMA, 2016). For instance, in a four-year 
cross-sectional study in Spain, the overall prevalence of colistin-resistant clinical isolates was 
as low as 0.67% (91/13579), and the mcr-1 gene was only identified in one E.coli, strain and 
no mcr-2 was detected (Prim et al., 2017). The overall prevalence of mcr-producing (mcr-1 
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and mcr-2) Enterobacteriaceae strains from human UTIs in Switzerland was also very low 
(0.05%) (Liassine et al., 2016). It might be because of the limited use of colistin for the 
treatment of community-acquired infections therefore limiting the selective pressure for the 
emergence of MCR-1-producing bacteria. Although the detection rate of mcr-1 in humans is 
still rare when compared to the higher abundance of mcr-1 gene in animals, the finding of 
mcr-1 gene in Enterobacteriaceae from patients with severe infections, highlights the risk of 
increasing co-resistance in pathogens causing difficult-to-treat infections in hospitals. It has 
been hypothesized that mcr-1 originated from animals, due to their extensive use of colistin 
on the animals, and subsequently transferred to humans (Al-Tawfiq et al., 2017, Wang et al., 
2018). The major host of mcr-1 gene, E. coli, is a part of the normal human intestinal 
microbiome, but also a common cause of urinary tract and bloodstream infections world-wide. 
It has been reported that the mcr-1 gene was detected in E. coli from human bloodstream 
infections and human gut microbiota (Hasman et al., 2015). In Wang’s report, 76/91 (83.5%) 
mcr-1 positive isolates were E.coli, followed by K. pneumoniae (13/91, 14.3%), indicating 
that E. coli is responsible for the substantial horizontal dissemination of mcr-1. A variety of 
sequence types (ST) including the most virulent, ST131 clone, were found among MCRPEC 
(Wang et al., 2017). ST131 is a worldwide pandemic clone, which potentially harbors a broad 
range of virulence and resistance genes, and the link between mcr-1 gene and ST131 clone is 
concerning. Moreover, the mcr-1 gene has also been detected in ESBL- and carbapenemase-
producing E. coli isolated from human wound infections (Falgenhauer et al., 2016). These 
XDR/PDR pathogens are of special concern, as very few antibiotics are left to treat life-
threatening infections. Apart from mcr-1, mcr-3 gene also has been found in clinical strains 
(Litrup et al., 2017, Liu et al., 2017), and chromosomal-linked mcr-5 has been found in a P. 
aeruginosa strain from a patient from United States (Snesrud et al., 2018). However, mcr-2, -
4, -6, -7 and mcr-8, have not been reported in patients. Most recently, a high prevalence of 
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mcr-1 gene ranging from 3.7% to 32.7%, was determined from human samples from 30 
provinces in China (Shen et al., 2018). In Shen et al. report, mcr-1 is already disseminating in 
the community, which posts a great concern for the usage of colistin in clinical treatment, In 
addition, the high abundance of mcr-1 gene in some provinces are closely associated with 
higher aquaculture industries, suggesting that the complex interface between human, 
environment and food-producing animals (Shen et al., 2018) (Fig.1.6). 
Taken together, the prevalence of mcr-like genes in both animal and human samples are 
varied; the mcr-1 gene is most prevalent, followed by mcr-3. It is speculated that the origin of 
mcr-1 gene is from the animal world, supporting by the following evidence: i) in contrast 
with only some scattered reports of mcr-1-producing isolates obtained from humans, a much 
higher prevalence of mcr-1 gene has been identified worldwide from animals and animal 
products including pigs and piglets, chickens and chicken meat, cattle and turkeys. ii) 
polymyxins have been widely used in veterinary medicine as growth promoter/food additive 
or disease treatment. Retrospective data shows that mcr-1 increased dramatically in China, in 
2008/9 coinciding with the increase in colistin usage at exactly the same time (Shen et al., 
2016). iii) The genetic features of mcr-1 also support the hypothesis of animal origin for mcr-
1. For instance, mcr-1 is often associated with the insert region ISAPI1, which was identified 
in a common animal pathogen, Pasteurella multocida. As the use of colistin in human 
infections is increasing, the spread of mcr-like genes may be largely underestimated, 
suggesting that prospective epidemiological surveys are needed, and the association between 
various ‘hot spots’ of MCR-producing microbiotas need to be further explored (Fig.1.6).   
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Fig.1.6 Schematic representation of complexity of the transmission pathways of mcr-like 
genes between human, animals, food and the environment. mcr-like genes have been detected 
in all sections shown in this figure, including human (Liassine et al., 2016, Zhang et al., 
2018), animals (Fukuda et al., 2017) (Shen et al., 2016), wastewater (Lekunberri et al., 2017), 
soil (Zheng et al., 2017), blowflies (Zhang et al., 2018), vegetables (Luo et al., 2017) and 
meat products (Nishino et al., 2017, Yi et al., 2017). Light green arrows show major selective 
pressure of the emergence of mcr genes. The various reservoirs of mcr- genes are indicated 
by black arrows (updated from (Rhouma et al., 2016)). 
 
1.3.2.2 Mechanism of mcr-1 mediated colistin resistance  
    Generally, the mechanism for colistin resistance is associated with the decrease in 
membrane affinity for polymyxins by the modification of LPS, as described above. Plasmid-
borne mcr-1 represent a novel transferable mechanism for colistin resistance. MCR-1 acts as 
a membrane-anchored enzyme that catalyses the transfer of phosphoethanolamine to the head 
group of lipid A, ultimately resulting in the reduced polymyxin affinity of the bacterial outer 
membrane (Liu et al., 2015, Gao et al., 2016, Hinchliffe et al., 2017). Therefore, the colistin 
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resistance mechanism mediated by the plasmid-borne mcr-1 is similar to the chromosome-
encoded two-component systems (pmrAB and phoPQ) (Gunn et al., 1998, Olaitan et al., 
2014). Structural analysis of MCR-1 shows that it is closely related to LptA (LPS PEA 
transferase A, also referred as EptA), which is intrinsically responsible for polymyxin 
resistance in Neisseria via addition of PEA to 1’ and 4’ head groups of lipid A (Fig.1.5) 
(Wanty et al., 2013, Liu et al., 2015). Despite the fact that plasmid-borne mcr-1 and 
chromosomal-encoded lptA share very low DNA sequence identity, phylogenetic analysis 
suggests that both mcr-1 and lptA are highly homologous to the PEtN lipid A transferase 
family, and fall into two different subclades (Gao et al., 2016). Both mechanisms of colistin 
resistance mediated by mcr-1 and lptA are associated with the modifications of lipid A that 
decrease colistin affinity for LPS, but their regulation systems seem to be different: the 
expression of lpxA is influenced by pmrAB (Fig.1.4), whereas the pathway or regulation of 
plasmid-borne mcr-1 is not yet fully understood. In comparison with chromosomal resistance 
genes mediating vertical distribution of colistin resistance, the plasmid-borne mcr seems to be 
a more effective mechanism for colistin resistance to mobilise horizontally. Most intriguingly, 
just within the space of a few months after its first discovery, mcr-1 had been reported around 
the world testimony to  the strength of whole genome sequencing and publicly available 
sequence databases, even if those same databases did not originally recognise it as a PEA 
transferase demonstrating the frailty of DNA databases  (Skov & Monnet, 2016).  
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Fig.1.7. Phosphoethanolimine transfer to lipid A by MCR-1 mediating colistin resistance. MCR-1 
catalyses transfer of phosphoethanolamine from a phosphatidylethanolamine donor substrate onto 
lipid A with 1’or 4’-phosphate position.  
 
1.3.2.3 Structural mechanism of lipid A PEA transferases conferring colistin resistance  
        Plasmid-encoded MCR-1 protein is an integral membrane protein, consisting of a trans-
membrane domain anchoring the enzyme to the periplasmic space of a soluble catalytic 
domain. It has been shown that removal of the transmembrane domain from MCR-1 protein 
can restore colistin susceptibility in recombinant E .coli, suggesting that MCR-1 
transmembrane domain anchoring of its soluble domain is required for MCR-1 catalytic 
activity (Gao et al., 2016).  So far, the structures of the soluble domain of three different 
colistin-resistance associated PEA transferases: MCR-1 from E .coli (Hinchliffe et al., 2017), 
EptA (also labelled as LptA) from Neisseria meningitidis (Wanty et al., 2013) and EptC from 
Campylobacter jejuni (Fage et al., 2014), have been determined. The crystal structures of 
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MCR-1 have been further examined following substitutions of five putative conserved sites in 
the catalytic domain of MCR-1 protein (E246, T285, H395, D465, and H466) that are 
essential for its function and all were found to induce significant reductions in the MIC of 
colistin (Gao et al., 2016, Hinchliffe et al., 2017). These results indicate that both 
transmembrane and soluble domains are critical for catalytic activity of MCR-1. The former 
would be required to enable the MCR-1 enzyme to correctly localize in the outer membrane 
and orientate the binding of substrates (Wanty et al., 2013); the latter contains the catalytic 
nucleophile (T285) essential for PEA transfer (Gao et al., 2016, Hinchliffe et al., 2017). The 
structure of the MCR-1 catalytic domain reveals that the MCR-1 enzyme is a zinc 
metalloproteinase with an alkaline phosphatase/sulphatase-fold containing three disulphide 
bonds. Zinc ions are present in the active site and associated with T285, which is a 
phosphorylated form of the putative nucleophile. Zinc deprivation can restore colistin 
susceptibility in MCR-1-producing E. coli demonstrating that the zinc is critical to MCR-1 
activity (Hinchliffe et al., 2017).  
 
 
Fig.1.8 Structure of MCR-1 catalytic domain. (A) putative organisation of MCR-1 showing five 
predicted membrane-spanning α-helices and the soluble periplasmic domain (residues 219–541) 
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crystallised here. (B) Overall fold of MCR-1 catalytic domain. Intramolecular disulphide bonds are 
labeled and metal centre (active site) is boxed. (C) Active site of P21 crystal form showing single 
bound zinc ion (grey sphere) and phosphorylation of Thr285. (D) Active site of P41212 crystal form 
showing dinuclear zinc centre and coordination of Zn2 by residue Glu300 (pink) from an adjacent 
molecule in the crystal lattice (cited from (Hinchliffe et al., 2017). 
 
 
    It has been proposed that the crystal structure of a full-length PEA transferase may 
facilitate our understanding of the lipid structure binding and catalysis. Very recently, 
structure of a full-length LptA protein has been determined (Anandan et al., 2017). This 
provides a model of its homologous PEA transferases such as MCR-1, and insights into the 
structural mechanism of lipid A modification by PEA addition. LptA structure also reveals 
that the helical transmembrane domain and periplasmic facing soluble domain are linked by a 
bridging helix that embeds in the outer membrane interacting with the phospholipid head 
group. Five transmembrane helices (TMH1-TM5) forming an aromatic belt, are predicted to 
be parallel to one another and span the inner membrane (Fig.1.6). There are a number of 
tryptophan, tyrosine and histidine residues observed in the transmembrane domain that may 
facilitate the stabilization and orientation of the protein in the bacterial membrane bilayer 
Fig.1.6D. TMH5 is connected to the soluble domain by an extended periplasmic loop 
followed by a helix structure. The full-length structure confirms that there is a ligand bond 
between the two domains, this kind of structural arrangement can efficiently sequester the 
catalytic site (Anandan et al., 2017).  The substrate binding pocket involves a soluble domain 
and two helices, PH2 and PH2’, which are linked with TMH3 and TMH4 on the membrane 
domain. In a recent study, two substrate-binding pockets were demonstrated in the MCR-1 
catalytic reaction, and addition of the PEA analog, ethanolamine, can restore bacterial 
susceptibility of polymyxin (Wei et al., 2017). These data suggests the crucial role of PEA- 
and lipid A-binding pockets in the action of PEA transferases mediating colistin resistance. 
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However, except the crystal structure of soluble domain of MCR-1(Hinchliffe et al., 2017) 
and MCR-2 (Coates et al., 2017), full-length MCR protein are still under explored. 
 
 
 
Fig.1.9 Molecular structure of full-length EptA from Neisseria meningitidis. In A, red and blue 
ribbons are represented the amino-terminal TM domain and the carboxylterminal soluble domain, 
respectively. The yellow spheres are indicated as the three TM domain tryptophan residues (Trp126, 
Trp148, and Trp207). In B, the putative orientation of the EptA protein relative to the periplasmic and 
cytoplasmic membrane is presented. C and D indicate the secondary structure of the soluble domain 
and TM domain with the helical numbering labeled, repectively. (E) Electrostatic surface 
representation of EptA, calculated using APBS. The bound Zn2+ ion in A and C is shown as an orange 
sphere (cited from (Anandan et al., 2017)) 
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1.4 Fitness costs of antibiotic resistance and compensatory evolution 
The actions of antibiotics interfere with bacterial normal physiological processes including 
cell wall synthesis, DNA replication, RNA transcription and protein synthesis. It is not 
therefore surprising that resistant mutants usually cause the perturbation of cellular activities. 
Any resistance mechanism seems to be an ‘equilibrium double-edge sword’: on one hand, it 
protects bacterium from antibiotics by altering antibiotic targets; but, on the other hand, it can 
potentially confer a biological cost, associated with diminished bacterial growth, increased 
survival and transmission inside or outside a host (Andersson & Levin, 1999, Andersson, 
2006) . It has been proposed that the high fitness cost of fosfomycin resistance may account 
for the low prevalence of E. coli clinical isolates from UTIs (Pourbaix et al., 2017). Both 
experimental and theoretical data suggest that the biological cost of resistance is a major 
determinant of resistance development and potentially reversibility. It has been proposed that 
the fitness-cost plays a significant role in limiting the emergence of antibiotic resistance.  
Ergo: the higher the fitness-cost, the slower the rate of resistance development, which would 
lead to a decreased proportion of resistant bacteria and perhaps even a disappearance from the 
population (Hughes & Andersson, 2015). Therefore, understanding bacterial fitness-cost is 
important to predict the development of MDR/XDR in different clinical settings, as well as to 
evaluate intervention to reduce resistance (Andersson, 2006).                                                                                                                                                                                                                                                               
1.4.1 The impact of trade-offs and constraints on adaptive evolution  
The fitness cost of antibiotic resistance can be compensated by either reversion (which is 
rare) or compensatory mutations. It has been long thought that because the deleterious fitness 
burden caused by antibiotic resistance, resistant bacteria may reverse back to antibiotic 
sensitivity or be out-competed by their ancestral susceptible bacteria. This theory raises the 
hope that the frequency of resistant bacteria will decrease through natural selection, and the 
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current problem caused by MDR/XDR bacteria would simply be solved in a reasonable 
amount of time (Andersson & Levin, 1999). However, there is increasing evidence 
suggesting that resistance mutations such as those found in bacteria isolated from patients, 
have evolved to ameliorate the bacterial fitness-cost imposed on them by antibiotic resistance. 
As a result, compensated-resistant bacteria would stabilize in the population, becoming less 
reversible to their ancestral susceptible phenotypes. Furthermore, in a computer simulation 
model, it has been suggested that mutation rates for intermediate-fitness compensatory 
mechanisms are higher than those for high-fitness revertants, probably because of larger 
mutational targets (Levin et al., 2000, Sommer et al., 2017).  As shown by theoretical 
modelling, bacteria carrying antibiotic resistance genes, which engender deleterious effects 
on bacterial fitness, subsequently evolved, by mutation with a moderate fitness burden, or 
even no fitness-cost in the absence of antibiotics, rather than reversion to complete antibiotic 
sensitivity (Bjorkman et al., 1998, Rozen et al., 2007, Pacheco et al., 2017). Compensatory 
mutations in Pseudomonas spp. carrying a MDR plasmid, RP4, has been found to increase 
plasmid permissiveness, because the fitness cost turned into a benefit after 600 generations 
(Andersson & Hughes, 2010). Another example of adaptive compensations has been 
examined by Sousa J et al. (de Sousa et al., 2017), who stated that double-resistant bacteria 
(an E. coli resistant to both streptomycin and rifapicin) compensate faster than those of 
single-resistant strains, more importantly, compensated mutations that only found in double 
resistance strains have strongly beneficial effects, observed by increased fitness. 
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Fig.1.10 the development and evolution of fitness burdens imposed by antibiotic resistances (updated 
from (Hughes & Andersson, 2015))  
 
1.4.2 Fitness cost of antibiotic resistance conferred by plasmids carrying AMR genes 
    In many cases, plasmids can carry beneficial genes like AMR genes to the host bacteria by 
enabling them to persist in hostile environments, e.g. protection against potentially lethal 
antibiotics. However, because plasmids are an extra-chromosomal genetic element presented 
in host cells, an additional metabolic burden would be imposed by intragenomic conflict 
between chromosomal genes and plasmids, which are prone to elimination from bacterial 
genomes in the absence of selective (antibiotic) pressure (Zielenkiewicz & Ceglowski, 2001, 
Yang & Walsh, 2017). Therefore, the acquisition of plasmids generally causes a fitness cost, 
associated with the replication and maintenance of the plasmids themselves within the host. 
In spite of this fitness loss, it can be alleviated over time through compensatory changes, the 
initial fitness burden associated with plasmid-bearing is the main constraint on the horizontal 
transferability and maintenance of these genetic elements in the host bacterium (San Millan 
40#
#
& MacLean, 2017). Generally, there are pleiotropic fitness effects of plasmids in their every 
life cycle in the host. For example, during the first phase of plasmid entry into a new host via 
conjugation, plasmid DNA transiently becomes single-stranded, which is the trigger for the 
bacterial SOS response. Conjugation-triggered SOS responses mediate the inhibition of cell 
division, which would cause bacterial slow growth and fitness loss, in a recent study, the loss 
of the conjugation region in the IncN antibiotic resistance plasmid pKP33, reduced the fitness 
cost in E. coli (Porse et al., 2016). It has been proposed that the plasmid-encoded replication 
initiation proteins, which control the plasmid copy number, are responsible for a fitness loss. 
Initiation of plasmid replication play a crucial role in the maintenance of plasmids, such that 
they must keep producing enough copies to allow their distribution to all daughter cells after 
cell division.  Thus, more DNA polymerases and helicases are needed to process plasmid 
replication from the bacterial host. Over-producing plasmid replication proteins therefore 
would cause energetic exhaustion of the host leading to disruption of the efficiency of cellular 
DNA replication machinery, inducing stress responses and ultimately inhibiting cell division 
(Wegrzyn & Wegrzyn, 2002). This deleterious effect has been observed in bacteria carrying 
multi-copy plasmid pNUK73 in P. aeruginosa (San Millan et al., 2014, San Millan et al., 
2015) and pQBR103 in E. coli (Harrison et al., 2015). However, there is a conflict between 
plasmid-bearing fitness-cost and the widespread occurrence of plasmids in environmental or 
clinical bacteria, suggesting that some mechanisms contributing to plasmid stabilization 
and/or ameliorating the fitness-costs, would may explain this plasmid paradox. Genes 
involved in the genetically expensive conjugative process are tightly self-regulated. It has 
been found that the plasmid compensatory evolution repeatedly targeted to the a global 
regulatory system, gacA/gacS, and its mutations may ameliorate the cost of plasmid carriage 
by relieving the translational demand imposed by the plasmids (Harrison et al., 2015, 
Harrison et al., 2016). In the Dahlberg and Chao study, in spite of initial fitness cost, 
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plasmids R4 and RP4, were persistent and the fitness-cost of the plasmids was reduced by 
compensatory evolutions through changes in both plasmids and bacteria (Dahlberg & Chao, 
2003). Moreover, evolved plasmids no longer imposed a cost on their host when transferred 
to a plasmid-free ancestral E. coli (Dahlberg & Chao, 2003, Dionisio et al., 2005), indicating 
that even with the reduction of antibiotic use, plasmid-mediated AMR can still persist in 
bacterial populations (Lopatkin et al., 2017).   
1.4.3 Assessing horizontal evolution of resistance under the perspective of bacterial 
fitness 
On the basic knowledge we have today on the evolution of resistance genes (here we 
mainly focus on plasmids-mediated resistance, which is a particularly common genetic route 
to emerge antibiotic resistance in clinical relevant bacteria), the risk assessments of the 
acquisition of gene that confers antibiotic resistance would be of great importance in 
predicting future emergence and development of AMR and therefore guiding therapeutic 
choices. Several parameters that affect HGT (horizontal genetic transfer) need to be 
considered, including genetic characteristics of plasmids (such as some plasmids have broad 
host range and can transfer across species, whereas others have a much narrower host range) 
(van Hoek et al., 2011); the frequency of HGT between relevant species, the fitness effects on 
the host following the acquiring of resistant plasmids, and gene expression that would 
mediate high-level antibiotic resistance to clinical pathogen (Fig.1.11) (Sommer et al., 2017).  
All of these parameters can be experimentally determined to provide a rational assessment of 
the risk of the evolution, transmission and maintenance of resistance (Fig.1.11). 
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Fig.1.11 Methods summary for the experimental assessments of the risk of bacterial resistance 
A. generating resistant bacteria in vitro: antibiotic resistant bacteria can be evolved by challenging 
with an increasing concentrations of antibiotics in agar plates. Any viable colony is further studied by 
its phenotypic and genotypic characterizations. 
B. magnitude of bacterial fitness: bacterial fitness can be measured by its growth rate in pure culture 
over time or by competitive fitness against the wild-type ancestral strains. The fitness differences 
between susceptible and resistant strains can be achieved by measuring their exponential growth rates. 
It is possible to discriminate differences of ~5% per generation (Andersson & Hughes, 2010). In a 
competition model (in vitro or in vivo), the susceptible and resistant strains are initially mixed at 1:1 
ratio and then are serial passaged through growth cycles, followed by measuring the changes in the 
ratio of both populations. It would be more sensible to discriminate fitness differences of 0.1% per 
generation, by using florescent-activated cell sorting with fitness-neutral fluorescent markers 
(Andersson & Hughes, 2010). Additionally, combination with epidemiological studies, fitness burden 
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conferred by antibiotic resistance can provide insights into real-life fitness over longer time periods in 
clinical and nature environments and prediction of dynamics and development of the resistance 
(Rossolini et al., 2010, Hughes & Andersson, 2015). Furthermore, compensatory adaptation also can 
be observed by laboratory experiments. Briefly, resistant bacteria are cultured in the fresh medium 
without antibiotics and then serial passaged every day. The changes in fitness can be detected 
quantitatively by measuring growth rate or competitive fitness as described above (B), and 
qualitatively by a change in colony size and resistance phenotype when bacteria are plated on 
selective agar plates (MacLean et al., 2010). Furthermore, any intragenetic/extragenetic changes 
responsible for compensated fitness can be confirmed by whole genomic sequence and targeted 
sequencing (MacLean et al., 2010, de Sousa et al., 2017). 
C. The game of gains and loses. The rate of gene transfer and the stability of the acquired resistance 
gene in the pathogen (the possibility of being lost?), can be measured by conjugation and serial 
passaging with or without selective pressure.  
 
    Taken together, the following is the summary of factors influencing bacterial fitness cost. 
    (i) Fitness cost can be compensated by different trajectories. There are substantial 
findings to suggest that the fitness-cost can be compensated without loss of resistance, by 
second-site mutations during the evolution of bacterial resistance in an experimental host or 
laboratory medium (Hall et al., 2010, Harrison et al., 2015). The differences in compensatory 
mutations and fitness cost were observed in the bacteria evolving through serial passages in a 
murine model and in a laboratory medium (Bjorkman et al., 2000). These data indicate that 
different growth conditions would affect the spectra of compensatory mutations. Bjorkman 
and colleagues provided an elegant example to show that the fitness-cost of resistance is 
compensated by different mutations under different growth conditions (Bjorkman et al., 
2000). In a S. Typhimurium strain with streptomycin resistance (SmR) caused by mutations in 
rpsL gene, the bacterial growth rate and the opportunity for compensated mutations to arise 
and evolve were similar in LB and the murine model. However, different spectra of 
compensated mutations were identified under both growth conditions: in LB-selective 
44#
#
conditions, all SmR strains contained extragenic mutations in either rpsD or rpsE, whereas all 
murine-selected mutants preferentially contained one specific intragenic compensatory 
mutation. The specific types of compensatory mutations observed in both LB and mice 
suggests that different evolutionary pathways are responsible for reducing the cost of AMR 
within and outside a host.  
    (ii) The genetic interactions (epistasis) can affect fitness cost. Since mutations that 
confer multiple AMR are known to impair bacterial fitness, the genetic interactions (epistasis) 
between resistance mutations may provide additional insight as to how bacteria cope with 
deleterious effects mediated by AMR (MacLean et al., 2010, Chou et al., 2011). Here, 
epistatic interactions describe how the bacterial fitness effects of a mutation depend on 
second mutations, usually in the core genome. Theoretically, if the epistasis is synergistic 
(when mutations are cumulative), then the cost of multiple AMR would be high and 
eventually resistant microbes will be eliminated in the absence of antibiotics (Khan et al., 
2011). Unfortunately, antagonistic epistasis (when mutations compensate each other’s 
fitness-cost), which would reduce fitness loss by interaction with resistance mutations, have 
been identified in MDR bacteria (Trindade et al., 2009, MacLean et al., 2010). In Trindade’s 
study, the majority of antagonistic epistasis has been identified in E. coli associated with the 
rpsL, rpoB and gyrA alleles, which confer resistance to streptomycin, rifampicin and nalidixic 
acid, respectively (Trindade et al., 2009). This specific genetic combination therefore 
alleviates the costs of double resistance, allowing the accumulation of resistant bacteria in the 
population. Another example of an epistasis effect on fitness is shown by second mutations in 
the genes, par and gyr, responsible for resistance to fluoroquinolones in Streptococcus 
pneumoniae (Rozen et al., 2007). Generally, single mutation in both par and gyr gene, cause 
low level resistance to fluoroquinolones in S. pneumoniae, associated with a fitness burden. 
Interestingly, with the addition of second mutation in par or gyr gene, a higher level of 
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fluoroquinolone resistance was observed without any fitness loss and even increasing the 
fitness (Rozen et al., 2007). Furthermore, the genetic linkage between resistance mutations 
are important to the fitness cost associated with its acquisition. One example is the fitness 
cost imposed by SmR in P. aeruginosa, which seems to depend on environmental and 
epistatic effects (Ward et al., 2009). In the absence of antibiotics, the cost of SmR mutants is 
greater in a rifampicin sensitive (RifS) P. aeruginosa, than those in a rifampicin resistance 
genetic background (RifR). In the presence of rifampicin, SmR mutants have no detectable 
costs in some RifR background, while massive fitness cost detected in others (Ward et al., 
2009). Taken together, the patterns of epistasis may differ from within- and between-gene 
networks during bacterial adaptations. 
    (iii) Some mutations are cost free by metabolic pathways. One largely accepted 
paradigm is that the acquisition of resistance is generally associated with a fitness cost, but 
there is always an exception. It has been reported that fitness costs depend on the mutation 
involved, with some of them occurring with no cost. For instance, the mutations in the β-
subunit of the rifampicin target enzyme, RNA polymerase, contributes to rifampicin 
resistance in Staphylococcus aureus,  with no measurable cost (O'Neill et al., 2006). It has 
been determined that overexpression of efflux pumps MexAB-OprM, MexCD-OprJ, or 
MexXY, responsible for AMR in P. aeruginosa, did not cause any fitness loss. In turn, 
metabolic changes including an increase in anaerobic nitrate respiratory chain when cells are 
under full aerobic environment, may serve as a feasible strategy to cope with the cost 
associated with the acquisition of AMR (Pacheco et al., 2017).  
    (iv) The cost of resistance to the same antibiotic can be different by alternative 
mechanisms. There are two main mechanisms of colistin resistance in A. baumannii, the 
PEtN modification of LPS regulated by a two-component system pmrAB (Mu et al., 2016), 
and the complete loss of LPS due to the mutations of LPS synthetic genes lpxACD (Moffatt et 
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al., 2010). Both mechanisms are associated with a noticeable fitness loss evaluated by the 
growth rates and competitive experiments in vitro (Beceiro et al., 2011, López-Rojas et al., 
2011) and in vivo (Lopez-Rojas et al., 2013), with LPS deficient conferring a higher fitness 
burden (Beceiro et al., 2014, Mu et al., 2016). It has been shown that the lpx mutant can be 
selected in one single passage on Mueller-Hinton agar supplemented with 10 mg/l of colistin 
sulfate, and the mutants usually confer high-level of colistin resistance (MICs>128 mg/l) 
(Beceiro et al., 2014). On the contrary, colistin-resistance strains with pmrAB-mutationts 
were generated from multiple passages with increasing concentrations of colistin and give 
rise to lower levels of colistin resistance. This may explain the higher fitness cost mediated 
by lpx mutations, with significant genetic and LPS structural changes in a single step. 
Moreover, pmrAB-mutants did not alter the susceptibility to other antibiotics, while the LPS-
deficient mutations affect the sensitivity to other antibiotics including cefepime and 
azithromycin (Beceiro et al., 2014). These laboratory observations that LPS-deficient A. 
baumannii with the higher fitness burden and more susceptible to other antimicrobials, also 
mirrors the literature - that a higher number of pmrAB-mediated colistin resistance A. 
baumannii have been reported than that of lpx-mutants. 
 Taken together, and as noted above, the acquisition of AMR generally imposes a fitness 
burden. Concurrently, in order to stabilize the resistant population in unfavorable 
environments, bacteria evolve to compensate the pleiotropic fitness effects mediated by 
antibiotic resistance. Unsurprisingly, some compensatory adaptations increase the fitness-cost 
in bacteria that can even out-compete their wide-type sensitive phenotypes, resulting in the 
predominance and persistence of MDR/XDR even in the antibiotic-free environments 
(Bjorkman et al., 1998, Hall et al., 2010). The knowledge of AMR mediated fitness burden 
and its complex interplay between bacterial genetics and both natural and antibiotic-rich 
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ecology, provides some insights to predict and combat the development of AMR in the 
pathogenic bacteria. 
 
1.5 The main objectives of my study 
To date, eight mcr- variants have been identified as PEA transferases, contributing to PEtN 
addition to lipid A and thereby conferring colistin resistance. This novel mechanism of 
plasmid-mediated colistin resistance provides an efficient way in distribution and evolution 
of colistin resistance. The worldwide emergence and epidemiology of mcr-mediated colistin 
resistance has been actively studied, a deeper understanding of how these transferable mcr-
genes evolve and disseminate successfully among animals, the environment and human, is 
lacking. Furthermore, the biological and clinical role of mcr-1-mediated colistin resistance is 
still poorly understood. Thus, there are two major aims in this study:  
Firstly, I seek to define the mechanism(s) of mcr-1-mediated colistin resistance in E. coli 
and the effects of mcr-1 expression on the overall fitness, including morphological changes, 
cell viability, competitiveness and the virulence impact in an in vivo model. Ultimately the 
objectives of such work are to provide mechanistic insights into mcr-conferring biological 
costs, and evidence to debate necessary actions that might prevent the spread of colistin 
resistance pathogens.  
Secondly, to characterize mcr-positive strains, including the identification of new mcr 
variants, their genetic characteristics by using whole genome sequencing, and their potential 
reservoirs by screening samples from various sources (food-producing animals, water, human, 
flies, pets and meat). This will help to expand the knowledge regarding the diversity of 
genetic contexts associated with mcr genes mainly found in E. coli and K. penumonae strains 
from Thailand and Vietnam, in where large amount of colistin has been consumed in food-
producing animals.  
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Chapter 2  
Materials and Methods 
 
2.1 Bacterial strains studied and materials used in this study 
    Ready-made reagents supplied directly from the manufacturers are given in the main text 
of this chapter. Recipes for reagents made up locally are provided in Appendix I. 
    In this study, a total of 236 mcr-positive Enterobacteracae have been characterized. These 
isolates are contributed from our collaborators from Thailand and Vietnam and all details of 
these strains used in this study are described in Appendix II Table 2.1. The following are the 
brief methods of collecting samples from blowflies: blowflies were trapped at different areas 
in Northern Thailand, 100 blowflies from each area:  local market in urban community, rural 
area and suburb of the city Phitsanulok. These locations are approximately 10 kilometers 
apart. The flies were individually pulverized in enriched peptone water for 30 min and then 
aliquots of the resultant suspensions (100 µl) were plated on Eosin-Methylene-Blue (EMB)-
agar plates supplemented with 2 mg/l colistin and incubated at 37oC overnight. One to three 
representative colonies with different species from each plates were purified and 
subsequently identified the mcr-1 gene by PCR. The mcr-1-positive bacteria were sub-
cultured in liquid nutrient broth for 18 h before DNA extraction for species identification and 
whole-genome sequence.  
2.2 Plasmid constructs and cloning 
    All constructed plasmids in this study are described below. All E. coli strains were grown 
at 37 oC in LB medium unless indicated differently. The antibiotics used for selections were 
used at the following concentrations: Ampicillin 100 mg/l, Kanamycin 50 mg/l, Tetracycline 
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20 mg/l, and Chloramphenicol 25 mg/l. several strategies have been used to construct the 
target plasmids (the details described below). 
2.2.1 mcr-1-plasmid construct  
    The mcr-1 containing fragment was excised from plasmid pUC-19-mcr-1(Liu et al., 2015) 
by double digestion with EcoRI and XbaI and T4-ligated into pSU18 and pBAD vector, 
respectively. The resultant constructs, pSU18-mcr-1 and pBAD-mcr-1, were transformed into 
E. coli TOP10 (Invitrogen, UK). The plasmids were purified and their integrity verified by 
PCR and DNA sequencing.  
    The generation of mcr-1-mutation: An MCR-1 non-active enzyme was created by a single 
substitution (E246A). Its encoding gene was excised from mcr-1-pUC19 (E246A) (Hinchliffe 
et al., 2017) and sub-cloned into plasmid pBAD-HisA to generate E246A/pBAD. To test the 
effect of the MCR-1 soluble domain on bacterial growth, the gene encoding the MCR1 
soluble domain (lacking the five predicted transmembrane helices; codons 219–541) was 
cloned into pBAD-HisA vector with forward and reverse primers (mcr-1-F soluble and mcr-
1-R soluble, Table 2.1). As a negative control, a ß-lactamase gene, blaTEM-1b, an 861bp 
fragment were generated by PCR with forward and reverse primers (Table 2.1) and then 
inserted into pBAD-HisA vector using the restriction sites EcoRI and KpnI. All resultant 
plasmids were transformed into E. coli TOP10 cell (Invitrogen, UK), purified and its integrity 
confirmed by PCR, double restriction digestion and DNA sequencing. 
2.2.2 mcr-3.5 plasmid construct      
    The mcr-3.5 coding region with its own promoter (201 bp) and downstream sequence (36 
bp) was PCR amplified from strains PN218 using primers mcr-3.5-F and mcr-3.5-R (Table 
2.2). The fragment was purified by gel purification kit (Qiagen, Germany), digested with Pst1 
and EcoRI enzymes (NEB, UK), and cloned into pUC19 and pBAD vectors. The resulting 
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plasmids were confirmed by PCR using the primers (mcr-3.1-F and mcr-3.1-R, in Table 2.2) 
and the following cycling conditions: 30 cycles of 95°C for 30 s, 50°C for 30 s, and 72°C for 
45 s, followed by 1 cycle of 72°C for 7 min. The presumptive 542-bp PCR product of mcr-3 
was sent for sequencing (Eurofins Genomics, Germany). 
Table 2.1 primers of gene mcr-1 and mcr-3 for construction, screening and qPCR 
primer 
name Sequence (5'->3') length 
Tm 
(°C) application reference 
mcr-1-F GCTACTGATCACCACGCTGT 958bp 
  
60 
  
PCR 
screening 
(Yang et 
al., 2017) mcr-1-R TGGCAGCGACAAAGTCATCT 
mcr-3.1-F  TTGGCACTGTATTTTGCATTT  542bp 
  
50 
  
PCR 
screening  
(Yin et al., 
2017) mcr-3.1-R TTAACGAAATTGGCTGGAACA 
mcr-3.5-F-
pstI 
AAAACTGCAGATGTTACAATGT
GGGAGTATCAG 
1863bp 
 
60 
 
 plasmid 
construct 
This study 
 
mcr-3.5-R- 
EcoRI 
CGGAATTCCAGATGATTGGGGG
CCTGA 
mcr-1 
soluble-F 
GGGGTACCACCATTTATCACGC
CAAAGACG 969 
 
 
60 
 
 
PCR 
(plasmid 
construct) 
This study 
(Yang et 
al., 2017) 
mcr-1 
soluble-R 
CGGAATTCGCGGATGAATGCGG
TGCG 
blaTEM-1b-F 
GGGGTACCATGAGTATTCAACA
TTTTCGTGTCG 861 
 
 
60 
 
 
PCR 
(plasmid 
construct) 
This study 
(Yang et 
al., 2017) blaTEM-1b-R 
CGGAATTCTTACCAATGCTTAAT
CAGTGAGGC 
16S-qF CATTGA CGTTACCCGCAGAA 
100bp 
 
 
60 
 
 
qPCR 
 
 
 
 
(Spano et 
al., 2005) 
16S-qR CGCTTTACGCCCAGTAATTCC 
16S-probe (FAM)CGTGCCAGCAGCCGCGGT
A-(TAMRA) 
rpoB Ec F3 TCCTTTCTATCCAGCTTGACTCG
T ~200bp 
  
  
 60 
  
  
qPCR  
  
  
Chapter3 
(Yang et 
al., 2017) 
rpoB Ec R3 CGCAGTTTAACGCGCAGCGG 
rpoB Ec 
probe 
(HEX)ACGTCAGCTACCGCCTTG
GCGAACCGGTGT-(BHQ1) 
mcr-3-qF CGTGTTCCTATGCAGGTGTG 
  
 ~150bp 
  
  
60 
  
  
 
qPCR  
  
  
Chapter 4 
 
mcr-3-qR CGAGTATCAGCGGCTTTCTG 
mcr-3-
probe 
(FAM)TGCAAACACGCCATATCA
ACGCCT-(BHQ1) 
mcr-1-qF TGGCGTTCAGCAGTCATTAT 
  
 ~120bp 
  
60 
  
  
qPCR  
  
  
 Chapter 4 
(Yang et 
al., 2017) 
mcr-1-qR AGCTTACCCACCGAGTAGAT 
mcr-1-
probe 
(FAM)AGTTTCTTTCGCGTGCATA
AGCCG-(BHQ1) 
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2.2.4 Generation of site-directed point mutations in mcr-3-encoding sequence region  
A total of six targeted mutations were generated at 1626bp mcr-3.5 sequence using the 
Q5® Site-Directed mutagenesis kit (NEB, UK). Primers were designed by NEBaseChanger 
(http://nebasechanger.neb.com/), as specified in Table 2.2. In brief, PCR amplicons were 
acquired using specific primers and a master mix containing Q5 hot start High-Fidelity DNA 
polymerase (Invitrogen, UK) (reaction conditions as see in Table 2.3 and 2.4), follows by 
incubated with kinase-ligase-DphI (KLD) enzyme mix. This step is designed for the 
circulation of the PCR product and removal of the template. Then the ligated plasmid DNA 
was transferred into chemically competent TOP10 cells (ThermoFisher, UK). The mutations 
were confirmed by plasmid extraction and sequencing. 
Table 2.2 primers for point mutations in mcr-3-encoding sequencing region 
Plasmid 
template 
amino acid substitution 
(nucleotide mismatch) 
primers Resultant mutants 
mcr-3.5/pBAD M23V+A457E+T488I See Table 2.1 mcr-3.5  
mcr-3.1/pBAD M23V(a67g)_forward TTTTGCATTTaTGCTGAAC
TG 
mcr-3 (E457A+ 
I488T) 
_reverse TACAGTGCCAAAAAGAA
C 
mcr-3.5/pBAD A457E (c1370a) 
_forward 
TCACTGGGAGcATTAGGG
CTTTAC 
mcr-3 (M23V+ T488I) 
_reverse TTCACCATGATCGGAGAC  
mcr-3.5/pBAD I488T(c1463t) _forward CCTGGATTTAcCAAAGAG
AAAGGC 
mcr-3(V23M+ E457A) 
_reverse TGACATCCACACCTGCAT  
mcr-3 (M23V+ 
T488I) 
I488T(c1463t) Primers see above mcr-3 (M23V) 
mcr-3 (M23V+ 
A457E 
M23V(a67g) 
 
Primers see above mcr-3 (A457E) 
mcr-3 (A457E+ 
T488I) 
A457E (c1370a) Primers see above mcr-3 (T488I) 
* mcr-3.1/pBAD plasmid was provided by our collaborators in China. mismatched nucleotides are 
indicated in red 
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Table 2.3 Components of PCR conditions for the generation of mcr-3-positive PCR products 
with targeted point mutations 
 
 Component Final Concentration Volume pipetted (µl) 
Reaction 
Conditions 
H20 - 9.0 
Q5 2X Master Mix 1x 12.5 
Forward Primer  0.5µM 1.25 
Reverse Primer  0.5µM 1.25 
Template DNA 1-25ng 1.0 
Template DNA Plasmid size  (bp) (same 
as expected PCR 
product size) 
4100bp of pBAD backbone, plus 1826bp 
(with additional 200bp of promoter sequence  
of mcr-3 gene) 
Purify Method  plasmid miniprep 
 
Table 2.4 PCR conditions for the generation of mcr-3-encoding sequencing region with 
targeted point mutations 
 Cycle Temperature (°C) Time (seconds) 
Reaction Conditions Initial Denaturation  98 30 
Denaturation 98 10 
Annealing 58-61* 30 
Extension 72 180 (30seconds/kb) 
Number of cycles: 25 
 Final Extension 72 120 
Template DNA: Hold 4  
*annealing temperatures are 60°C for these different primers shown in Table 2.3. 
 
 
2.2.5 Construction of promoter-gfp fusions 
    The vector pGLOW-TOPO (Invitrogen, UK) was used to measure the transcription 
activities of mcr genes (mcr-1 and mcr-3). The features of pGLOW-TOPO vector include a 
TOPO cloning site, pUC-original high copy number replication, ampicillin resistance gene 
and a green fluorescent protein (GFP) allowing to monitor transcriptional changes in real 
time. The PCR reverse primers were designed including a ribosomal binding site (-AGGA-), 
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an initiation codon (ATG) in frame with the GFP initiation codon and additional 8-12 
nucleotides between the ribosomal binding site and the initiation codon, according to the 
manufacturer’s instructions. primers were listed in Table 2.5. Promoter regions were 
amplified by PCR using Supermix high fidelity (Thermo Fisher Scientific, UK), and 
confirmed by agarose gel electrophoresis. The amplified PCR products were ligated with the 
pGLOW-TOPO vector at room temperature for 10-15 min and transferred into chemical 
competent E.coli TOP10 cell (Invirtogen, UK), according to the manufacturer’s instructions. 
The orientation of the inserted promoter was confirmed by PCR and sequencing using the 
upstream GFP primer. Overnight cultures were used to detect in-vitro GFP Fluorescence by 
flow cytometer (Becton Dickenson, Biosciences, UK). 
 
Table 2.5 primers used for promoter-gfp constructs 
primer name Sequence (5'-3') length 
Tm 
(°C) 
P_mcr-1-F GCCCACATATTTGCGGGCTTAA 
500bp 
  
60 
  
P_mcr-1-R* 
TCATAGATCCTTTCTCCT+GAGAAACTAC
TCAAAAAATAAACGG 
P_mcr-3-F TACTGGTCGGAGATATGGGT 
300bp 
 
60 
 
P_mcr-3-R* 
TCATAGATCCTTTCTCCT+ 
ACTTACTCCATTAATAGTCCAAC 
 
*Underlined sequence are the additional nucleotide and a reverse RBS site –TCCT- (in bold), 
followed by promoter sequence. 
 
 
2.3 plasmid DNA extraction 
Plasmid DNA was extracted from 5 ml bacterial cultures, grown to stationary phase in LB, 
using the QIAprep Spin Miniprep Kits (Qiagen, Germany), according to the manufacturer’s 
specifications, and eluted in 30-50 µl sterile water.  
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2.4 Polymerase Chain Reaction (PCR) 
    Amplification of DNA, for cloning or mutagenesis, was carried out using the 
Thermocycler high Fidelity PCR system (ThermoFisher, UK), according to the 
manufacturer’s specifications. A total volume of 12 µl in a reaction contained 1xPCR master 
mix, 0.1 µM forward primer and 0.1 µM reverse primer and 1 µl DNA template (sequence of 
primers used in this study are list in Table 2.1, -2.2 and -2.6). Thermocycler parameters 
varied depending on the amplicon size and GC content. A typical PCR cycle was: 
denaturation at 95 ˚C for 5 min and then 30 cycles of denaturation at 95 °C for 30 sec, 
annealing at 50 ˚C for 30 sec, extension at 72 ˚C for 30s-60s per kb of amplicon, final 
extension at 72˚C for 10 min. PCR products were separated via electrophoresis through 1.5% 
agarose dissolved in 1xTris-borate EDTA buffer (TBE) gels and visualised with Ethidium 
Bromide Stain (Invitrogen, UK) at a dilution of 1:10 000, using a Geneflash UV 
transilluminator (Syngene, Bangalore, IND). Fragment size was determined using 
SmartLadder (Eurogentec, UK) as a marker.  
    After gel electroporation, DNA can be purified using gel purification kit (Qiagen, 
Germany), according to the manufacturer’s specifications. The purified DNA can be further 
used for Sanger sequence (Eurofins, Germany) and DNA-probing (see 2.17.3). 
 
2.5 Reverse-Transcription quantitative PCR (RT-qPCR) 
    To optimize the expression of mcr-1 gene, I tried a series concentration of L-arabinose 
over a 10,000-fold range (0.00002% to 0.2%).  Each transformant or control was inoculated 
in 2 ml of LB medium containing 100 µg/ml ampicillin with a single recombinant E. coli 
colony for overnight at 37°C with shaking (225 r.p.m.). The next day, 10 µl of overnight 
culture were added unto fresh 10 ml of LB containing 100 µg/ml ampicillin. When OD492 
reached to approximate 0.4 (the cells normally reach in their mid-log phase), 10-fold serial 
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dilutions of 20% (w/v) L-arabinose (e.g., 2%, 0.2%, 0.02%, and 0.002%) were added to the 
five 10 ml cultures as follows, to induce the expression of mcr-1 gene and then grow at 37°C 
with shaking for 6-8 hours.  
    After for 6-8h incubation, the bacterial pellets were collected and total RNA was extracted 
using the RNeasy Plus kit with on column DNase digestion (Qiagen, Germany), according to 
manufacturers’ protocol. RNA was quantified by measurement at OD260/OD280 using a 
Nanodrop (Thermo Scientific, UK), followed by cDNA synthesis with DNA integrated 
genomic DNA removal using QuantiTect Reverse Transcription kit (Qiagen, Germany), 
according to manufacturers’ protocol. Quantitative PCR amplification was performed on the 
150-200 ng of cDNA cDNA using SsoAdvanced universal probes supermix (Bio-Rad, Hemel 
Hempstead, UK) on the Bio-Rad CFX384 (Corbett Research, Sydney, AUS) with the 
necessary primer pairs and the control primers specific to the rpoB housekeeping gene (Table 
2.1). A typical reaction mix contained 10 µl of SsoAdvanced universal probes supermix, 0.5 
mM of each primer, 0.2 mM of each probe and 100-300 ng of cDNA in a total volume of 20 
µl in triplicate. The absence of carry-over genomic DNA was verified for every experiment 
by comparative qPCR (or standard PCR) in the absence of reverse transcriptase. Typical 
parameters for the PCR amplification were as follows: 2 min denaturing at 95 ˚C, 40 cycles 
of 10 sec denaturing at 95 ˚C and 30 sec annealing at 60 ˚C. Analysis was based on 
comparative quantitation of a treated sample and the control mRNA levels were normalized 
to the control gene, rpoB. Relative expression results were obtained by the ∆∆CT analysis 
method using mean CT value. For details of used primers and probes, see Table 2.1. 
 
2.6 mcr-1 gene copy number measured by qPCR 
    DNA extraction as stated above. For qPCR determination of mcr-1 copy numbers per cell, 
0.1 ng of total genomic DNA was used as template with primers mcr-1-qF, mcr-1-qR and 
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mcr-1 probe and 16S primers and probe (Table 2.1). In parallel standard curves for mcr-1 
and 16s were obtained using as template serial dilutions of mcr-1-carring DNA extracted 
from pSU18-mcr-1 strain (Hinchliffe et al., 2017) (4.3 pg of DNA corresponding to 106 
copies, calculated through the website: http://cels.uri.edu/gsc/cndna.html) and E. coli TOP10 
(Invitrogen, UK) total genomic DNA (5 ng corresponding to 106 cells)(Bontron et al., 2016), 
respectively. 
  
2.7 E. coli multi-locus sequencing typing (MLST) 
    The E.coli MLST scheme used in this study was available at Warwick Medical School 
(http://mlst.warwick.ac.uk/mlst/dbs/Ecoli). The following seven housekeeping gene were 
used in this scheme: adk (adenylate kinase), fumC (fumarate hydratase), gyrB (DNA 
gyrase), icd (isocitrate dehydrogenase), mdh (malate dehydrogenase), purA (adenylosuccinate 
synthetase) and recA (ATP/GTP binding motif). The primers sequences are listed in Table 
2.6. The reaction condition were an initial denaturation step at 94oC for 2 min, followed by 
35 cycles of the following conditions: denaturation at 94oC for 2 min, annealing at 58 oC (for 
gyrB, mdh and recA) or 54 oC (for adk, fumC, idc and purA) for 1 min and extension at 72 oC 
for 1 min, with the final extension step at 72 oC for 10 min. The size of PCR products were 
confirmed by agarose gel electrophoresis, followed by gel purification using gel purification 
kit (Qiagen, Germany), according to the manufacturer’s instructions. The seven housekeeping 
genes were confirmed by sequencing (Eurofins genomics, Germany). The allelic profile was 
summarized by the assignation of an ST via the online database 
(http://mlst.warwick.ac.uk/mlst/dbs/Ecoli/). 
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Table 2.6 The list of primers used for MLST typing 
primers primer's sequence (5'-3')  
Length 
Tm 
adk-F  ATTCTGCTTGGCGCTCCGGG 
583 bp 
54° 
C adk-R  CCGTCAACTTTCGCGTATTT 
fumC-F TCACAGGTCGCCAGCGCTTC 
806 bp 
54° 
C fumC-R GTACGCAGCGAAAAAGATTC  
gyrB-F TCGGCGACACGGATGACGGC  
911 bp 
60° 
C gyrB-R ATCAGGCCTTCACGCGCATC 
icd-F  ATGGAAAGTAAAGTAGTTGTTCCGGCACA 
878 bp 
54° 
C icd-R GGACGCAGCAGGATCTGTT 
mdh-F ATGAAAGTCGCAGTCCTCGGCGCTGCTGGCGG 
932 bp 
60° 
C mdh-R TTAACGAACTCCTGCCCCAGAGCGATATCTTTCTT 
purA-F  CGCGCTGATGAAAGAGATGA 
816bp 54 
purA-R CATACGGTAAGCCACGCAGA 
recA-F  CGCATTCGCTTTACCCTGACC 
780 bp 
58° 
C recA-R  TCGTCGAAATCTACGGACCGGA 
 
2.8 Antimicrobial susceptibility testing  
2.8.1 Agar Dilution Method 
Minimal inhibitory concentrations (MICs) of antibiotics were performed by the agar 
dilution method, according to European Committee on Antimicrobial Susceptibility Testing 
(EUCAST). Briefly, organisms were inoculated on agar plates and adjusted the turbidity of 
bacterial suspensions reached the McFarland 0.5 Standard (approximately 1.5x108 CFU/ml) 
for the tests. Mueller-Hinton (Becton Dickinson, USA) agar plates supplemented with 
different concentration of colistin in a range of 0.125 -128 mg/L. The strain E. coli (ATCC 
25922) used for quality control purposes. Isolates were classified as either susceptible or 
resistant according to the interpretative standards recommended by the EUCAST clinical 
breakpoints. 
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2.8.2 Broth Microdilution Method 
    The colistin susceptibility of tested E.coli isolates was assessed by broth microdilution 
according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST). 
Briefly, overnight cultures were resuspended to an optical density corresponding to a 0.5 
McFarland standard (approximately 1.5x108 CFU/ml). Briefly, overnight cultures were 
diluted in sterile saline to an optical density corresponding to a 0.5 McFarland standard 
(approximately 1.5x108 CFU/ml), and then the standardised cell suspensions were aliquoted 
to 96-well microtiter plates containing cation-adjusted Mueller-Hinton medium (Becton 
Dickinson, USA) at colistin concentrations from 0.25 to 128 mg/L. Plates were incubated 
overnight at 37°C and optical density read on a microplate reader (EZ Read 400, 
BIOCHROM, UK.) at 492nm. 
 
2.9 The transferring procedures of mcr-bearing plasmids 
2.9.1 Heat shock transformation of Chemical competent bacteria 
    One vial of 50 µl TOP10 cells (ThermoFisher Scientific, UK) was thawed on ice for each 
transformation. 100 ng of each constructed plasmids/ligation reaction were added directly 
into the vial of competent cells and mixed by tapping gently. The remaining ligation 
mixture(s) can be stored at -20°C. Then, the mixture was incubated for 30 minutes on ice, 
followed by heat shock in the 42°C water bath for 45 s and placed them on ice immediately 
for 2-3 minutes. 950 µl of pre-warmed LB broth were then added to each vial and incubated 
at 37°C for 1 hour at 200 r.p.m. in a shaking incubator. 100 µl cultures from each 
transformation vial are spread on selective agar plates and incubated at 37°C overnight. The 
transformants were confirmed by plasmid isolation, PCR and sequencing.  
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2.9.2 Electroporation 
    (i) Preparation of electrocompetent cells. Overnight cultures were diluted (1:50) in 5 ml 
fresh LB broth and incubated at 37°C (220 r.p.m) until the OD600 of cultures are reached to 
0.5-0.7. Bacterial cell cultures were kept on ice for 20 minutes, followed by centrifugation at 
5000 r.p.m/min, 4°C for 15 min. The pellets were then re-suspended in 1ml chilled 10% 
glycerol and re-centrifuged for 15 min at 4°C.  After another twice washes in chilled 10% 
glycerol, supernatants were discarded and the pellets were suspended in the residual glycerol 
(about 100 µl). The electrocompetent cells are ready to use for electroporation.    
     (ii) Electroporation programme. 0.2 cm electroporation cuvettes (Bio-Rad, UK) must be 
kept on ice for at least 30min before use. 50-100 ng of plasmid DNA were added into 50 µl 
of electrocompetent cells as described above and then the DNA/cells mixture were 
transferred into a chilled cuvette without introducing bubbles. The following conditions were 
used for electroporation (Bio-Rad MicroPulser, France): EC3/EC2 (3.0/2.5kv) programme 
was used for E. coli, the typical time constant is ~5.5 milliseconds. Immediately 950 µl of LB 
broth were added to the cuvette and mixed well, followed by incubation at 37°C for 1 hour, 
shaking vigorously at 220 r.p.m. 100 µl of aliquot were plated onto a pre-warmed selective 
plate and incubated overnight at 37°C.  
2.9.3 Conjugation experiments 
To investigate the transferability of mcr-like-carrying plasmids, we performed conjugation 
assays with sodium-azide resistance E.coli J53 as the recipient strains. Briefly, overnight 
cultures of MCR-producing donors and the recipient strain were 1:2 or 1:4 mixed and 
incubated in 37oC without shaking for 16-20 h. After incubation, we subsequently ten-fold 
serial diluted the mixed culture in sterile saline and aliquoted 100 µl of diluted culture onto 
selective agar plates containing with 2-4 mg/l colistin and 150-200 mg/l Sodium Azide. The 
mcr-positive transconjugants were confirmed by PCR and transfer frequency was calculated 
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by the number of transconjugants per recipient (equations see below). Plasmid analysis were 
done by whole genome sequence as described below. 
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2.10 Selection for high-level colistin resistant mutants (HLCRMs) 
    HLCRMs were generated from seven wild-type mcr-1 positive strains through 14-day 
serial passaging with increasing concentrations of colistin (Alfa Aesar, USA). Briefly, 
overnight cultures were resuspended to an optical density (OD) corresponding to 
approximately 1.5x108 CFU/ml, followed by challenging with different concentrations of 
colistin (from 0.125 to 256 mg/L) in a 96-well microtiter plates containing cation-adjusted 
Mueller-Hinton medium (Becton Dickinson, USA). The next day, cultures in the last well 
that yielded visible bacterial growth were mixed with the first clear well (normally registered 
as the MIC) and challenged with colistin as described above. This passage lasts for 14 days 
and cultures at 0, 3, 7 11 and 14 days were retained and stored at -80oC for further analysis.  
 
2.11 Stability of high-level colistin resistance in HLCRMs  
    To detect whether the colistin resistance in HLCRMs is stable i.e. reversible or not, serial 
passages of HLCRMs were performed in colistin-free medium. Overnight cultures of 
HLCRMs were diluted (1:500) into fresh LB broth without colistin and incubated with 
vigorous shaking (220 r.p.m.) for 18h. To measure the proportion of colistin resistance 
bacterial population during reversion, overnight cultures were serial diluted, then plated on 
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chromogenic agar plates with or without colistin. Various concentrations of colistin (8, 16, 32, 
64, 128, 256 mg/l) were depending on the level of colistin resistance mediated by the 
HLCRM. The CFU/ml of colistin resistance cells were counted after 18-22 h incubation at 
37oC.  
 
2.12 Morphological analysis by transmission electron microscopy (TEM) 
    Overnight cultures were diluted into 50 ml of fresh media supplemented with 100 mg/L 
ampicillin for mcr-1/pBAD. For mcr-1/pBAD strain, 0.2% (w/v) of L-arabinose was added to 
induce the overexpression of mcr-1. After 8h incubation, samples were fixed by addition of 
glutaraldehyde to the broth to a final concentration of 1%. Bacteria were harvested by 
collection onto 0.45 mm pore filters, gently scraped off and dispersed in 4% low melting 
point agarose at 50oC. Preparations were allowed to gel at room temperature and cut into 1 
mm cubes. Cubes were post-fixed for 2 hours in 2% uranyl acetate, washed for 3 x 20 
minutes in reverse osmosis purified water and dehydrated through graded propan-2-ol (50%, 
70%, 90% for 10 minutes each, 100% for 2 x 15 minutes), infiltrated with LR White acrylic 
resin (London Resin Company, Aldermaston, U. K.) (50% in propan-2-ol 30 for minutes, 
neat resin for 4 x 20 minutes) placed in size 0 gelatine capsules with fresh resin and heat 
polymerised overnight at 50oC. Thin (80 nm) sections were cut on an Ultracut 
E.ultramicrotome with a glass knife and collected onto 300 mesh copper grids, stained with 
lead citrate and examined in a Philips CM12 (FEI U. K. Ltd. UK) TEM at 80kV. Digital 
images were captured with a Megaview III digital camera and AnalySIS (Soft Imaging 
System GmbH, Germany). 
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2.13 Methods used for in-vitro competition assays  
2.13.1 Bacterial competitiveness measured by flow cytometry 
    In-vitro competition experiments were used to measure the relative fitness of the mcr-
1/pBAD HLCRMs, E. coli TOP10 (mcr-1/pBAD) and E. coli TOP10 (pBAD only) and E. 
coli TOP10 (Table 2.8). These strains were competed against a GFP-labelled E. coli DH5-α 
carrying plasmid pHT315-pAphA3’-gfp for constitutive expression (Daou et al., 2009). All 
competitions were carried out in M9 medium (SIGMA-ALDRICH, UK) (Table 2.9) with six 
biological replicates per strain/condition, as previously described with some 
modifications(San Millan et al., 2016). For E. coli TOP10 (mcr-1/pBAD), mcr-1 expression 
was induced by adding different concentrations of L-arabinose (0, 0.0002, 0.002, 0.02 and 
0.2%, w/v). 
Table 2.7 Strains and plasmids used in this assay 
plasmids Strains list 
mcr-1/pBAD 
plasmid*(w/v) 
mcr-1 
0.0002% 
mcr-1 
0.002% 
mcr-1 
0.02% 
mcr-1  
0.2% 
mcr-1  
0% 
mcr-1/pBAD 
mutants 
mcr-1 D0 mcr-1 D3 mcr-1 D4 mcr-1 D8 mcr-1 D14 
Control strains TOP10 pBAD pHT315-GFP DH5-α 
* indicated the concentration of L-arabinose used to induce mcr-1 expression 
Table 2.8 preparation of M9 medium 
Components* Volume (ml) 
Sterile distilled water 492 
0.5M Magnesium (0.22uM filter) 2  
Total volume 500 
*Normally, M9 salts contain sterile distilled water, magnesium and glucose. But glucose in this experiment has 
been removed, because it may inhibit inserted gene GFP expression. 
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    (i) Preparation for initial mixture. The bacteria were cultured overnight in LB broth 
(SIGMA ALDRICH, UK), supplemented with the appropriate antibiotics (2 mg/l of colistin 
for HLCRMs, or 100 mg/l of ampicillin for E. coli TOP10 (mcr-1/pBAD), E. coli TOP10 
(pBAD) and the GFP-labelled E. coli DH5-α. The overnight cultures were diluted 1:400 in 
M9 broth and mixed at 1:1 ratio with GFP-labelled cells. Before starting the competitions, the 
exact initial proportion of fluorescent/non-fluorescent cells was estimated using flow 
cytometry (for details see below). Briefly, overnight cultures were firstly diluted into M9 
salts (1:200) and then their cell density (events/µl) were measured Accuri C6 flow cytometer 
(Becton Dickenson, Biosciences, UK). If the events/µl is higher than 3000, need to re-dilute 
samples to 1000-3000 events/µl. This measurement is more accurate than that using 
microplate reader. In order to get 1:1 mixture of the control and samples, a rough guideline to 
follow for E.coli as below: (for instance, the highest density was considered as template, 500 
µl as a volume of the control) 
Volume (µl) of sample = [events/µl (template)*500 µl]/ events/µl (sample) 
Finally, if the actual ratio was close to 1:1, we started the competition by diluting the initial 
mixtures into LB broth (1:2) and shifting the mixtures to a shaking incubator (MAXQ 8000, 
Therom Scientific, UK) in 37°C, 225 r.p.m. Otherwise, the preparation procedure was 
repeated.  
    As with all experiments, good controls are essential. Performing a competition between a 
tested strain and a GFP-tagged cheater strain, a pure culture of each as controls are needed. 
This is because the “fluorescence intensities” of tagged and untagged strains have a small 
region of overlap (see Fig.2.1). The pure cultures must be present so that mixtures can be 
corrected for this overlap and yield more accurate results.  
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Fig. 2.1 Controls used in a competition experiment between a GFPPlabelled strain and a nonPlabelled 
strain (tested strain). There is a small region of overlap which can be corrected for mathematically.     
 
    (ii) Data collection. After 22h, the competed bacteria were diluted 1:400 in NunclonTM 
Delta Surface 96-well plates (Therom Scientific, UK) with M9 medium and analyzed on a 
flow cytometer to estimate the resulting proportion of labelled versus unlabelled cells. Flow 
cytometer was performed on an Accuri C6 (Becton Dickenson, Biosciences, UK).  The cell 
densities were adjusted to give approximately 1000-3000 events per 1uL. During data 
acquisition, a lower cut off was set at 10 000 for FSC-H and at 8000 for SSC-H. For each 
competition, we ensured that the GFP-labelled strain can be well separated from non-
fluorescent strains by comparing non-mixed controls (overlap is usually less than 2% of the 
cells). Relative fitness was calculated using formula:  
Q+&6529+_/251+33 = logT( pUpV nWXYZ[X\])logT( 1 − pU(1 − pV) nWXYZ[X\]) 
where p0 is an initial proportion of an unlabelled stain, and p1 is a final proportion of an 
unlabelled stain after competition. The ndilution is the factor, which reflects a fold difference in 
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cell density at the beginning and at the end of the competition.  For HLCRMs, we expressed 
the fitness of daughter strains relative to their parental strains (i.e fdaughter/fparental) and followed 
the procedure of error propagation to account for the uncertainty of the two estimates: 
`a = - `bcdefghij/cdefghij T + `bldjimhdn/ldjimhdn T 
where / and `b are a mean estimate and its standard deviation for each corresponding strain 
based on 6 replicates. Similarly, the relative fitness of the HLCRMs at different L-arabinose 
concentrations was represented as the relative fitness at no induction (no L-arabinose). The 
differences in fitness were tested using non-parametric Mann-Whitney test, and the p-values 
were adjusted by Bonferroni method.  
 
2.14.2 Bacterial competitiveness measured by qPCR 
2.14.2.1 mcr-carrying plasmids competition in E.coli J53 model 
    To examine the stability and competitive ability of mcr-1- and mcr-3- carrying plasmids, 
the qPCR was used to measure changes in the abundance of mcr genes over 14-day passage. 
Two representative mcr-1 (PN23, IncX4) and mcr-3(F203, IncF) plasmids were transferred 
into the same recipient genetic background (E.coli J53) by conjugation.  Each competition 
was initiated with 1:1 mixture (equal CFU/ml) of mcr-1 and mcr-3.5 plasmid bearing bacteria 
in 5ml tubes containing 3 ml of culture medium. Competitions were maintained for at least 80 
generations of growth by serially transferring 1% of the overnight mixtures to fresh medium 
with or without colistin (2 mg/l) for 14 days. The negative controls, mcr-1 or mcr-3-plasmid 
monocultures, were also processed in the same manner. In total, the experiment have the 
following six treatments (biological triplicates were performed): 
(a) control mono-cultures 
(1) mcr-1 transconjugant (PN23), no colistin 
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(2) mcr-1 transconjugant (PN23), 2 mg/l colistin 
(3) mcr-3 transconjugant (F203), no colistin 
(4) mcr-3 transconjugant (F203), 2 mg/l colistin 
(b) mixed cultures 
(5) Mix of mcr-1 transconjugant (PN23) and mcr-3 transconjugant (F203), no colistin 
(6) Mix of mcr-1 transconjugant (PN23) and mcr-3 transconjugant (F203), 2 mg/l colistin 
    gDNA was extracted from overnight culture (2 ml) using a QIAcube automated machine 
(Qiagen, Germany)  at the following time points: day 0, 1, 3, 5, 8, 11, 14. The concentrations 
of gDNA were measured by a Qubit (ThermoFisher Scientific, UK). This is followed by 
measuring the dynamics of the mcr-1 and mcr-3 genes by qPCR (ABI StepOnePlus). 1 ng of 
gDNA was used as template with specific primers and probes (Table 2.1). A housekeeping 
gene rpoB was used as internal control using primers rpoB-qF, rpoB-qR and rpoB probe. 
Biological triplicates were performed and the ∆∆Ct method were used to compare the relative 
abundance between mcr-1 and mcr-3 genes in the mixture: 
1 ∆!5-(%0,-=+1+3) = !5(mcr-3 gene)-Ct (mcr-1 gene) 
2 ∆!5-(,.qr-=+1+3) = !5(mcr-3 sample)-Ct (mcr-1 sample) 
3 ∆∆!5 = ∆!5 56,=+5-=+1+ − ∆!5(,+/+,+10+-=+1+) 
Where Ct is the threshold cycle, target genes are mcr-1 and mcr-3, rpoB is the control to 
normalize the target gene expression. Target is mcr-1 and reference is mcr-3 gene. The fold 
change of genes were considered statistically enriched if p<0.01 using linear regression 
analysis. If there was no amplification, detection limit Ct 40 was used. The relative fitness of 
mcr-3 and mcr-1 plasmid were then estimated by the regression coefficient of the log value of 
67#
#
the ratio of mcr-3 to mcr-1 plasmid plotted against time (generation of competition). The 
bacterial generation time is calculated by the below formula: 
Generation-Time = log 2 -(42&)52.1-/605.,-.1-*605+,26&-q6336321=) 
(One condition for this formula is bacteria need to grow to saturation condition in everyday 
passaging. 1000-fold dilution I have used in this passaging, which means that 10 bacterial 
generations was achieved per day). 
2.14.2.2 mcr-carrying Plasmids competition in a clinical strain model 
    Co-existence of mcr-1 and mcr-3 plasmids were found in MCRPE collection in this study, 
and they are often located in different plasmids, which have been confirmed by conjugation 
and S1-PFGE. I have selected three of them as my wild-type competition model and 
examined the stability and competitiveness of both mcr-1- and mcr-3-carrying plasmids in the 
presence/lackness of colistin, the qPCR was used to measure changes in plasmid abundance 
over 14-day passage as above describe with slightly differences. Briefly, each competition 
was initiated with equal optical density in 5ml tubes containing 3 ml of culture medium. 
Competitions were maintained for at least 100 generations of growth by serially 1:1000 
dilution of the overnight mixtures to fresh medium with (4 mg/l) or without colistin for 14-
day serial passaging. Biological triplicates were performed. 
 
2.15 LPS isolation and macrophage stimulation 
2.15.1 LPS extraction 
    LPS was extracted using LPS extraction kit  LPS was extracted from induced E.coli 
TOP10 mcr-1/pBAD strain and control E.coli TOP10 pBAD strain, using LPS Extraction Kit 
(iNtRON Biotechnology, UK), according to the manufacturers’ instructions. Briefly, the 
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bacteria were cultured overnight in 5 ml of LB broth, supplemented with 100 mg/L of 
ampicillin, and for mcr-1/pBAD strain, mcr-1 gene was induced by 0.2% arabinose for 
approximately 12h. In order to eliminate contamination of protein, treatment with protease K 
(20 mg/ml, AppliChem, Germany) was performed prior to the extraction steps. Bacterial 
cultures were spun down at 13,000r.p.m at room temperature. Supernatants were removed 
and resuspended pelleted cells by adding 1 ml of Lysis Buffer, followed by adding 200 ml of 
chloroform and mixing well. The mixtures were incubated at room temperature for 5min. The 
purpose of adding the chloroform is to separate the phenol layer from aqueous layer and 
eventually isolate RNA and genomic DNA/protein. Then, 400 ml of supernatant were 
transferred to new 1.5 ml tube after centrifuged at 13,000r.p.m for 10 min at 4℃. In order to 
purify LPS from other extract of cell, such as protein, nucleic acids and lipids, 800 ml of 
purification buffer was added into supernatants and incubated for 10-20 min at -20℃. After 
centrifuging the solution at 13,000r.p.m for 15 min at 4℃, 1 ml of 70% EtOH was added to 
wash the LPS pellet to remove impurities such as salts. The upper layer was discarded after 
centrifuging the mixtures for 3 min at 13,000r.p.m at 4℃. Final purified LPS pellet was dried 
at room temperature and dissolved in 30-50 ml of 10mM Tris-HCl buffer (pH 8.0) by boiling 
it for 2 min. LPS was stored at -20℃ for further experiments. 
2.15.2 The quantity of LPS samples    
    To eliminate protein contamination, treatment with protease K was performed after the 
extraction steps. The protease K was added to the cell mixture and incubated at 56oC for one 
hour. The potency of LPS samples was determined by Limulus Amebocyte Lysate (LAL 
chromogenic Endotoxin Quantitation kit, ThermoFisher, UK) to measure the LPS 
concentration, according to the manufacturers’ instructions. 
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2.15.3 Propagation of THP-1 cell lines  
    THP-1 cell lines are monocyte-like cell line derived from leukemia from a one year old 
boy (American Type Culture Collection, ATCC TIB-202™). The cells are harvested with the 
complete medium (R.P.M. I 1640 medium supplemented with 10% FBS, 2 mM L-Glutamine, 
1 mM sodium pyruvate, 100 mg/l penicillin and 100 mg/l streptomycin, in order to inhibit 
bacterial contamination) in a humidified cell culture incubator with 5% CO2 at 37°C. Cell 
media can be changed when cell concentration reaches around 8x105 cells/mL by adding 1ml 
cells into 9ml of fresh media. THP-1 monocytes were differentiated into macrophage cells by 
stimulation with phorbol myristate acetate (PMA). In brief, cells were centrifuged and 
resuspended in fresh media to a concentration of 2x105 cells/ml. PMA (10 ng/ml) was added 
to diluted cells, and then aliquoted into 24-well plate (ThermoFisher, UK) by adding 1 ml of 
cell suspension per well. The differentiation of THP-1 monocytes were reached after 48 hours 
of incubation. Differentiated cells were adherent to the bottom of plate observed by 10X 
objective microscope, while undifferentiated cells were removed by discarding the cell media. 
2.15.4 LPS stimulation 
    To prepare the 24-well assay plate, 1 mL of macrophage cell cultures was first added to 
every well followed by adding serial concentrations of LPS (4.5, 0.45, 0.045, 0.0045, 0.00045 
ng/mL) to the appropriate wells in duplicate/triplicate. Macrophage cell cultures without LPS 
stimulation served as the negative controls. The wells are thoroughly mixed and incubated at 
37 °C for 24h. The samples were collected at 4, 6, 8 and 24h and stored at -20°C. The 
production of macrophage-derived cytokines (IL-6 and TNF-α) were analyzed using DuoSet® 
ELISA kit (R&D systems, UK), and cytokine concentrations were calculated according to the 
manufacturers’ instructions.  
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2.16 Galleria mellonella pathogenicity model 
    In vivo pathogenicity of seven wild type MCRPEC isolates and their corresponding 
mutants were evaluated using G .mellonella infection model. The wax moth G.mellonella in 
larval stage (Live Foods UK Ltd, http://www.livefood.co.uk) were stored in dark and used 
within three days from shipment. Prior to inoculation into larvae, bacterial pellets were 
washed with sterile saline and then diluted to an appropriate cell density (OD600 is 
approximately 0.6). Using a 50 µl Hamilton Syringe, 10 µl aliquots of serially diluted 
bacterial suspension (from 103 to 107 CFU/ml ) were injected into the hemocoel of each 
larvae, through the rear left pro-leg (Peleg et al., 2009). A group of ten larvae were randomly 
chosen to inject for each level of inoculation in triplicate. Followed by injection, larvae were 
incubated at 37ºC, and the survival of larvae was monitored daily for three days. Death was 
denoted when larvae no longer responded to touch. Results were analyzed by Kaplan-Meier 
survival curves (GraphPad Prism statistics software). For all experiments, three control 
groups were used: ten larvae in first groups were injected with 10 µl sterile saline, the second 
group included larvae that received empty stabbed to test if killing caused by physical trauma, 
and the larvae in third group with no injection.  In all case, no dead larvae were observed in 
the control groups. 
2.17 S1-nuclease based pulsed-field gel electrophoresis (S1-PFGE)  
To investigate whether mcr-genes were located on plasmids or chromosome, endonuclease 
S1 pulsed-field gel electrophoresis (S1-PFGE) were assayed as previously described (Yong et 
al., 2009, Toleman, 2018). In-gel hybridization was done with a mcr- probes labelled with ³²P 
(Stratgene, Amsterdam, Netherlands) with a random primer method according to 
manufacturers’ instruction. The following is the step-by-step procedure for S1-PFGE 
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contributed by our colleague Dr. Toleman Mark (Toleman, 2018) with minor modifications 
and ingredients of solutions are provided in Appendix 1.2. 
2.17.1 Agarose plugs preparation 
    Agarose plugs of bacterial strains (for E. coli only in this study) are prepared by using 
standard operating procedure, which is available on the Centres of Disease Control website: 
(https://www.cdc.gov/pulsenet/pdf/ecoli-shigella-salmonella-pfge-protocol-508c.pdf). First of 
all, tested isolates were streaked onto UTI plates and incubated at 37 oC overnight. Enough 
amount of bacterial pallets (usually one full 10µl- inoculating loop) were suspended them in 
1 ml cell suspension buffer and mixed well. Then 400 µl of each cell suspension were 
transferred into a new 1.5ml Eppendorf tube, followed by adding 20 µl of Proteinase K 
solution (20mg/ml) into each Eppendorf tube. Then equal volume (400 µl) of 1% Seakem 
Gold agarose (Fisher Scientific, UK) were gently mixed into cell suspension and dispensed 
the mixture into plug mold immediately. After 15-20 minutes (when plugs are solid), they are 
placed into 5ml cell lysis buffer supplemented with 25 µl Proteinase K solution (20mg/ml, 
final concentration is 0.1 mg/ml). Plugs were digested in a 54-54oC shaker at 200 r.p.m. 
After for 2 h incubation, lysis buffer was discarded and plugs were washed by sterile water 
twice in 54-54 oC shaker for 10-15 minutes each time, and subsequently washed in pre-heat 
1X TE buffer for another four times in 54-54 oC shaker for 10-15 minutes each time. After 
washing procedures, plugs can be stored in TE buffer with 1mM EDTA at 4 oC until needed.  
2.17.2 S1 enzyme digestion  
    Plugs are placed into a 48-well plate individually, then 300 µl of 1/10 TE buffer was added 
and incubated at room temperature for 20 minutes, followed by adding 200 µl of 1X S1 
buffer at room temperature for 20 minutes. After washing procedure, the S1 buffer is 
removed and 150U S1 enzyme (Invitrogen, Abingdon, UK) is added into each plug for 45 
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minutes at 37oC, or keep in the 4 oC overnight. After digestion, each plug is cut in one-third, 
and then added to the gel. Ethidium bromide (20 µl of 10 mg/ml solution) is added to the gel 
running buffer 0.5X TBE. Electrophoresis was conducted on a CHEF-DR III apparatus (Bio-
Rad, Hercules, CA, USA) under the following conditions: 6 V/cm at 14 oC, with an initial 
pulse time of 5 s and a final pulse time of 45 s for 18 h. The results are visualized after gel 
running on a UV trans-illuminator and photographed using a UVP geldoc II imaging system 
(UVP Cambridge, UK). Plasmid number and sizes are determined by comparison with the 
molecular size marker (PFG ladder, NEB, UK).  
2.17.3 In Gel Hybridisation 
    Gels are dried by placing in a drying cabinet at 50 oC overnight between 2 sheets of 
blotting paper. Once dried, gels are re-hydrated by placing in 200 ml of deionized DNase free 
water in a flat-bottomed pyrex glass bowl. After 5 minutes, 200 ml of denaturing solution is 
added to denature the DNA in the gel at room temperature for 45 minutes, followed by 
adding 200 ml of neutralising solution and incubated for 45 minutes at room temperature. 
Once the neutralising solution discarded, the gel was placed in a hybridisation tube with 20ml 
of pre-hybridisation solution and incubated at 65 oC for 12 h, in order to block the gel before 
probing.  
    The probe is prepared by the random priming labelling method using the purified PCR 
product (ideally PCR product with 800-1000bp and 200ng in 15µl sterile water) (Prime-It II 
Random Primer Labelling Kit, Agilent Technologies, UK) and radio-active P32 labeled dCTP 
(PerkinElmer, London, UK), according to the standard protocol provided by the manufacture. 
Once the probe has been labelled, unincorporated dCTP32 and unlabelled nucleotides are 
removed using a sephadex G50 gravity flow gel filtration column (illustraTM NickTM Columns 
Sephadex G-50 DNA grade, GE Healthcare Life Sciences, UK.): in brief, 60 µl of labelled 
probe is added to the gel filtration column, followed by adding 320 µl of 0.1M Tris buffer 
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(pH7.5). A new Eppendorf tube is then placed under the column and the labelled DNA is 
eluted with 430 µl of 0.1M Tris buffer. The labelled probe is then boiled for 6 minutes and 
then added to the pre-hybridised gel and left to hybridize at 65 oC overnight. Once hybridised, 
the probe is discarded and the gel is washed for 1 hour at 65 oC with 2X SSC 0.1% SDS 
(100mls) and the second washing is with 100mls of 0.1X SSC, 0.1% SDS at 65 oC for 1 hour. 
Once washed, gels are finally removed from the hybridisation tubes, washed with warm tap 
water for 1-3 minutes and blotted dry with blotting paper. They are then wrapped in clingfilm 
and placed against a sheet of Lumi-Film Chemiluminescent Detection film (Roche, 
Mannheim, Germany), in a film cassette for at least 24 hours before developing using 
standard film development and fixer solutions. 
 
2.18 Confocal Laser Scanning Microscopy imaging using LIVE/DEAD® staining 
    E. coli TOP10 (mcr-1/pBAD), E. coli TOP10 (pBAD only) and E. coli TOP10 (n=4) were 
grown overnight in LB broth supplemented with 100 mg/L ampicillin (Fisher Chemical, UK) 
at 37°C (220 r.p.m.). Overnight cultures were standardised to OD600 0.05 and inoculated 
(1:10; v/v) into 96-well glass-bottomed plates (Whatman®, UK) in LB broth for 16 h (37°C; 
50 r.p.m.).  The supernatant was gently removed and the biofilms were further incubated in 
fresh LB broth ± L-arabinose (0.2%, w/v) for 8 h.  The supernatant was removed and the 
biofilms stained with 6% LIVE/DEAD® (v/v; BacLightTM Bacterial Viability Kit, Invitrogen) 
in phosphate buffered saline (PBS) prior to confocal laser scanning microscopy 
(CLSM) imaging (Leica TCS SP5) with ax63 lens. The CLSM z-stack images were analysed 
using COMSTAT image analysis software for quantification of biofilm biomass. 
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2.19 Whole genome sequencing and bioinformatics analysis  
Total genomic DNA (gDNA) was extracted from an overnight culture (2ml) on a QIAcube 
automated system (Qiagen). Following extraction gDNA was quantified by fluorometric 
methods using a Qubit (ThermoFisher Scientific), with quality ratios of gDNA (A260/280 
and 260/230) determined via Nanodrop (ThermoFisher Scientific). gDNA libraries are 
prepared for whole genome sequencing using the NexteraXT kit (Illumina), as described by 
the manufacturer. Paired end sequencing was performed using the Illumina MiSeq platform 
(MiSeq Reagent V3 Kit; 2x 300 cycles). For each E. coli isolate, at least 80x coverage was 
generated. Raw sequence reads were trimmed using Trim Galore and the genomes were de 
novo assembled into contigs using SPAdes (3.9.0) with pre-defined kmers set.  Raw reads 
were also assembled with Geneious (10.0.9) de novo assembler, set at medium sensitivity for 
analysis of paired Illumina reads.  Geneious was used to map both sets of contigs to reference 
genes identified by closest BLAST homology and was also used to annotate genes from 
closest homologues in NCBI Genome database.  
 
2.20 Bioinformatic analysis  
    (i) MLST analysis. For each mcr-carrying E. coli isolate for which the whole genome 
sequence was available, wgMLST profiles were generated using the CGE platform 
(https://cge.cbs.dtu.dk/services/MLST/), coupled with the PubMLST.org database(Larsen et 
al., 2012). 
    (ii) WGS analysis. Resistance genes and virulence factors were identified using Resfinder 
and VirulenceFinder within CGE (https://cge.cbs.dtu.dk/services/) (Zankari et al., 2012). In 
addition, database for toxin-antitoxin systems (TAs) and metal resistance operons were 
created and determined using Geneious 10.0.7. Based on the genomic difference in their core 
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genome, phylogenetic tree was built using Harvest software and visualized using iTOL v3.3.1 
(http://itol.embl.de/).  
(iii) Plasmid analysis: Identification of plasmid incompatibility groups of mcr-bearing 
plasmids were performed using Plasmidfinder (https://cge.cbs.dtu.dk/services/PlasmidFinder/) 
(Carattoli et al., 2014). Alignment and visualization of plasmids was performed with BRIG 
v0.9555. The majority of the isolates and plasmids described in this study were sequenced 
using a short read Illumina Miseq, which are unable to generate a high quality assembly of 
the plasmids due to the high number of repeat copies present in their sequence. Therefore, no 
phylogenetic analysis of the mcr-carrying plasmids was conducted in this study. 
(iv) Genetic dataset of virulence factors in Klesiela pneumoniae: Briefly, using whole-
genome sequence data, we have developed a database with publicly available genomes 
(Genbank accession Numbers are abbreviated as GB.No.) [NTUH-K2044 (GB.No. 
AP006725.1, AB117611.1), pK2044 (GB.No. NC_006625.1), pLVPK (GB.N. 
NC_005249.1), allantoin metabolism (GB.No. AB115590.1), SB3193 (GB.No. LK022716.1), 
uge CDS (GB.No. AY294624.1), Kp52.145 (GB.No. FO834906.1), SB4536_2858 (GB.No. 
HG518478.1), pO26-Vir (GB.No. NC_012487.1), IHE3034 (GB.No. AM229678.1), kvg 
operon (GB.No.  AJ250891.2)] to determine the key virulence factors in K. pneumoniae 
strains. There are at least five groups of pathogenicity factors in this dataset, these include 
gene clusters associated with serum resistance (traT); adhesins (type I firmbrial operon 
fimABCDEFGH, and type III firmbrial operon mrkBCDEF); lipopolysaccharide (wabGHN); 
siderophore systems (enterobactin-encoding entABCDEFS, and aerobactin-encoding 
iucABCD, iutA) and capsular synthesis loci (wzi/wzc typing); the iron acquisition operons 
kfuABC, and iroE, urease-synthesis operon ureABCDEFG associated with gastric ulceration 
and urinary stone formation. 
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(v) Genetic dataset of TAs in MCRPEC strains: a total of 22 pairs of known TAs were 
created for the presence of TAs in our collection MCRPEC strains in Chapter 6. The 
Genbank accession Number of these TAs were provided as follow: ccdA/ccdB (GB.No. 
6382276/6382275); chpA/chpR (GB.No. 8183452/8183453), chpB/chpS (GB.No. 14970161/ 
14970992); dinJ-yafQ (GB.No. 8114747/8114741); doc-phd (GB.No. 2777474/2777473); 
ghoS/ghoT (GB.No. 948646/1450308); hicA/hicB (GB.No. 945989/946001); higA/higB 
(GB.No. 8115408/8116456); hipA/hipB (GB.No. 946064/946065); hok-sok (GB.No. 
16833926/16833886); mazE/mazF (GB.No. 947245/947252); mqsA/mqsR (GB.No. 
8116442/8116443); pemK/pemI (GB.No. 8319148/8139206); relB/relE (GB.No. 
12674638/6062222); stbD/stbE (GB.No. 10549005/5850679); tisA/tisB (GB.No. 
5061526/5061527); vagC/vagD (GB.No. 7324544/17500432); vapB (GB.No. 20492652); 
yacA/yacB (GB.No. 18252642/18252641); yafN/yafO (GB.No. 8179628/8179629); 
yeeU/yeeV (GB.No. 7148618/7148613); and yefM/yoeB (GB.No. 7149349/7148625). 
(vi) Genetic dataset of heavy metal determinants in MCRPEC strains: 26 representative 
heavy metal resistance genes were created and the Genbank accession Number of these genes 
were provided as follow:  
arsenic resistance genes: arsA (GB.No. 12884544), arsB (GB.No. 948011); arsC (GB.No. 
12884546); arsD (GB.No. 1446554); and arsR (GB.No. 12884461).  
copper resistance genes: copA/incA (GB.No. 24954233); cusS (GB.No. 945978); pcoA 
(GB.No. 5616826); pcoB (GB.No. 5616826). 
mercury resistance genes: merA (GB.No. 18252634); merC (GB.No. 30522719); merR 
(GB.No. 16834528). 
silver resistance genes: sliA (GB.No. 12880691); sliB (GB.No. 7145791); sliC (GB.No. 
5616818); sliE (GB.No. 7145035); sliF (GB.No. 15486578); sliP (GB.No. 12756650); sliR 
(GB.No. 5616817); sliS (GB.No. 5616816). 
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Chapter 3  
Balancing mcr-1 expression and bacterial survival is a delicate equilibrium 
between essential cellular defence mechanisms 
 
3.1 Brief background 
     The global concern over colistin resistance has profound implications as to how we 
successfully manage and treat serious Gram-negative infections, particularly those caused by 
Enterobacteriaceae (Olaitan & Li, 2016, Jeannot et al., 2017). Until recently, our 
understanding of colistin resistance was limited to chromosomal changes such as the 
pmrA/pmrB activation of arnBCADTEF and pmrE, that collectively modify 
lipopolysaccharide (LPS), the component of the Gram-negative outer-membrane by the 
addition of 4-amino-4-deoxy-L-arabinose (Olaitan et al., 2014).  However, the advent and 
subsequent reporting of plasmid mediated colistin resistance, mcr-1, in both animal and 
human health, has invoked commentaries announcing a return to the pre-antibiotic era. Since 
the first described mcr-1 in November 2015, it has been reported in over 40 countries (see 
Fig.1.5 in Chapter 1). Regrettably, as the main bacterial host of mcr-1 is Escherichia coli, 
there are also significant public health4 and environmental issues as MCR-1 positive E. coli 
(MCRPEC) has been reported from migratory birds (Wang et al., 2017, Wang et al., 2017), 
flies (Wang et al., 2017), dogs (Wang et al., 2017), imported reptiles (Unger et al., 2017), 
rivers (Zurfuh et al., 2016) and inevitably public water facilities (Sun et al., 2017) (see 
Fig.1.6 in Chapter 1). However, mcr-1 encodes an enzyme that catalyzes the transfer of 
phosphoethanolamine onto a phosphate of the N-acetylglucosamine head group of lipid A in 
the bacterial outer-membrane, which may modify the structure of lipid A and alter its ability 
to induce the innate immune response and modify the clinical pathogenicity of bacterial 
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infections. Furthermore, colistin MICs displayed by MCRPEC are moderate (usually 2-8 
mg/L) when compared to the level of colistin resistance (usually 8-256mg/l) mediated by, for 
example, increased expression of pmrA/pmrB, inferring that the expression of mcr-1 is tightly 
controlled (Olaitan et al., 2014, He et al., 2017, Wang et al., 2017). This, in part, is supported 
by recent studies on plasmid copy number where mcr-1 were only found on plasmids of a 
relatively low copy number (Bontron et al., 2016, Denervaud Tendon et al., 2017). Here, I 
investigated the impact of mcr-1 expression on bacterial morphological changes, fitness, 
competitiveness, immune stimulation and virulence. Furthermore, we analyse the fitness and 
virulence MCRPEC high-level colistin resistant mutants.  
 
3.2 Results 
3.2.1 Molecular models of colistin binding and mcr-1-catalyzed phosphoethanolamine 
transfer to lipid A  
    It has been well-known that the antibacterial activity of polymyxins depends on 
electrostatic attraction between cationic residue of polymyxin and the anionic phosphate 
head-groups of lipopolysaccride (LPS) in the outer membrane of GNB, resulting in 
disarrangement of the bacterial cell membrane (Newton, 1956, Falagas et al., 2005) (see 
Fig.1.3 in Chapter 1). A molecular model of polymyxin B binding to lipid A is displayed in 
Fig.3.1, which is based on the three-dimensional nuclear magnetic resonance (NMR) 
structure of polymyxin in complex with lipid A (Pristovsek & Kidric, 1999, Velkov et al., 
2010): the positively-charged Dab residues closely interact with the negatively-charged 1’- 
and 4’-phosphate groups of lipid A, reducing the net-negative charge of lipid A. The 
hydrophobic leucine residues and tail of polymyxin interact with the fatty acid tails of lipid A. 
This initial electrostatic interaction between polymyxin and LPS molecules in the outer 
membrane of the GNB leads to displace divalent cations, magnesium (Mg+2) and calcium 
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(Ca+2), which act as a bridge to stabilize the LPS molecules, allowing polymyxins to insert 
into the bacterial outer-membrane (Storm et al., 1977, Yu et al., 2015). As a result, this 
insertion of hydrophobic residues [(D-Phe6 -L-Leu7 (polymyxin) or D-Leu6 -L-Leu7 (colistin)] 
and the fatty acyl chain acts to disrupt and destabilize the monolayer of outer-membrane, 
eventually the permeability of the cell wall to polymyxins is increased, that ultimately causes 
cell death.  
    However, mcr-1 encodes an enzyme that catalyzes the transfer of phosphoethanolamine 
onto a phosphate of the N-acetylglucosamine head group of lipid A in the bacterial outer-
membrane (Fig.1A) (Gao et al., 2016, Hinchliffe et al., 2017). Positively-charged 
phosphoethanolamine addition onto the 1’-PO4 of lipid A likely interferes with the interaction 
of positively charged Dab8 and Dab9 side chains with the phosphate group, reducing colistin 
affinity to the outer-membrane of Gram-negative bacteria (Fig.1C). 
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Fig.3.1 Molecular model of colistin binding to lipid A.  
A, Schematic of phosphoethanolamine transfer to the 1-PO4 group of hexa-acylated lipid A as 
catalysed by MCR-1.  
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B. Chemical structure of colistin, a polycationic peptide containing the hydrophobic tail and 
hydrophilic cyclic peptide made of amino acids L-threonine (Thr), D-leucine (Leu) and L-α,γ-
diaminobutyric acid (Dab).  
C, Models of colistin (blue sticks) binding to lipid A (left) or phosphoethanolamine-lipid A (right) 
(spheres coloured green, red, blue and orange for C, O, N and P atoms, respectively). The model is 
based on the NMR and docking studies of polymixin B binding to lipid A with lipid A coordinates 
from PDB 3fxi (Pristovsek & Kidric, 1999) and colistin coordinates adapted from the NMR structure 
of polymixin B bound to lipid A (Park et al., 2009). The positively-charged Dab colistin residues 
closely interact with the negatively-charged 1’ and 4’ phosphate groups of lipid A, reducing the net-
negative charge of lipid A. The hydrophobic leucine residues and tail of colistin A interact with the 
fatty acid tails of lipid A, allowing colistin A to insert into, and disrupt, the bacterial outer-membrane. 
(right), model of colistin binding to phosphoethanolamine-lipid A indicates addition of positively-
charged phosphoethanolamine onto the 1’-PO4 of lipid A likely interferes with the interaction of 
positively charged Dab8 and Dab9 side chains with the phosphate group, preventing colistin binding 
to the outer-membrane of Gram-negative bacteria. Figures were created using Pymol 
(https://www.pymol.org/). 
 
3.2.2. Effects of mcr-1 overexpression on bacterial growth and fitness 
    The mcr-1 coding region obtained from pHNSHP45 was constructed into plasmid pBAD 
to generate strain E. coli TOP10 mcr-1/pBAD (mcr-1/pBAD) (see Methods 2.2 in Chapter 
2).  Laboratory strains and plasmids studied in this Chapter are list in Appendix III Table 
3.1. To determine whether the expression of mcr-1 affects bacterial growth rate and fitness, 
we examined growth curves, qRT-PCR and competition assays for E. coli TOP10 carrying 
the mcr-1-pBAD plasmid construct. The expression level of mcr-1 was induced by increasing 
concentrations of L-arabinose and measured by qRT-PCR (Fig.3.2B). Maximal mcr-1 
induction was observed at 0.02% L-arabinose, where mcr-1 expression was approx. 2-fold 
and 3-fold more than the arabinose concentrations of 0.002% and 0.2%, respectively. As 
shown in Fig.3.2A, after 8 h, the growth rates of E. coli strains induced by 0.2% and 0.02% 
(w/v) of L-arabinose showed approximately a 3-log10 unit decrease when compared to E. coli 
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TOP10 (mcr-1/pBAD) without L-arabinose. As the initial inoculum was approx. 7.5 log10 
(CFU mL-1), and this decreased to approx. 5 log10, it also suggests over-expression of mcr-1 
decreases cell populations. In-vitro competition experiments were also performed to 
determine the effect of mcr-1 expression on the relative fitness of E. coli (mcr-1/pBAD) with 
different mcr-1 levels (see Methods 2.13 in Chapter 2). Results are shown in Fig.3.2C and 
indicate that increased mcr-1 expression levels were associated with a significant fitness 
burden in vitro. For example, inducing high levels of mcr-1 expression with 0.2% L-
arabinose remarkably decreases relative fitness (average relative fitness 0.43, p=0.0022, using 
non-parametric Mann-Whitney test, see Methods 2.13 in Chapter 2) by more than 50% 
relative to uninduced controls (Fig.3.2C and Appendix III Table 3.2). Although the 
maximal expression of mcr-1 was induced by 0.02% arabinose, the greatest fitness loss was 
observed in 0.2% arabinose-induced strain, this disparity is probably because bacteria 
viability is lower in 0.2% arabinose-induced strains showed in Fig.3.2A, when comparing to 
that in 0.02% arabinose-induced strains. Additionally, to eliminate these observations being 
singularly due to the overexpression of a random protein, our negative control, blaTEM-1b, 
when overexpressed showed very similar growth curves to the uninduced E. coli cells 
(Fig.3.3).    
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Fig.3.2 Effects of mcr-1 overexpression on bacterial growth and fitness in vitro. A. Overproducing 
mcr-1 causes variable effects on growth rate depending on the concentrations of L-arabinose (n=3). B, 
the expression levels of mcr-1 gene induced by increasing concentrations of arabinose for 8 h, were 
measured by qRT-PCR (n=2). C, relative fitness of mcr-1 overexpressing strain mcr-1/pBAD 
competing control strain pHT315 under increasing concentrations of L-arabinose (0.0002% vs 0%, 
0.002% vs 0%, 0.02% vs 0%, 0.2% vs 0%). Error bars represent the S.D (n=6). The differences in 
fitness were tested using non-parametric Mann-Whitney test, ** indicates the p-values is less than 
0.05. The average relative fitness and p-values are listed in supplementary Table 6.  
 
 
 
Fig. 3.3 In vitro growth curve of mcr-1 derivatives and a negative control E. coli TOP10 strain 
carrying blaTEM-1b. The means of three independent replicates were shown and the error bars 
represent the S.D (n=3). 
 
3.2.3 Over-expression of mcr-1 affects cellular morphology  
    As mcr-1 encodes the transfer of phosphoethanolamine onto a phosphate of the N-
acetylglucosamine head group of lipid A in the bacterial outer-membrane9. We employed 
transmission electron microscopy (TEM) and study the cellular morphology of E. coli 
(TOP10) under induced (0.2% [w/v] L-arabinose) and non-induced conditions (Fig.3.4). Both 
control strains, E. coli TOP10 with pBAD minus mcr-1, and E. coli TOP10 (mcr-1/pBAD) 
without L-arabinose induction, showed normal cellular characteristics with a multi-layered 
cell surface consisting of a distinct, structured outer-membrane, a peptidoglycan layer in the 
periplasmic space, a normal cytoplasmic membrane and typically granular cytoplasm 
(Fig.3.4A and Fig.3.4B). Significant morphological changes were however, observed in E. 
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coli TOP10 (mcr-1/pBAD) treated with 0.2% L-arabinose for 8 h (Fig.3.4C). In particular, 
with the outer cell membrane cell envelope (Fig.3.4F). The outer-membrane region exhibited 
altered structural integrity, varying markedly in thickness and density it could not be 
differentiated from the cell wall or the cytoplasmic membrane (Fig.3.4D, E and F). TEM 
analysis on E. coli where mcr-1 is over-expressed shows other gross cellular changes 
including complete loss of the “bacilli” morphology and absence of electron-dense material 
appeared as empty ‘ghost’ cells (Fig.3.4C). By comparison, E. coli TOP10 with pBAD minus 
mcr-1, and E. coli TOP10 (mcr-1/pBAD) without L-arabinose induction possess 
homogeneous electron densities in the cytoplasm and exhibited unaltered multi-layers of cell 
membrane (Fig.3.4A and B) confirming that it is the high-level expression of mcr-1 that has 
induced these gross morphological changes. In order to rule out effects caused by high 
concentration of L-arabinose, we examined E. coli TOP10 with pBAD alone (minus mcr-1) 
with 0.2% L-arabinose induction (Fig.3.5). Induction resulted in an intact cell wall with a 
well-define inner and outer-membrane, and a highly homogeneous electron density in 
cytoplasm were observed (Fig.3.5), further supporting that cell membrane impairment is due 
to the expression of mcr-1 gene only. 
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Fig.3.4 TEM micrographs of untreated and treated E. coli. In A and B, TEM micrographs of 
untreated control cells (E. coli TOP10 with pBAD minus mcr-1, and E. coli TOP10 (mcr-1/pBAD) 
without L-arabinose induction, respectively) (see methods 2.12 in Chapter 2). Both control cells are 
intact with a well-define inner and outer-membrane, and showed a highly homogeneous electron 
density in cytoplasm region. C, TEM micrographs of mcr-1 over-producing cells, the damaging outer-
membrane and some completely lysed cells were observed.  
 
 
Fig.3.5 TEM micrographs of control cells: E. coli TOP10 with pBAD minus mcr-1 with L-
arabinose induction (0.2%) for 8 h (see methods 2.12 in Chapter 2), cells are intact with a well-define 
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inner and outer-membrane, and showed a highly homogeneous electron density in cytoplasm region. 
This result can rule out effects caused by high concentration of L-arabinose. 
 
3.2.4. Effects of mcr-1 overexpression on bacterial survival  
    As the growth curves from Fig.3.2A suggest that over-expression of mcr-1 reduces cell 
counts and given its profound effect on the E. coli cell structure and morphology, we 
investigated the effects of mcr-1 on cellular viability and biofilm assembly, using 
LIVE/DEAD® staining with confocal laser scanning microscopy (CLSM) imaging and 
COMSTAT analysis in E. coli TOP10 (mcr-1/pBAD) biofilms with/without 0.2% L-arabinose 
induction (Fig.3.6). The observed marked reduction of viability in bacterial cell 
overexpressing mcr-1 (Fig.3.6), was contrast with the minimal reduction in bacterial viability 
observed in E. coli TOP10 with pBAD minus mcr-1, and E. coli TOP10 (mcr-1/pBAD minus 
L-arabinose induction) (Fig.3.6A and B). COMSTAT analysis of the CLSM biofilm images 
revealed that relative dead/live biomass ratio (Fig.3.6D) of induced E. coli TOP10 (mcr-
1/pBAD) was at least six times higher than E. coli TOP10 with pBAD minus mcr-1, and E. 
coli TOP10 (mcr-1/pBAD) minus arabinose (0.33 versus 0.06; p<0.001, using one-way 
analysis of variance (ANOVA)). Morphological alterations were also apparent in CLSM 
imaging, where the live cells (green) in Fig.3.6C appeared more spherical and “bloated”, in 
keeping with the changes observed in the TEM studies (Fig.3.4C). Overexpression of blaTEM-
1b showed no evidence of increased cell death compared to that of E. coli TOP10 with pBAD 
minus mcr-1, and E. coli TOP10 (mcr-1/pBAD) minus L-arabinose induction (Fig.3.8 and 3.9) 
providing further evidence that the cellular effects seen with increased expression of MCR-1 
are not due to the fitness burden of protein expression.     
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Fig.3.6 The toxic effects of mcr-1 overexpression on cell viability. A-C, Confocal Laser Scanning 
microscopy images of cells treated with/without L-arabinose for 8 h and stained with LIVE/DEAD® 
(n=3). Live and dead cells presented green and red colour, respectively (see methods 2.18 in Chapter 
2). Scale bar is 15 µm. D, Ratio of Dead to Live bacteria (biomass) obtained from CLSM z-stack 
images through COMSTAT analysis of E. coli biofilms grown for 16 h in LB broth, followed by ± L-
arabinose (0.2% w/v; 8 h) treatment, where the biofilms were stained with LIVE/DEAD® (n=4). The 
COMSTAT data was assessed using one-way analysis of variance (ANOVA) followed by Tukey-
Kramer Multiple comparisons post-hoc test. Statistical significance was set at p < 0.05. 
 
3.2.5. mcr-1-mediated membrane-bound resistance mechanism 
Our previous study has shown that MCR-1 is a membrane-bound enzyme consisting of 
five hydrophobic transmembrane helixes and a soluble form located in the periplasmic 
domain (Hinchliffe et al., 2017). To examine whether the transmembrane domain or MCR-1 
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catalytic domain (typified by aspartate at position 246) plays a role on cell integrity and 
bacterial fitness, MCR-1 (E246A), and a MCR-1 soluble domain (residues 219-541 and 
lacking the N-terminal membrane-bound region) mutant, were cloned into a pBAD–hisA 
plasmid. Both constructed plasmids were transferred into TOP10 cells and induced with 0.2% 
(w/v) L-arabinose at exponential phase. Results show that increased expression of MCR-1 
(E246A) produced a toxic effect on the E. coli cells as evidenced by decreased growth rate 
(Fig.3.3), moderate fitness loss (Fig.3.7) and significant membrane degradation (Fig.3.8). In 
contrast, the increased expression of the MCR-1 soluble domain (219-451) did not show any 
marked changes in growth rate, fitness loss or membrane architecture (Fig.3.3, 3.7 and 3.8). 
However, the toxic effects of the MCR-1 (E246A) mutant is moderate, compared to the 
marked effect of MCR-1 wild-type (Fig.3.2, 3.4 and 3.6).  For example, increased expression 
of the full-length mcr-1 gene caused at least three times higher bacterial death than E.coli 
with over-producing incomplete MCR-1 (E246A) (dead/live bacteria ratio, 0.33 versus 0.09) 
(Fig.3.9). Therefore, our data indicate that the fitness loss and the destruction of the 
membrane architecture is due to both the embedding of the protein in the E. coli outer 
membrane and the phosphoethanolamine modification of LPS. Phosphoethanolamine 
addition on Lipid A in MCRPEC has been observed by ESI-QTOF/MS (Appendix III 
Fig.3.1). 
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Fig.3.7 Relative fitness of E. coli TOP10 stains with full-length mcr-1, catalytically inactivated mcr-1 
(E246A) and mcr-1 soluble domain. Fitness of the blaTEM-1b-positibve strain as a negative control. 
Error bars represent the S.D (n=6). The differences in fitness were tested using non-parametric Mann-
Whitney test, ** indicates the p-values is less than 0.05. 
 
 
 
Fig.3.8 TEM micrographs of mcr-1 mutants. A and B, TEM micrographs of mcr-1 mutation 
implicated in its active site, E246A, and MCR-1 soluble domain, respectively. C, TEM micrographs 
of a negative control, blaTEM-1b, a highly homogeneous electron density in cytoplasm region were 
observed.  
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Fig.3.9 The toxic effects of mcr-1 mutants on cell viability. A-C, Confocal Laser Scanning 
microscopy images of cells treated with L-arabinose (0.2% w/v; 8 h) and stained with LIVE/DEAD® 
(n=4). Live and dead cells presented green and red colour, respectively. D, Ratio of Dead to Live 
bacteria (biomass) obtained from CLSM z-stack images through COMSTAT analysis (n=4). The 
COMSTAT data was assessed using one-way analysis of variance (ANOVA) followed by Tukey-
Kramer Multiple comparisons post-hoc test. 
 
3.2.6 mcr-1-mediated LPS modification reduced the stimulation of macrophage  
    mcr-1 encodes an enzyme that catalyzes the transfer of phosphoethanolamine onto a 
phosphate of the N-acetylglucosamine head group of lipid A, which may modify the structure 
of lipid A and alter its ability to induce the innate immune response and eventually modifying 
the clinical pathogenicity of bacterial infections. Therefore, to investigate whether the 
modified LPS of MCRPEC alters the activation of human macrophage THP-1, LPS-mediated 
human macrophage stimulation assays were undertaken. The macrophages were activated by 
serial concentrations (4.5, 0.45, 0.045 and 0.0045 ng mL-1) of LPS extracted from E. coli 
TOP10 with pBAD minus mcr-1, and E. coli TOP10 (mcr-1/pBAD plus 0.2% L-arabinose). 
The production of IL-6 and TNF were assayed by using DuoSet® ELISA kit (R&D systems, 
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UK). The concentrations of IL-6 produced by macrophages induced by unmodified LPS were 
consistently higher than IL-6 levels produced by MCR-1 modified LPS at 8 and 24 h 
(Fig.3.10A and B). Additionally, TNF-alpha levels were also higher in macrophages 
stimulated by unmodified LPS than compared to modified LPS (Fig.3.10C).  
 
 
 
Fig.3.10 Expression of cytokines in LPS-mediated THP-1 macrophage. A, B and C, indicated IL-
6 (n=2) and TNF-alpha (n=3) productions in the modified LPS (Grey) or normal LPS (Red)-treated 
cell culture, respectively. Error bars represented S.D. 
 
3.2.7. Acquisition of high-level colistin resistance mutants 
    MCRPEC was first discovered on the premise that E. coli can rarely acquire colistin 
resistance by chromosomal mutations alone and that the levels mediated by mcr-1 are 
moderate compared with other mechanisms1, 2, 9. Data previously published by us would 
suggest that the level of in vivo colistin resistance mediated by MCRPEC can protect the cells 
compared to control strains9. However, the data from Fig.3.2-Fig.3.6 would suggest that the 
expression of mcr-1 is also very tightly controlled because of the fitness cost of increased 
mcr-1 expression. We have generated high-level colistin resistance mutants (HLCRMs) from 
wild type MCRPECs with low levels of colistin resistance (MIC 4-8 mg/l) (Yang et al., 
2017). We also exposed E. coli TOP10 (mcr-1/pBAD), E. coli TOP10 (pBAD) and E. coli 
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TOP10 in increasing concentrations of colistin. After a 14-day serial colistin challenge, E. 
coli TOP10 (mcr-1/pBAD) (in the absence of arabinose) displayed a 64-fold (from 0.5 to 32 
mg/L) increase in colistin MICs (Fig.3.11). However, both E. coli TOP10 (pBAD) and E. coli 
TOP10 did not show any elevation in colistin MICs remaining at 0.25 mg L-1 +/- one dilution 
over the 14-day challenge. These data indicate that the increase in colistin resistance shown 
by E. coli TOP10 (mcr-1/pBAD) is singularly due to the presence of mcr-1.  
 
Fig.3.11 Acquisition and stability of high-level colistin resistance mutants. Changes in colistin 
minimum inhibitory concentrations (MICs) during 14-day challenging with increasing concentrations 
of colistin, in three laboratory strains  
 
3.2.8 in vitro relative fitness of HLCRMs 
    Our data examining the physiological burden of mcr-1 would suggest that the HLCRMs 
might even be defective in fitness and pathogenicity. Therefore, to compare the growth rates 
of the MCRPEC isolates with their respective HLCRMs, we measured growth over a serial 
time course of HLCRMs strains that showed different resistance levels of resistance to 
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colistin at day 0, 3, 7, 11 and 14. The growth curves results suggested that day-8 and day-14 
HLCRMs generated from E. coli TOP10 (mcr-1/pBAD) (both MICs of 16 and 32 mg L-1 for 
colistin, respectively), showed a decreased growth compared to that of their parental strains 
(Fig.3.12A). 
    Based on our data from bacterial growth curves, we propose there is substantial fitness 
disadvantage to the HLCRMs when compared to their MCRPEC parent strains. To test this 
hypothesis, in vitro competition assays were performed HLCRMs were directly competed 
against their MCRPEC parental strains. The fitness of the MRCPEC parent strains and 
HLCRMs were relative to the growth of the control strain which was fixed at 1.0 (see 
Methods). We examined the fitness cost for E. coli TOP10 (mcr-1/pBAD), E. coli TOP10 
(pBAD) and E. coli TOP10 (Fig.3.12B). Day 3 and 4 HLCRMs of E. coli TOP10 (mcr-
1/pBAD) had slightly less fitness (1.0 versus 1.1 of E. coli TOP10 (pBAD) and E. coli 
TOP10) and day 8 and 14 were less fit (0.83 versus 1.1, and 0.79 versus 1.1, respectively) 
(Fig.2.12B). Generally, our data shows a significant fitness burden with HLCRMs compared 
to their MCRPEC parent strains.  
 
 
Fig.3.12 Growth curves and relative fitness of mcr-1/pBAD HLCRMs. A. indicated the growth rate of 
E. coli TOP10 (mcr-1::pBAD) and their derivatives (samples from serial time points: D0, D3, D4, D8 
and D14). B. relative fitness of HLCRMs of E. coli TOP10 (mcr-1/pBAD) competing a control strain 
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pHT315. Error bars represent the S.D (n=6). The differences in fitness were tested using non-
parametric Mann-Whitney test, ** indicates the p-values is less than 0.05. The average relative fitness 
and p-values are listed in Appendix Table 3.2. 
 
3.2.9 Virulence reduction of MCRPEC 
In wild-type strains, the level of colistin resistance mediated by mcr-1 gene is often 
moderate (2-8 mg L-1). The in-vitro generated HLCRMs possessed reduced fitness and 
virulence. We also determined that even the low level of colistin resistance mediated by mcr-
1 gene in clinical strains attenuates bacterial virulence in the G. mellonella infection model. 
We chose four non-MCRPEC clinical strains, belonging to different ST types: ST638 (ff112), 
ST589 (ff141), ST127 (ff156) and ST648 (CX37), which is one of diverse ST groups 
associated with mcr-1 gene in China10. Three different mcr-1 plasmids isolated from 
MCRPEC strains (PN16, PN23 and ZJ487) were transferred to these non-MCRPEC strains 
by electroporation. We have shown that the acquisition of mcr-1 naturally occurring plasmids 
do not affect bacterial growth of the host (wild-type clinical strains) strain and so their fitness 
cost is modest (Fig.3.13). However, their virulence is markedly depleted (Fig.3.14) 
supporting our hypothesis that the loss of virulence shown by MCRPEC is not due to growth 
rate but by the activity of mcr-1 on the E. coli outer membrane.   
  In order to rule out of other factors harbouring in wild-type plasmid such as virulence 
clusters or toxin-antitoxin systems, would affect bacterial virulence, a length of 1626bp of 
mcr-1-coding region was cloned into a pUC19 vector, generating a pUC19::MCR-1 plasmid. 
The pUC19::MCR-1 plasmid was then transferred to two non-MCRPEC clinical isolates 
(ff141 and ff156) by electroporation. As showed in Fig.3.15A and B, the acquisition of mcr-1 
in clinical strain ff156 caused a significant decrease of bacterial virulence. When compared to 
the parental strain ff141, the virulence loss was also observed in clinical strain ff141 carrying 
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pUC19::MCR-1 plasmid, even their differences are minimal, further suggesting that the 
impaired virulence due to the activity of MCR-1 on bacterial endotoxin lipid A. 
 
Fig.3.13 In-vitro growth curve of six MCRPEC strains and their counterpart non-MCRPEC. The 
means of three independent replicates were shown and the error bars represent the S.D (n=3). 
 
 
Fig.3.14 Kaplan-Meier plots showing the percent survival of G. mellonella over 72 h post-infection 
with MCRPEC and non-MCRPEC human clinical strains. Survival curves were plotted using the 
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Kaplan-Meier method (GraphPad Software). Error bars represent the S.D (n=3) and p-value for A 
(t=8.654, d.f=4), B (t=8.050, d.f=4), C [t=12.07, d.f=4 for strain ff112 with pMCR-1(PN16) and 
t=3.479, d.f=4 for strain ff112 with pMCR-1(PN23)] and D (t=3.801, d.f=4) were calculated by 
student t-test. 
 
 
 
Fig.3.15 Kaplan-Meier plots showing the percent survival of G. mellonella over 72 h post-infection 
with MCRPEC and non-MCRPEC human clinical strains. Survival curves were plotted using the 
Kaplan-Meier method (GraphPad Software). 
 
3.3 Brief discussion 
    Acquiring antibiotic resistance by mutation or horizontal gene transfer tends to be 
associated with a fitness cost (Andersson & Levin, 1999, Andersson & Hughes, 2010, 
Vogwill & MacLean, 2015). This cost plays a key in limiting the spread and maintenance of 
resistance in pathogen populations by generating selection against resistant strains under 
conditions where antibiotic doses are low, for example, during transmission between hosts 
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(Andersson & Hughes, 2010, MacLean et al., 2010). However, recent studies have 
challenged this paradigm and provide evidence supporting the notion that, at least in some 
systems, the evolution of resistance can be associated with fitness advantages including the 
enhanced ability to cause disease (Roux et al., 2015, Guillard et al., 2016, Schroeder et al., 
2017). We have shown that the case for mcr-1 imposing a fitness cost on its E. coli host is 
substantial. Increased expression of mcr-1 not only impairs cell growth (Fig.3.2A) and 
diminishes bacterial fitness (Fig.3.2C), but also alters the cell’s architecture (Fig.3.4C) and 
kills the bacteria (Fig.3.6C). Evolving colistin resistance by acquiring mcr-1 therefore 
challenges bacterial populations with an evolutionary trade-off: high-levels expression of 
mcr-1 provide protection against the antibiotic, but this increase in resistance compromises 
growth rate, fitness, membrane structural integrity and increases cellular death. This trade-off 
may explain several important phenomena. First, mcr-1-mediated colistin MICs are at best 
moderate (usually 2-8 mg L-1) when compared to colistin resistance (8-256 mg L-1) mediated 
by pmrA/pmrB (Olaitan et al., 2014, Liu et al., 2015, Wang et al., 2017). Secondly, we show 
that mcr-1 plasmid copy number is very low (1-5 copies/cell), and this appears to protect the 
cell from too many copies of mcr-1 (Yang et al., 2017).  
    As a negative control, we show that the high-expression of blaTEM-1 has negligible effect on 
E. coli fitness and survival (Fig.3.3-3.9), and therefore the effects witnessed with MCR-1 are 
due to its incorporation into the E. coli membrane or by its catalytic action – the 
phosphoethanolamine modification of LPS. It is interesting to note, that only a few mobile 
membrane-associated antibiotic resistance mechanisms have been characterised. One of them 
is the tetracycline efflux system, e.g. tetA(B) which is tightly regulated by its neighbouring 
gene, tetR. It has been shown that over-production of tetA is lethal, which is probably due to 
its effect on the membrane topology (Moyed et al., 1983, Eckert & Beck, 1989, Coyne et al., 
2011). Unlike the tetA-like efflux pump system, mcr-1 does not possess an adjacent repressor 
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to control its expression and its expression is control by other regulatory systems such as low 
plasmid copy number. Compared with the considerable burden of high expression of MCR-1 
(Fig.3.2-3.6), the toxic effects of its two derivatives, MCR-1 E246A and MCR-1 soluble 
region, are moderate, which can be observed by some restoration of its outer membrane 
integrity and a reduction in death rate (Fig.3.8 and 3.9). However, as the toxic effects are 
more evident in MCR-1 E246A than the MCR-1 soluble region, therefore, cellular burden is 
due to both the embedding of the protein in the E. coli outer membrane and MCR-1 mediated 
PEtN modification of LPS.  
    Our data previously, and the stability data on HLCRMs, suggests that colistin resistance in 
MCRPEC and HLCRMs can be stable (Liu et al., 2015, Yang et al., 2017). Additionally, our 
data on E. coli TOP10 (mcr-1/pBAD) herein, shows that HLCRMs can be generated from a 
lab-strain, but only after acquisition of mcr-1 suggesting the increase in colistin resistance is 
not dependent on the strain background which is further supported by the fact that all our 
selected wild-type MRCPECs readily generated HLCRMs.  Finally, it is possible that colistin 
resistant strains will evolve compensatory adaptations that allow for mcr-1 to be expressed at 
high levels at a low fitness cost. Compensatory adaptation is routinely detected in 
vitro(Andersson & Hughes, 2010), and there is some evidence that compensatory adaptation 
maintains otherwise costly resistance mutations in vivo (Comas et al., 2012).   
     Due to its central clinical role in causing Gram-negative bacterial sepsis, lipid A as an 
immune modulator has been thoroughly scrutinised (Matsuura, 2013, Needham & Trent, 
2013).  However, despite the fact that both mechanisms of 4-amino-4-deoxy-L-arabinose and 
phosphoethanolamine LPS modification are well known, there have been very few systematic 
studies examining their impact on lipid A as an immune stimulant. Studies on Salmonella 
have examined the addition of phosphoethanolamine and found no significant change in 
virulence (Tamayo et al., 2005). This data is supported by a recent study in Haemophilus 
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ducreyi that used knock-out deletions of phosphoethanolamine modifying genes (lptA, ptdA 
and ptdB) and concluded that the triple mutant was a virulent as the parent (Trombley et al., 
2015). A recent study by John and colleagues examined the phosphoethanolamine and its 
effect in Neisseria meningitidis by comparing invasive and carrier isolates and found more 
phosphoethanolamine and sialic acid substitutions from invasive strains suggesting that 
phosphoethanolamine-lipid A modification enhances virulence (John et al., 2016). This 
finding also has been identified in non-mcr-1 mediated colistin resistance in K. pneumoniae, 
where lipid A remodelling mediated by the mgrB mutation, resulted in increased colistin 
resistance enhancing the virulence of K. pneumoniae by decreasing the affinity of colistin and 
attenuating host defence response (Kidd et al., 2017). These data are further supported by 
O’Brien and colleagues examining Campylobacter jejuni phosphoethanolamine modified 
lipid A, showed increased recognition of a human Toll-like receptor and increased 
commensal colonisation in mice (Cullen et al., 2013). However, Zughaier et al. examined 
Neisseria gonorrhoeae phosphoethanolamine modified lipid A and showed that it reduced 
autophagy in human macrophages and useful mechanism to evade the host immune system  
(Zughaier et al., 2015). Thus far, there are no similar studies on E. coli and this is the first 
examining the effect of mcr-1 on E. coli fitness and virulence. The data presented in this 
study indicates that E. coli [in this case E. coli TOP10 (mcr-1/pBAD)] is forced to finely tune 
the expression of mcr-1 or else the over-expression becomes toxic resulting in profound 
changes in the architecture of the outer-membrane, causing leakage of cellular cytoplasm 
(Fig.3.4C) and death (Fig.3.6C).  
    As mcr-1 continues to spread globally, and the clinical impact is assessed, it will be 
interesting to examine how virulent MCRPEC compare with non-MCRPEC. In this study, 
mcr-1 positive plasmids were transferred to non-MCRPEC clinical strains (ST638 (ff112), 
ST589 (ff141), ST127 (ff156) and ST648 (CX37)) by electroporation. We have shown that 
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the growth rate of all mcr-1 positive transformants appears to be lower than that of their non-
MCR parents, but the difference is not statistically significant (Fig.3.13). Compared to non-
MCRPEC strains from phylogenetic group D (considered as second-most virulent ExPEC 
group), the mortality of G. mellonella showed a marked reduction after acquisition of a mcr-
1-positive plasmid (Fig.3.14). To conclude, it would appear the acquisition of mcr-1 by E. 
coli is a “poisoned chalice” -on the one hand mcr-1 is required to provide protection in a 
colistin rich environment, yet acquisition compromises the bacterium’s normal physiology; 
furthermore, over-expression results in acute “toxicity”.  
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Chapter 4     
The effect of the expression of two variant of mcr-3 genes on bacterial fitness and 
competitiveness 
 
4.1 Brief introduction 
Since the discovery of mcr-1 gene in late 2015, another seven different mcr-like genes and 
their variants have been subsequently found, namely, mcr-2, mcr-3, mcr-4, mcr-5, mcr-6, 
mcr-7 and mcr-8 (Xavier et al., 2016, AbuOun et al., 2017, Borowiak et al., 2017, Garcia et 
al., 2018, Wang et al., 2018, Yang et al., 2018). Compared to other mcr- variants (mcr-2, -4, , 
-5, , -6, , -7 and mcr-8) which are reported sporadically in some countries (Fig.1.5 in 
Chapter 1), mcr-1 and mcr-3, are relatively common and distributed worldwide, but are 
especially prevalent in Europe and Asian countries including China (Ling et al., 2017, Yin et 
al., 2017) and Vietnam (Trung et al., 2017). A recent study reported a considerably higher 
presence of mcr-1, -2, and -3 genes in pigs and poultry from China when direct sampling was 
used rather than isolates growing in media supplemented with colistin, indicating that the 
prevalence of mcr-like gene family in many studies is probably underestimated, due to the 
limitation of bacterial isolation and current screening techniques (Wang et al., 2017, Zhang et 
al., 2018). Thus, the expanded group of mcr-1-like phosphoethanolamine transferases seems 
to provide multiple pathways for bacteria to evade the antimicrobial activity of colistin under 
human clinical and animal treatment.  
Recently, concerns were raised regarding the increasing reports of mcr-mediated colistin 
resistance in Enterobacteriaceae, especially when combined with ESBL- or carbapenemase-
producing isolates (Li et al., 2016, Sun et al., 2017). The emergence of this type of multi- or 
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pan-drug resistance poses severe therapeutic challenges due to the limited remaining effective 
antibiotics available against bacterial infections. Compared to the global prevalence of mcr-1 
has been widely reported (see Fig.1.5 in Chapter 1), however, the prevalence and 
significance of a new mcr-variant, mcr-3, has not been fully examined. In June 2017, this 
new transferable mcr-3 gene (with only 45% nucleotide homology to mcr-1), has been 
identified on an IncHI2-type plasmid in an E. coli isolate from pig feces from China. Shortly 
thereafter, mcr-3 was found in animals, environmental and hospital settings worldwide 
including Denmark, Spain, Thailand and Vietnam (Hernandez et al., 2017, Litrup et al., 2017, 
Roer et al., 2017, Zhang et al., 2018). Co-occurrence of mcr-1- and mcr-3-positive plasmids 
has been identified in many samples from South Asia in my study and other research groups 
(Hernandez et al., 2017, Liu et al., 2017), highlighting that mcr-3 may have spread widely. 
Notably, an NDM-5-producing E. coli has been identified to carry two mcr-1- and mcr-3-
positive plasmids (Liu et al., 2017), the combination of these resistance genes in clinical 
isolates results in limited treatment options. 
Therefore, there is an urgent need to develop new methods to predict and prevent the new 
emergence of mcr-conferring colistin resistance. One of major factors determining the 
dissemination and maintenance of antibiotic resistance in a bacterial population is the fitness 
burden of resistance. The contribution of mcr-1 expression to conferred fitness costs, 
virulence loss and changes in innate immune response in E. coli, have been fully discussed in 
Chapter 3. While the impact of mcr-3 expression on bacterial fitness and virulence is still 
unknown. In addition, according to the mcr-positive E. coli (MCRPEC) isolates from human 
contributed by our collaborators from Vietnam, the nucleotide sequences of mcr-3 genes were 
highly conserved, with two dominant variants, mcr-3.1 and mcr-3.5, which differ by only 
three nucleotide substitutions. It remains unclear whether these mutations influence the level 
of colistin resistance, bacterial fitness and pathogenicity. Above all, there are three main 
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objectives in this chapter: (1) Characterization of isolates carrying new-variant mcr-3 from 
human from Vietnam, using whole genome sequencing; (2) Investigation of the biological 
cost imposed by MCR-3 conferring colistin resistance, the maintenance and competitiveness 
between mcr-1 and mcr-3-carrying plasmids; and (3) Provide evidence to support the 
potential evolution pathway of colistin resistance through step-wise accumulation of 
mutations in mcr-3. 
 
4.2 Results 
4.2.1 Characteristics of mcr-3-bearing E. coli from Vietnam collection 
   We have received 143 MCRPEC isolates originating from human stool from our 
collaborators in Vietnam. All of these MCRPEC isolates have been subjected to whole 
genome sequencing (see the details in Appendix IV Table 6.2). In this study, all 51 mcr-3 
positive isolates were chosen to be further analysed. Unsurprisingly, highly distinct mcr-3-
linked E. coli isolates were observed, belonging to at least 25 STs including ST744 (n=6), 
ST10 (n=5), ST641 (n=3), ST206 (n=3) and ST101 (n=2) (Table 4.1). Based on SNPs in 
their core genome, phylogenetic tree analysis was generated by harvest software using their 
raw sequencing reads. The majority of these clinical isolates resided on distinct branches of 
the phylogenetic tree of 51 study genome (Fig.4.1), suggesting a high-level of diversity in the 
Vietnam E. coli population. Apart from mcr-like genes, MDR genotypes were identified in 
most of the studied isolates, with an average of 13.4 (range = 9 to 17) antibiotic resistance 
genes (Table 4.1). The most prevalent resistance genes found were ampH, blaACC-1 encoding 
AmpC1-type β-lactamase, and blaACC-2 encoding AmpC2-type β-lactamase, which were 
found in all isolates (n=5).  Next most prevalent were resistance genes dfrA (n=44) and sul3 
(n=42), conferring resistance to trimethoprim and sulfonamides, respectively. Gene qnrS1 
encoding low-level fluoroquinolone resistance were also present in 23 isolates.  
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Fig.4.1 phylogenetic tree of 51 mcr-3-harboring isolates from Vietnam, was determined by Parsnp-
harvest and visualized by iTOL.  represents maximum-likelihood tree based on concatenated core 
genome sequences. Bacterial MLST , the presence of mcr- genes , mcr-3-linked Inc plasmid 
types   and AMR genes  , which are all analyzed by CGE website 
(http://www.genomicepidemiology.org/), are presented in this tree. Legends of each data set are also 
indicated in the left of this tree. 
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Table 4.1 characteristics of 51 mcr-3-positive E. coli isolates from Vietnam 
Stain code Source Year species MLST mcr-like genes 
genetic location of mcr-like gene 
mcr-1 gene mcr-3 gene 
AV106.1 human stool 2015 E.coli ND mcr-1, mcr-3.5 ~40kb plasmid ~50kb IncP1 
AV28.1 human stool 2015 E.coli 101 mcr-1, mcr-3.5 plasmid IncP1 
HN1050.1 human stool 2015 E.coli NF mcr-1, mcr-3.1 NA  NA 
HN1142.2a human stool 2015 E.coli 744 mcr-3.1 NA NA 
HN1142.2b human stool 2015 E.coli 744 mcr-3.1 NA NA 
HN1142.3a human stool 2015 E.coli 744 mcr-3.1 NA NA 
HN1142.3b human stool 2015 E.coli 744 mcr-3.1 NA NA 
HN1142.4 human stool 2015 E.coli 744 mcr-3.1 NA NA 
HN1142.5 human stool 2015 E.coli 744 mcr-3.1 NA NA 
HN1270.5 human stool 2015 E.coli 10 mcr-1, mcr-3.5 ~40kb plasmid ~50kb plasmid 
HN1271.2 human stool 2015 E.coli 48 mcr-1, mcr-3.1 ~50kb plasmid ~120kb plasmid 
HN1271.3 human stool 2015 E.coli 1114 mcr-1, mcr-3.5 ~50kb plasmid ~120kb plasmid 
HN1272.2 human stool 2015 E.coli 1114 mcr-1, mcr-3.5 chromosome ~50kb IncP1 
HN1272.5 human stool 2015 E.coli 5044 mcr-1, mcr-3.5 NA  NA 
HN1335.1 human stool 2015 E.coli 10 mcr-1, mcr-3.5 chromosome ~50kb IncP1 
HN1335.2 human stool 2015 E.coli 10 mcr-1, mcr-3.5 chromosome ~50kb  
HN1364.4 human stool 2015 E.coli 10 mcr-1, mcr-3.5 chromosome ~50kb IncP1 
HN1380.4 human stool 2015 E.coli 1415 mcr-3 (D295E) NA   
HN1398.5 human stool 2015 E.coli 7588 mcr-3.5 NA IncP1 
HN1404.2 human stool 2015 E.coli 101 mcr-1, mcr-3.5 chromosome ~50kb plasmid 
HN1409.2 human stool 2015 E.coli 215 mcr-3.1 NA ~50kb plasmid 
HN1410.4 human stool 2015 E.coli 1602 mcr-3 (D295E) NA IncFII 
HN1456.5 human stool 2015 E.coli 6335 mcr-1, mcr-3.5 chromosome ~50kb IncP1 
HN1466.4 human stool 2015 E.coli 410 mcr-1, mcr-3.5 NA NA 
HN1466.5 human stool 2015 E.coli 410 mcr-1, mcr-3.5 NA NA 
HN1499.1 human stool 2015 E.coli 48 mcr-1, mcr-3.1 NA NA 
HN1545.1 human stool 2015 E.coli ND mcr-3.1 NA NA 
HN1570.3a human stool 2015 E.coli 206 mcr-1, mcr-3.5 NA NA 
HN1570.3b human stool 2015 E.coli 609 mcr-1, mcr-3.5 NA NA 
HN2.5 human stool 2015 E.coli 871 mcr-1, mcr-3.5 chromosome ~100kb plasmid 
HN225.1 human stool 2015 E.coli 641 mcr-1, mcr-3.1 ~120kb plasmid ~150kb plasmid 
HN225.2 human stool 2015 E.coli 641 mcr-1, mcr-3.1 ~120kb plasmid ~150kb plasmid 
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Stain code Source Year species MLST mcr-like genes genetic location of mcr-like gene 
HN225.4 human stool 2015 E.coli 641 mcr-1, mcr-3.1 ~120kb plasmid ~150kb plasmid 
HN225.5 human stool 2015 E.coli 641 mcr-1, mcr-3.1 ~120kb plasmid ~150kb plasmid 
HN269.2 human stool 2015 E.coli 1121 mcr-1, mcr-3.5 ~40kb plasmid ~50kb IncP1 
HN269.3 human stool 2015 E.coli 1121 mcr-1, mcr-3.5 ~40kb plasmid ~50kb plasmid 
HN367.2 human stool 2015 E.coli 1716 mcr-3.5 NA  NA 
HN367.4 human stool 2015 E.coli 1716 mcr-3.5 NA  NA 
HN514.1 human stool 2015 E.coli 641 mcr-3.1 NA IncFII 
HN621.1 human stool 2015 E.coli 10 mcr-1, mcr-3.1 ~50kb plasmid ~50kb plasmid 
HN657.1 human stool 2015 E.coli 7057 mcr-1, mcr-3.5 chromosome ~50kb plasmid 
HN657.4 human stool 2015 E.coli 7057 mcr-1, mcr-3.5 chromosome ~50kb plasmid 
HN657.5 human stool 2015 E.coli 7057 mcr-1, mcr-3.5 chromosome ~50kb IncP1 
HN75.3 human stool 2015 E.coli 206 mcr-1, mcr-3.5 chromosome ~100kb plasmid 
HN75.5 human stool 2015 E.coli 206 mcr-1, mcr-3.5 chromosome ~100kb plasmid 
HN763.3 human stool 2015 E.coli 2197 mcr-1, mcr-3.1 chromosome ~90kb plasmid 
HN83.2 human stool 2015 E.coli 1494 mcr-1, mcr-3* ~50kb plasmid ~50kb plasmid 
HN83.5 human stool 2015 E.coli 1494 mcr-1, mcr-3* ~80kb plasmid ~50kb IncX1 
HN943.3 human stool 2015 E.coli 48 mcr-3 (D295E) NA IncFII 
HN961.3a human stool 2015 E.coli 6860 mcr-1, mcr-3.1 chromosome ~50kb plasmid 
HN964.4 human stool 2015 E.coli 7588 mcr-3.5 NA  NA 
*mcr-3 variant with two amino acid substitutions (M23V+G373V), ND indicates no determined, and 
NA means not available. 
 
In addition, four mcr-3 variants that differed by up to 3 nucleotide were identified in 51 
isolates: mcr-3.1(n=19), mcr-3.5 (M23V+E457A+T488I, n=27), mcr-3 (D295E, n=3) and 
mcr-3 (M23V+G373V, n=2). Most interestingly, co-occurrence of mcr-1 and mcr-3 genes 
have been found in 36 isolates from the MCRPEC collection (Table 4.1 and Fig. 4.1). The 
genetic location of both mcr-1 and mcr-3 genes in randomly selected MCRPEC isolates were 
performed using PFGE with S1 nuclease, followed by hybridisation with mcr-1 and/or mcr-3 
labelled probes. As shown in Fig.4.2, chromosomal and plasmid-borne mcr-1 genes were 
detected in 34 isolates, with equivalent relative prevalence (55.9%, 19 each out of 34 the 
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MCRPEC isolates). In addition, more than one copy of mcr-1 gene was found in several 
isolates; for example, the two isolates 1270.5 and AV106 both contained two mcr-1 genes, 
one on a plasmid and a second in chromosome. In contrast, mcr-3 is located on plasmids in 
single copy from different size plasmids, suggesting high plasticity of genetic backgrounds 
and horizontal gene transfer of mcr-1 may facilitate its global spread. 
 
 
 
Fig.4.3 MCEPEC isolates were analysis by pulse-field gel electrophoresis (PFGE) with S1-nuclease, 
followed by 32P hybridization with mcr-1 or mcr-3-probe.  
Labels of 1-12 lands in A: 1474.1; 1492.2; 1412.1; 1472.1; 1479.1; 1518.1; 1466.1; 1535.1; 1537.1; 
1404.2; 1272.2, 1271.3.  
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Labels of 1-14 lands in B: 1271.1; 1456.5; 1409.2; 1404.2; 1050.1; 961.3a;763.3; 657.1; 657.4; 657.5; 
621.1; 1364.4; 1335.2; 1335.1. 
Labels of 1-14 lands in C: 75.5; 75.3; 2.5; 225.5; 225.4; 225.2; 225.1; 83.5; 83.2; 269.2; 269.3; 1270.5; 
AV106.1; AV28.1  
  
Using PlasmidFinder (https://cge.cbs.dtu.dk/services/PlasmidFinder/), the Inc-types of 
mcr-3-linked plasmids were identified in thirteen isolates, including nine IncP1 plasmids, 
three IncFII plasmids and one IncX1 plasmid (Table 4.1). Due to the limitations of short-read 
sequencing and the abundance of repeat regions in the plasmids, it is difficult to obtain the 
complete sequence of mcr-3-bearing plasmids. Fortunately, using primer walking 
(HN1364.4_Forword primer: CAGCTTGGAGACATGAAGCG; HN1364.4_Reverse primer: 
TGGCCGTGTACGTGTCATAC), followed by sanger PCR sequencing (Eurofins Genomics, 
Germany), one fully complete 51,958bp IncP1 plasmid has obtained (Fig.4.3A). Its 
nucleotide sequence is close to two mcr-3-carrying plasmids pMCR3_WCHEC1943 
(GenBank accession No. MF678351.1, China), and pMCR3_WCHEC-LL123 (GenBank 
accession No. MF489760.1, China), with 97% coverage and 99% nucleotide identity. This 
plasmid has a typical IncP-type backnone coding replication initiation (ssb-trfA operon), 
conjugative transfer (trb gene cluster regulating the mating-pair formation, and tra cluster 
ecoding transfer protein) and maintenance modules (kle and klc genes promoting stability 
inheritance; parB gene activating the participation of plasmid copies into daughter cells) 
(Schluter et al., 2007, Norberg et al., 2011). The colistin resistance encoding region is approx. 
4000bp mcr-3-dgk cassette, which is bracketed by two mobile transposons (Tn3 transposon 
located at upstream and IS6 transposon at downstream). Additionally, the backbone of this 
mcr-3-positive IncP1 plasmids in are highly conserved in another eight IncP1 plasmids 
identified in the studied strains (Fig.4.3B), suggesting that MCR-3_IncP_HN1364.4-like IncP 
plasmid is widely distrubuted in Vietnam. Due to its broad host-rangs, IncP plasmids can act 
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as a efficient vector to transfer mcr-3 gene between different species, posting a great threat to 
human health. 
 
 
 
 
Fig.4.3A Circular presentation of the complete nucleotide sequencing of mcr-
3 containing IncP plasmid in E. coli strain HN1364-4 from human stool in Vietnam. Arrows indicate 
open reading frames (ORFs) with annotation, ORFs without annotation indicates hypothetical protein. 
Numbers indicate nucleotide positions. The inner circle represent CG (blue) /AT (green) content. 
 
 
110#
#
 
Fig.4.3B Alignment of 10 mcr-1-positive IncP1 plasmids and visualized using BLAST Ring Image 
Generator (BRIG v0.9555). First inner ring is the plasmid obtained from HN1364-4, used as reference 
for the alignment, name and size of the reference plasmid indicated in the middle of rings.
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4.2.2 The fitness cost of mcr-3-mediated colistin resistance in E. coli 
In chapter 3, the results show that mcr-1-mediated colistin resistance is associated with 
great fitness cost observed by growth arrest, cell viability and morphological changes. It is 
important to understand the effects of colistin resistance mediated by two new variants mcr-
3.1 and mcr-3.5 on bacterial fitness. The mcr-3.1 and mcr-3.5 genes were cloned into an 
expression vector pBAD/hisA and transferred it into E. coli TOP10, generating E. coli 
TOP10 (mcr-3.1::pBAD and mcr-3.5::pBAD). Once expression was induced with 0.2% (w/v) 
L-arabinose, a markedly slower growth was observed in both mcr-3-strains, when comparing 
to their respective uninduced controls (Fig.4.4), suggesting that the overexpression of both 
mcr-3 variants is also associated with a reduced competitive ability against antibiotic-
sensitive strains. Of note, the over-production of mcr-3.5 seemed to be ‘less toxic’, observed 
by higher growth rates, compared to that of mcr-1 and mcr-3.1. These results indicate that 
over-expression of mcr-3 impose a lesser fitness cost, when compared to mcr-1-producing E. 
coli. 
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Fig.4.4 Effects of the expression of three mcr-variants, mcr-1, mcr-3.1 and mcr-3.5 on bacterial 
growth rate in vitro (n=3). 
 
 
4.2.3 The effect of the expression of mcr-3 genes on E. coli cell viability  
Based on the above growth rate and cell population, mcr-3-carrying E. coli may provide a 
relative fitness advantage over mcr-1-positive isolates. LIVE/DEAD® staining with confocal 
laser scanning microscopy (CLSM) imaging and COMSTAT analysis was used to assess cell 
viability. After 8h induction of gene expression with 0.2% (w/v) L-arabinose, a minimal 
reduction (less than 9%) in bacterial viability was observed in both mcr-3-producing (mcr-3.1 
and mcr-3.5) E. coli TOP10 strains, compared with the over-producing mcr-1 E. coli TOP10 
cells (Fig.3.4 in Chapter 3). COMSTAT analysis of the CLSM biofilm images revealed that 
relative dead/live biomass ratio of induced E. coli TOP10 (mcr-3.1/pBAD) was 
approximately three times higher than induced E. coli TOP10 (mcr-3.5/pBAD) (9% vs. 3%) 
(Fig.4.5). The above data suggest that both mcr-3 novel variants (mcr-3.1 and mcr-3.5) have 
evolved to attenuate the toxic effect of this gene’s expression, and supports the above fitness 
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results. Furthermore, the three amino acid substitutions in mcr-3.5 may play an important role 
in bacterial compensatory mutation that can alleviate the fitness burden and toxicity imposed 
by over-producing mcr-3.1, without altering the level of colistin resistance. 
 
Fig.4.5 The toxic effects of mcr-3 overexpression on cell viability. A-D, Confocal Laser Scanning 
microscopy images of cells treated with/without L-arabinose and stained with LIVE/DEAD® (n=3). 
Live and dead cells presented green and red colour, respectively. Scale bar is 15 µm. D, Ratio of Dead 
to Live bacteria (biomass) obtained from CLSM z-stack images through COMSTAT analysis of E. 
coli biofilms grown for 16 h in LB broth, followed by ± L-arabinose (0.2% w/v; 8 h) treatment, where 
the biofilms were stained with LIVE/DEAD® (n=4). The COMSTAT data was assessed using one-
way analysis of variance (ANOVA) followed by Tukey-Kramer multiple comparisons post-hoc test.  
 
4.2.4 Over-expression of mcr-3 significantly effects cellular morphology  
    MCR-3 belongs to mcr-1-like phosphoethanolamine transferase group, which can catalyze 
the transfer of phosphoethanolamine onto the phosphate group of lipid A in the bacterial 
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outer-membrane (Hinchliffe et al., 2017). I investigated whether both mcr-3.1 and mcr-3.5 
affect bacterial morphological changes by using transmission electron microscopy (TEM). 
Without mcr-3 expression, E. coli TOP10 (pBAD alone) showed normal cellular 
characteristics with a multi-layered cell surface and identical electron density (Fig.4.6). 
However, following mcr-3 gene expression induction by 0.2% (w/v) arabinose for 8 h, a loss 
of electron density and impaired cell wall integrity were observed in both mcr-3.1- and mcr-
3.5-produicing E. coli TOP10 relative to empty pBAD vector transformed control cells 
(Fig.4.6). These findings are consistent with my previous findings of the influence of mcr-1 
overexpression on bacterial morphology. Ergo, it is the high-level expression of mcr genes 
(mcr-1, mcr3.1 and mcr-3.5) that induced these gross morphological changes.  
 
 
Fig.4.6 TEM micrographs of mcr-3.1 and mcr-3.5 over-producing cells in A and B, respectively, the 
damaged outer-membrane and some completely lysed cells were observed.  C. TEM micrographs of 
of control strain TOP10 (pBAD alone) E. coli, exhibited the intact outer membrane structure and 
highly homologous electron density.  
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4.2.5 Transcription activity of mcr-3-linked promoters 
    So far, the regulation of mcr-3 gene expression is still unknown and the impact of mcr-3 
linked promoter on gene expression needs to be further explored. Based on the Illumina 
sequencing data, putative mcr-3-linked promoter sequences are either intact or truncated 
(Fig.4.7). It would be interesting to compare the transcription activities in these two types of 
promoters. Unfortunately, no truncated mcr-3-linked promoters was found in my MCRPEC 
collection, the mcr-3-linked truncated promoter was obtain from plasmid pWJ1 (GenBank 
accession No. KY924928) (Yin et al., 2017). Promoter sequencing was analysed online 
(http://www.softberry.com/berry.phtml?topic=bprom&group=programs&subgroup=gfindb). 
Primers were designed and approximately 500bp and 300bp DNA fragment containing mcr-1 
and mcr-3 putative promoters, respectively, was cloned into the pGLOW-TOPO vector 
(ThermoFisher, UK), as per manufacturer’s instructions, resulting in two constructs P_mcr-1-
pGLOW and P_mcr-3_intact-pGLOW (see methods 2.2.5 in Chapter 2). Equal background 
fluorescence emission was seen in the cultures carrying negative control plasmid (empty 
pGLOW-TOPO vector). Transcriptional activity of both mcr-3-linked promoters was 
measured by the GFP reporter assay using flow cytometry. Unexpectedly, Fig.4.8 shows that 
GFP expression driven by an intact promoter was approx.10-fold higher than that of mcr-1 
promoter; however, the GFP expression observed under the mcr-1 promoter appeared the 
same as the negative control pGLOW vector. Further analysis of the incomplete promoter 
sequence indicates that the promoter sequence has been truncated by a nimC/nimA gene 
(Fig.4.7), resulting in lack of transcription factor binding site. It is necessary to further 
analyse the effect of mcr-3-truncated promoter on mcr-3 expression.  
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Fig.4.7 A and B, mcr-3-linked promoter sequencing analysis. ‘TF’ binding site indicates transcription 
factor binding sites, which present the most essential elements in a promoter (Browning & Busby, 
2004). In (A), mcr-3-linked promoter sequence were truncated by nimC/nimA gene and no TF binding 
sites were found in the promoter. In (B), mcr-3-linked promoter sequence seems to be intact. (C) 
Transcriptional analyses of the MCR-3 protein. The strength of GFP expression driven from two 
different mcr-3- and mcr-1- linked promoter constructs in strain TOP10 E. coli. To measure bacterial-
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GFP activity, log-phase cultures of E. coli TOP10 carrying the transcriptional fusions of either P_mcr-
3.5-intact-pGLOW or P_mcr-1-pGLOW were sampled, followed by GFP signal measurement using 
flow cytometer. The data presents five biological replicates. The data suggested that the 
transcriptional level of the intact promoter is appreciably 10-fold higher than that of the incomplete 
promoter.  
 
4.2.6 Compensatory adaptation to the deleterious effects of mcr-3 genes in E. coli  
The above results of bacterial growth curves suggested that there is a relative beneficial 
fitness to the isolates carrying mcr-3 genes, especially for mcr-3.5, when compared to 
carrying mcr-1. To test this hypothesis, in vitro competition experiments were performed 
using flow cytometry (see methods in 2.13.1 in Chapter 2). The relative fitness is shown in 
Table 4.2 and as anticipated from above observations, the expression of mcr-3.5 has a fitness 
advantage over than that of mcr-3.1. These results indicate that the high-level expression of 
both mcr-3.1- and mcr-3.5- was associated with a fitness burden in vitro (average relative 
fitness is 0.73 and 0.85, respectively), compared to its relative uninduced control E.coli 
TOP10 (mcr-3/pBAD) (Fig.4.8). Fitness costs can often be ameliorated by compensatory 
mutations, without losing antibiotic resistance. In contrast to a dramatic fitness loss for 
overexpression of mcr-3.1, evidenced by lower growth rate, mcr-3.5 appears to have 
genetically evolved through three second-site compensatory mutations, which may play an 
important role in decreasing the deleterious effect of expression of mcr-3.1. To test this 
hypothesis, a total of six single and/or dual site mutations were constructed using Q5 Site-
Directed mutagenesis kit (NEB, UK), resulting in a total of eight mcr-3 variants constructed 
(Table 4.2). Except for the single mutation V23M, which confers the same fitness cost to the 
strain carrying mcr-3.1, the rest of six mutants showed a higher fitness over mcr-3.1-
harboring strain (Fig.4.8 and Table 4.2). Mutant T488I has already been found in patients 
with bloodstream infection (Roer et al., 2017), moreover, as described above, 51 mcr-3-
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positive E. coli isolated from human stool in Vietnam, 27 isolates were mcr-3.5 while 19 
were mcr-3.1 positive (Table 4.1). In combination with epidemiological data, the fitness data 
indicates that mcr-3.5 might become the predominant mcr-3 variant in Vietnam. 
 
 
 
Fig.4.8 A. average relative fitness of eight mcr-3 variants. All data presents six biological repeats and 
error bars represent the SD (n=6). B. The adaptive landscape of colistin resistance mcr-3.5 conferred 
by three amino acid substitutions in the sequence of mcr-3.1 gene. 
 
 
 
 
 
 
 
 
 
 
 
 
 
# 119#
 
Table 4.2 Eight possible evolutionary trajectories of mcr-3 variants constructed by site-directed 
mutagenesis (see methods 2.2.4 in Chapter 2) 
Plasmid templates Primers’ name Targeted mutations Relative fitness 
mcr-3.5/pBAD WT(M23V+A457E+T488I) M23V+A457E+T488I 0.85 
mcr-3.5/pBAD V23M A457E+T488I 0.95 
mcr-3.5/pBAD E457A M23V+T488I 0.84 
mcr-3.5/pBAD I488T M23V+A457E 0.85 
mcr-3.5/pBAD V23M+ E457A T488I 0.95 
mcr-3.5/pBAD V23M+ I488T A457E 0.83 
  mcr-3.5/pBAD E457A+ I488T M23V 0.73 
mcr-3.1/pBAD WT  0.73 
 
 
4.2.7 Competitive ability of mcr-1 and mcr-3-plasmids 
    The above observations raise an interesting puzzle: Why do bacteria need two different 
mcr-like genes, both with the same activity to reduce colistin affinity to the bacterial outer 
membrane? The above data examining the effect of the expression of mcr-like genes on 
bacterial growth rates, morphological changes and cell viability, indicates that E. coli 
carrying mcr-3.5 in particular, has fitness advantages over E. coli carrying mcr-1 gene. In 
order to test this hypothesis, two in vitro competition models were built. Firstly, three non-
duplicate clinical strains harboring both mcr-1 and mcr-3 plasmids were chosen to examine 
the dynamics and abundance of both mcr-genes during 14-day serial passaging in the 
presence and absence of colistin. In this experiment, qPCR was performed to quantify the 
relative changes of mcr-1 and mcr-3 genes in each culture. As shown in Fig.4.9, the 
abundance of both mcr-1 and mcr-3 gene/plasmids was significantly decreased in colistin free 
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medium (p<0.001), indicating that both plasmids confer fitness cost and plasmid-free cells 
are more successful when the selective pressure of colistin is removed. However, there were 
decreases in mcr-1 or mcr-3 carriage in the presence of colistin as well, just less marked. The 
stability of mcr-1 plasmid seemed to be slightly higher in the presence of colistin than that in 
antibiotic-free medium. Most importantly, the relative fitness of mcr-3 was higher over time. 
I plotted the y axis as log10 (MCR3/MCR1), therefore the slope of this regression gives the 
relative fitness of the two strains (Fig.4.9). In this case, there is no significant difference in 
the presence of colistin, indicating that both relative fitness of mcr-1 and mcr-3 plasmids are 
consistent under colistin selective pressure (4 mg/L). However, a marked change is observed 
in the antibiotic-free condition (p=0.023), which suggests that mcr-3 plasmid probably has a 
higher fitness even in the absence of the antibiotic (Fig.4.9). 
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Fig.4.9 Change in the relative abundance of mcr-1 and mcr-3 gene/plasmid in clinical E. coli strains, 
which naturally carry both mcr-1 and mcr-3 plasmids. (A) and (B), the dynamic changes of both mcr-
1 and mcr-3 gene in monocultures, respectively. (C) The relative frequency of mcr-3 gene to mcr-1 
gene in both different treatments (with or without colistin). These estimates were calculated by linear 
regression. Standard errors were based on the regression and all p values of the regressions were 
indicated in the figures. 
 
   In order to rule out other influencing factors in clinical strains, a pair of mcr-1- and mcr-3-
carrying plasmids were transferred to J53 strain by conjugation. The strains were allowed to 
adapt over the course of 80 generations to serial transfer culture in colistin free or 2 mg/l 
colistin LB broth. As controls, monocultures of each plasmid were also processed in the same 
way. Fig.4.10 shows that the abundance of both plasmids declined strikingly in the 
monocultures. Plasmid abundance tended to be higher when the medium was supplemented 
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with 2mg/l colistin, than that of colistin-free medium. Furthermore, initial plasmid abundance 
was higher for mcr-1 than mcr-3, possibly reflecting a difference in plasmid copy number. 
Interestingly, the rate of decline in both mcr-1- and mcr-3 was essentially constant across the 
14-day passage (Fig.4.10). The changes in the relative frequency of mcr-3 abundance relative 
to mcr-1 in mixed cultures can be observed in Fig.4.10C. The dynamics of both plasmid 
bearing strains was decreased, moreover, the mcr-3 strain had a higher fitness than the mcr-1-
carrying strain in the presence of colistin. This is consistent with the above observations of 
clinical strains with both mcr-like-carrying plasmids. Taken together, both mcr-1 and mcr-3-
carrying plasmids impose a fitness burden in the host, and mcr-3 plasmid in both clinical and 
laboratory strains has fitness advantage over mcr-1-plasmid in the presence of antibiotic. 
 
 
Fig.4.10 The relative abundance and stability of mcr-1 and mcr-3 gene/plasmid in laboratory E. coli 
strain J53. (A) and (B), the dynamic changes of both mcr-1 and mcr-3 gene in monocultures, 
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respectively. (C) The relative frequency of mcr-3 gene to mcr-1 gene in both different treatments 
(with or without colistin). These estimates were calculated by linear regression. Standard errors were 
based on the regression and all p values of the regressions were indicated in the figures. 
 
 
4.3 Brief Discussion 
    Currently, attention towards antibiotic resistance is growing, reflected by increased global 
reports of antimicrobial resistance by surveillance projects, and diversity of the underlying 
mechanisms studied by global scientific researchers. There is no doubt that colistin is the 
main driver for the emergence of colistin resistance. Large quantities of colistin have been 
used in food-producing animals as therapeutics or growth promoters in some countries 
(Carrique-Mas et al., 2015, Liu et al., 2015, Health, 2016), and colistin is still considered to 
be of vital  importance to treat human infections (Kluytmans, 2017). Bacteria always can find 
some strategies to continue growing even under such selective pressure, generating some 
potential trajectories of evolution through step-wise accumulation of resistance mutations, or 
acquiring resistance genes to colistin. The presence of varied concentrations of colistin in 
different settings such as hospital, community, animal farms and environment, provide many 
adaptive landscapes for bacteria to evolve genotypes of colistin resistance, therefore resulting 
in the diversity of genotypes in bacterial populations. Up to the preparation of this thesis, 
there are eight groups of plasmid-borne mcr-like gene conferring low-level resistance to 
colistin, have been identified.  It should be noted that few data are available on the prevalence 
of mcr-like genes including mcr-2, -3, -4, -5, -6, -7 and -8, other than mcr-1 in human 
samples. However, it is still unclear to what extent these mcr-like genes influence the 
evolution of colistin resistance. We are currently expanding this research programme by 
studying whether the carriage of mcr-like genes would affect bacterial evolution to high-level 
resistance to colistin under antibiotic pressure, and the genetic variations between mutants 
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from the same ancestor during in vitro evolutional pathway, which may enable us to identify 
associated genes driving antibiotic resistance.  
    In order to better understand the genetic reservoirs and transfer trajectories of antibiotic 
resistance genes, we need to determine the characteristics of plasmids linked to resistance 
genes, such as efficiency of replication, the range of hosts, conjugative transfer rate and 
plasmid stability. It has been reported that over 90% of mcr-1-linked plasmids belonged to 
three narrow host-range plasmids, IncX4, IncHI2 and IncI2, to a lesser extent, other 
incompatibility groups such as IncFII, IncFIB or IncHIA/B, also have been identified 
(Matamoros et al., 2017). Worryingly, in this study, mcr-3 gene from nine E. coli strains were 
identified on plasmids carrying IncP1, which is widely distributed in GNB, including E. coli, 
Pseudomonas spp. and Klebsiella aerogenes (Popowska & Krawczyk-Balska, 2013). The 
association of mcr-like genes and the broad-host range plasmid is of increasing concern, due 
to its highly efficient conjugative transfer and ability to replicate in a broad range of hosts. 
Future studies are required to determine the risk factors on the spread of mcr-like genes 
located on these plasmids. 
Predicting evolutionary paths to antibiotic resistance is key to understanding and 
preventing the rapid emergence of drug resistance, and antibiotic resistance can evolve 
through the sequential accumulation of multiple resistance-conferring mutations in a single 
gene (Hartl, 2014). Given the relatively small number of mutation in the same gene or 
different genes that might contribute to bacterial compensatory adaption, it would be helpful 
to understand adaptive evolution pathways by constructing all possible combination of these 
mutations and determining their contribution to adaption. For example, Palmer and 
colleagues have identified multi-peak adaptive landscapes for trimethoprim resistance by 
constructing all combinatorial alleles of seven mutations in dihydrofolate reductase (Palmer 
# 125#
et al., 2015). The epistasis interactions increase the accessibility of each path, and more 
indirect rather than direct pathways were observed, where mutations are adaptively gained 
and later adaptively lost or changed (Palmer et al., 2015). The complex interactions allow the 
evolution of trimethoprim resistance to proceed through multiple adaptive steps, hindering 
our ability to predict or control the emergence and spread of trimethoprim resistance. So far, 
more than 10 variants were identified in mcr-3 gene, with few nucleotide mismatches (0-8 
amino acid substitutions) (Zhang et al., 2018). Two variants of mcr-3, mcr-3.1 and mcr-3.5 
possess three nucleotide mismatches, with two choices for each, then there are 23 different 
combinations. Therefore, in this study, I have characterized the adaptive fitness landscape 
among mcr-3 variants by constructing six possible combinatorial alleles of these mutant sites, 
followed by assaying their relative fitness by flow cytometry. I observed that six out of eight 
mutation combinations increased bacterial fitness, compared to the strain carrying the parent 
mcr-3.1 gene, which was first discovered in porcine E. coli from China. Except for mcr-3.1 
and mcr-3.5 identified in 19 and 27 mcr-3-posistive strains, respectively, another two mutated 
combinations (double mutants M23V+G373V, and single mutant D295E) were found in our 
collection. Our data suggests that the process of mutational gain in mcr-3 gene may increase 
the opportunity of evolutionary pathways leading to the widespread colistin resistance in ever 
changing environments. However, it remains unclear which adaptive evolution pathway is 
affected by differences in amino acid sequence that do not alter the substrate binding or the 
catalytic activity of the enzyme, but may play an essential role in protein folding and the 
proper orientation of residues in and around the active site. The answer to this question needs 
to be further explored. 
This study describes 51 mcr-3 positive human E.coli isolates from Vietnam, and 39 of 
these isolates are especially relevant as they were positive for both mcr-1 and mcr-3. Thus, it 
raises the question: Why do bacteria need to carry two mcr-like genes, although both mcr-
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bearing plasmids conferring fitness burden with or without selective pressure? As shown in 
our competition model, both mcr-1 and mcr-3-bearing plasmids had a significant fitness cost 
reflected by declining abundance of both genes during serial passages. Therefore, some 
strategies need to favor the plasmid-carrying hosts, allowing the resistant plasmids to persist 
in the population. Integrating the mcr-1 gene into their chromosome seems to be a good 
strategy to maintain the mcr-1 gene in the bacterial host. In this study, chromosome-located 
mcr-1 gene was identified in 18 out of 51 mcr-3-bearing isolates, therefore, there is no chance 
for these bacteria to easily remove mcr-l gene conferring colistin resistance. Taken together, 
there are at least four ways for bacteria to persist colistin resistance mediated by mcr-like 
genes: i) The fitness burden caused by mcr-3.1 expression was reduced by epistatic mutations 
within the gene. ii) The mcr-1 gene was integrated into chromosome, in order to increase the 
stability of mcr-1 gene in bacterial population. iii) The combination of mcr-1 and mcr-3 
genes in the same strain provides greater maintenance capacity for colistin resistance. iv) 
Diversity of mcr-linked genotypes were found in microbial populations. If the consumption 
of colistin does not reduce in livestock in particular, bacteria are continually exposed to a 
colistin-rich environment, thus, there is a strong reasons to expect bacteria to evolve new 
mcr-like variants: mcr-6, mcr-7 (Yang et al., 2018), mcr-8 (Wang et al., 2018) ad infinitum. 
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Chapter 5  
Dissemination of highly virulent mcr-1 positive Klebsiella pneumoniae clone by 
Chrysomya spp. (common blowfly): an under rated factor in the AMR contagion 
story    
 
5.1 Brief background 
      There is growing public health concern for environmental dispersal of antibiotic 
resistance. Flies have been recognized as potential reservoirs participating in the spread of 
antibiotic-resistant pathogens among animals, environments and human (Fig.5.1). It has been 
demonstrated that houseflies are involved in the mechanical transmission of nosocomial 
infections with multidrug resistant bacteria in hospital environments, such as Shigella spp.; 
Escherichia coli; Klebsiella spp. and Enterobactor spp. (Graczyk et al., 2001). Recent studies 
reported flies are also responsible for the spread of mcr-like genes conferring colistin 
resistance in pig farms in Germany (Guenther et al., 2017), as well as in a Chinese university 
hospital with high-prevalence of  mcr-1 (51.1%) and mcr-3 (44.4%) (Zhang et al., 2018), 
suggesting that blow flies may servers as a reservoir for mcr genes. Among them, mcr-1 was 
most commonly found in E. coli isolates, although several other Enterobacteriaceae including 
K. pneumoniae have been detected in other sources such as animals (Wang et al., 2018) and 
human clinical isolates (Li et al., 2018). K. pneumoniae is known to be a leading cause of 
hospital-acquired infections, such as pneumonia, post-surgical wound and urinary tract 
infections (Holt et al., 2015). It is especially problematic in hospitals when resistance to 
colistin, the last-resort antibiotic, leaves very limited therapeutic options. More attention need 
to be paid to the transmissions of mcr-1-positive Enterobacteriaceae (MCRPE), in E. coli and 
# 128#
K. pneumoniae in particular, in order to provide a better understanding to control their threat 
to human health.  
     In this study, we screened blowflies (Chrysomya spp.) from different areas near the city of 
Phitsanulok, Northern Thailand, for the presence of AMR genes and in particular, mcr-1, 
using whole genome sequencing (WGS). In total, 48 mcr-1-positive isolates were recovered, 
consisting of 17 mcr-1-positive Klebsiella pneumoniae (MCRPKP) and 31 mcr-1-positive 
Escherichia coli (MCRPEC) strains. The 17 MCRPKP were shown to be clonal (ST43) and 
by indistinguishable PFGE patterns and few single poly nucleomorphs (SNPs) by WGS 
analysis. In in-vitro models, the MCRPKP were shown to be highly virulent. In contrast, 31 
recovered MCRPEC isolates are varied, belonging to 12 different MLST groups shared with 
those causing human infections.  The majority of mcr-1 genes are located on IncX4 plasmids 
(29/48, 60.42%), sharing an identical plasmid backbone. WGS-based analysis of mcr-1-
carrying isolates from blowflies (Chrysomya spp.) provide evidence that flies serve as a 
potential ‘hot spots’ for the spread of mcr-1-mediated colistin resistance including hyper-
virulent MDR Klebsiella pneumoniae isolates. These findings highlight the contribution of 
flies to the AMR contagion picture in low- and middle-income countries and the challenges 
of tackling global AMR.  
 
 
Fig. 5.1 Multiple routes of bacterial transmission between humans and animals through flies. Flies can 
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transmit microbes from place to place through their exoskeleton (such as legs and wings) and 
defecation (updated from (Junqueira et al., 2017, Onwugamba et al., 2018). Since flies share their 
habitat with both animals and humans, transmission of antimicrobial resistance is therefore possible: 
Flies can ‘pick’ bacteria on their legs and wings up from sewage and animal feces, and then deposit 
their microbial ‘passengers’ in elsewhere including food, water, meat in local markets or hands. Red 
sticks on the body of blowfly indicate bacteria. 
 
5.2 Results 
5.2.1 Details of mcr-1-positive isolates recovered from Blowflies 
In early 2016, a total of 300 blowflies were trapped at three different areas in Northern 
Thailand, 100 blowflies from each area: local market in urban community, rural area and 
suburbs around Phitsanulok. These locations are approximately 10 kilometers apart. The flies 
were individually pulverized in enriched peptone water for 30 min and aliquots of these 
suspensions (100 µl) were plated on Eosin-Methylene-Blue (EMB) agar supplemented with 2 
mg/l colistin and incubated at 37oC overnight. One to three representative colonies with 
different colours from each agar plates were purified and the mcr-1 gene identified by PCR. 
The mcr-1-positive bacteria were sub-cultured in liquid nutrient broth for 18h before DNA 
extraction for species identification and whole-genome sequencing. In total, we recovered 48 
mcr-1-positive isolates from 300 collected blowflies (16.0%, each isolate represents one 
blowfly), consisting of 31 E. coli and 17 K. pneumoniae. Among them, four MCRPE strains 
are recovered from local market in the urban community, 16 and 28 are recovered from rural 
and urban areas, respectively. In addition, minimum inhibitory concentrations (MICs) of 
colistin for 48 mcr-1-bearing isolates was performed using broth microdilution, in accordance 
with the guideline of the European Committee on Antimicrobial Susceptibility Testing 
(EUCAST). Reference strain E. coli ATCC25922 served as a quality control. Colistin MICs 
for all MCR-1-producing isolates range from 4-16 mg/l (Table 5.1).
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Table 5.1. Characteristics of 48 MCRPE strains recovered from blowflies in Northern Thailand 
Strain ID Species Isolated area colistin 
MIC 
wgMLST Inc plasmid type 
(size: kb) 
Conjugation 
frequency 
PN100 K. pneumoniae Suburb area 4 43 IncX4(~31,778) 2.1x10-5 
PN104 K. pneumoniae Rural area 16 43 IncX4(~31,778) 1.5x10-6 
PN105 K. pneumoniae Suburb area 8 43 IncX4(~31,778) 1.5x10-5 
PN106 K. pneumoniae Suburb area 8 43 IncX4(~31,778) 2.1x10-5 
PN107 K. pneumoniae Rural area 16 43 IncX4(~31,778) 9.45x10-7 
PN110 K. pneumoniae Rural area 16 43 IncX4(~31,778) 2.08x10-6 
PN114 K. pneumoniae Suburb area 8 43 IncX4(~31,778) 7.63x10-6 
PN118 K. pneumoniae Suburb area 8 43 IncX4(~31,778) 2.44x10-5 
PN120 K. pneumoniae Rural area 4 43 IncX4(~31,778) 2.0x10-5 
PN77 K. pneumoniae Suburb area 4 43 IncX4(~31,778) 1.5x10-6 
PN79 K. pneumoniae Rural area 4 43 IncX4(~31,778) 3.13x10-5 
PN81 K. pneumoniae Suburb area 4 43 IncX4(~31,778) 2.86x10-5 
PN84 K. pneumoniae Suburb area 4 43 IncX4(~31,778) 3.0x10-5 
PN95 K. pneumoniae Suburb area 8 43 IncX4(~31,778) 1.0x10-5 
PN96 K. pneumoniae Suburb area 4 43 IncX4(~31,778) 7.11x10-7 
PN97 K. pneumoniae Suburb area 4 43 IncX4(~31,778) 2.31x10-6 
PN98 K. pneumoniae Suburb area 4 43 IncX4(~31,778) 8.03x10-7 
PN123 E. coli Local market in 
urban community 
4 2345 IncHIA 1.44X10-7 
PN33 E. coli Local market in 
urban community 
4 10 NA 1.33x10-3 
PN93 E. coli Local market in 
urban community 
4 162 IncX4 ND 
PN103 E. coli Rural area 8 10 IncHIA 3.1x10-7 
PN109 E. coli Rural area 16 1244 IncX4(~31,778) 7.6x10-4 
PN111 E. coli Rural area 8 457 NA ND 
PN116 E. coli Rural area 4 648 NA ND 
PN119 E. coli Rural area 8 549 NA ND 
PN74 E. coli Rural area 16 10 IncX4(~31,778) ND 
PN75 E. coli Rural area 4 58 IncHIB ND 
PN87 E. coli Rural area 4 549 NA ND 
PN88 E. coli Rural area 4 10 IncX4(~31,778) ND 
PN91 E. coli Rural area 4 181 IncX4(~31,778) 6.67x10-5 
PN101 E. coli Suburb area 4 58 NA ND 
PN102 E. coli Suburb area 4 648 NA ND 
PN108 E. coli Suburb area 8 549 IncX4(~31,778) ND 
PN112 E. coli Suburb area 8 181 IncX4(~31,778) ND 
PN117 E. coli Suburb area 8 201 IncX4(~31,778) 5.94x10-3 
PN121 E. coli Suburb area 8 5487 NA ND 
PN122 E. coli Suburb area 8 549 NA ND 
PN124 E. coli Suburb area 8 181 IncX4(~31,778) 5.33x10-4 
PN126 E. coli Suburb area 4 648 IncHIB NS 
PN127 E. coli Suburb area 4 648 IncHIB 1.85x10-7 
PN73 E. coli Suburb area 4 648 IncHIB NS 
PN76 E. coli Suburb area 4 58 IncHIA_IncHIB 8.70x10-8 
PN78 E. coli Suburb area 4 10 IncX4(~31,778) ND 
PN80 E. coli Suburb area 8 218 NA 1.14x10-4 
PN83 E. coli Suburb area 8 10 IncX4(~31,778) 6.27x10-7 
PN85 E. coli Suburb area 4 2705 NA NS 
PN86 E. coli Suburb area 8 218 IncX4(~31,778) ND 
PN92 E. coli Suburb area 4 10 NA ND 
NA, not available; ND, not determined; NS, not successful 
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In July 2017, our collaborators discovered a new mcr-variant, mcr-3 (Yin et al., 2017). 
MCR-3, belongs to the family of phosphoethanolamine transferases, only exhibited 
approximately 45% and 47% nucleotide sequence identity to mcr-1 and mcr-2, respectively. 
For the screening of this new mcr-3 genes, I received 148 mcr-1 negative, colistin-resistant 
isolates recovered from blowflies in Thailand. Seven out of 148 isolates are mcr-3-positive. 
When comparing with mcr-3.1, which is available in NCBI, the mcr-3-like gene belongs to 
mcr-3.5 with three difference amino acid mutations: Met23 to Val (position 67: ATG to 
GTG), Ala457 to Glu (position 1370: GCA to GAA) and Thr488 to Ile (position 1463: ACC 
to ATC). To elucidate the genetic mechanism of mcr-3-mediated colistin resistance, whole 
genomic sequencing were also performed on these seven MCRPEC strains isolated from 
Thailand (see full details in Appendix II and Chapter 6). 
 
5.2.2 WGS-based analysis of mcr-1-positive isolates 
    A total of 48 mcr-1 positive isolates were sequenced using Illumina Miseq platform. In 
brief, total gDNA was extracted from an overnight culture (2 ml) on a QIAcube automated 
system (Qiagen, Germany), and genomic DNA libraries are constructed using the Illumina 
MiSeq platform (MiSeq Reagent V3 Kit; 2x300 cycles). The CGE platform 
(http://www.genomicepidemiology.org/) were used for analysis of multi-locus sequence 
typing (MLST). As a result, the distinct E. coli isolates belonged to 12 STs (Table 5.1): ST10 
(n=7), ST648 (n=5), ST549 (n=4), ST58 (n=3), ST181 (n=3), ST218 (n=2), ST201 (n=1), 
ST162 (n=1), ST457 (n=1), ST1244 (n=1), ST2345 (n=1), ST2705 (n=1) and ST5487 (n=1).  
    Most interestingly, all 17 K. pneumoniae isolates belonged to ST43, then we further 
determined the clonal relationship of 17 ST43 K. pneumoniae isolates using pulse-field gel 
electrophoresis identified with speI restriction enzyme, according to the CDC instruction 
(https://www.cdc.gov/pulsenet/pdf/ecoli-shigella-salmonella-pfge-protocol-508c.pdf). The 
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indistinguishable PFGE patterns were observed in all K. pneumoniae isolates mainly obtained 
from local market in urban community and rural area (Fig. 5.2). Moreover, phylogenetic tree 
analysis for 17 strains based on their raw sequencing reads showed that their core genome 
differed only by a few SNPs (n<10), suggesting clonal dissemination of ST43 K. pneumoniae 
isolates in blowflies from Thailand. 
 
Fig.5.2 PFGE patterns of 14 MCRPKP strains from blowflies. The node of isolates are displayed at the top of 
the PFGE pattern images. 
     
    Analysis of genomic AMR genes, showed significant variations in resistance gene content. 
Firstly, the CGE services were used for identification of acquired resistance genes (ResFinder, 
https://cge.cbs.dtu.dk/services/ResFinder/). Apart from mcr-1 gene, multiple antibiotic 
resistance genes were identified in the studied isolates, with the average number 8.34 and 
7.82 in E. coli strains and K. pneumoniae strains, respectively. In the 31 E. coli, 24 different 
resistance genes were identified, conferring resistance to nearly all current available 
antibiotics, such as ß-lactams, aminoglycoside, chloramphenicol, fluoroquinolones and 
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sulfonamide (Fig.5.3). The most prevalence AMR gene is the ß-lactamase-encoding ampC 
(n=30, 93.75%), followed by aadA gene conferring streptomycin resistance (n=28, 87.50%). 
Plasmid-mediated fluoroquinolone resistance genes, qnrS1, oqxA and oqxB, are present in 20, 
3 and 3 isolates, respectively. Several ß-lactamase-producing genes, blaTEM, blaampH, blamrdA 
blaCTX-M-55 are detected in 21 (65.63%), 16 (50.0%), 16 (50.0%) and 6 (18.75%) isolates, 
respectively. In contrast, a total of 14 AMR genes were found in MCRPKP. Fluoroquinolone 
resistance genes (qnrS1, oqxA and oqxB), blaTEM-1b and tetracycline resistance gene tetA are 
identified in all K. pneumoniae, followed by blaSHV encoding SHV β-lactamase present in 14 
isolates. Three aminoglycoside modifying enzymes, AAC(3’)-Iia (n=2) and APH (n=3) are 
detected. dfrA and sul2 conferring sulfonamide resistance are only found in one MCRPKP 
strain. 
 
Fig.5.3 Heat-map analysis of antibiotic resistance genes in 48 MCRPE isolates recovered from 
blowflies, using Morpheus website version (https://software.broadinstitute.org/morpheus/). The 
presence or lack of AMR genes is colored in orange or light blue, respectively. 
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5.2.3 Plasmid types and transferability of mcr-1 gene  
    De novo bacterial genome assembly was performed and the mcr-1-carrying contigs were 
analyzed. Replication origins are located in the mcr-1 contigs, allowing to analyze 
incompatibility groups of these plasmids by using PlasmidFinder 
(https://cge.cbs.dtu.dk/services/PlasmidFinder/). 35 out of 48 isolates are able to identify 
replicon sequence type: IncX4 (n=29, 12 E. coli and all 17 K. pneumoniae isolates), IncHI1A 
(n=2), IncHI1B (n=3) and IncHI1A-IncHI1B (n=1). Ten randomly chosen mcr-1-bearing 
IncX4 plasmids obtained from K. pneumoniae isolates were probed with mcr-1 gene using 
S1-PFGE. As shown in Fig.5.4, 10 mcr-1 genes were all located on a ~32-kb IncX4 plasmid. 
PCR was performed to fill the gap in the mcr-1-carrying contigs with primers (PN_IncX4_F: 
CGACCTTTAAGTCGTATTTGCAAGT; PN_IncX4_R: ATTGCGCCCGTAGTTCGCTA), 
followed by sanger sequence (Eurofins, Germany). The complete plasmid sequence were 
conducted by de novo assembly using Geneious (10.0.7). As a results, complete sequences of 
26 IncX4-mcr-1-carrying plasmids were achieved. Alignment of ~32-kb IncX4-mcr-1-
carrying plasmid visualized by BRIG showed that all mcr-1-carrying plasmids share the most 
parts of the reference plasmid Incx4-pMR0617mcr (GenBank accession number CP024041), 
including the typical region encoding ~11kb T4ss conjugation system and a toxin-antitoxin 
system hicAB, further suggesting that IncX4 plasmids acts as a reservoir of mcr-1 gene (Fig. 
5.5 and Fig. 5.6).  
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Fig.5.4 PFGE analysis of MCR-1-producing strains digested with S1 nuclease (right) and 
hybridization with mcr-1 gene probe (right). 
 
The transferability of mcr-1-bearing plasmids were assessed by conjugation and E. coli 
J53 as a recipient. We randomly selected 31 mcr-1-positive isolates as donors, containing at 
least four different mcr-1-linked Inc-type plasmids: IncX4 plasmids (n=25), IncHI1B 
plasmids (n=3), IncHI1A (n=2) and IncHI1A_HI1B (n=1) (Table 5.1). We performed mating 
assays with sodium-azide resistance E. coli J53 as the recipient strains. Briefly, overnight 
cultures of mcr-1-producing donors and the recipient strain were 1:2 mixed and incubated in 
37 oC for 16-20 h. After incubation, we subsequently ten-fold serial diluted the mixed culture 
in sterile saline and aliquoted 100 µl of diluted culture onto selective agar plates containing 
with 2 mg/l colistin and 150 mg/l sodium azide. The mcr-1-positive transconjugants were 
confirmed by PCR and transfer frequency was calculated by the number of transconjugants 
per recipient. As a results, 12 out of 14 mcr-1-bearing plasmids were successfully transfered 
to E.coli J53, IncX4-mcr-1 plasmids are able to transferred into the recipient with higher 
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frequency (mean 1.46x10-3 in E. coli and mean 2.11x10-5 in K. pneumoniae), comparing with 
other four mcr-1-related IncHI1 types (2.77x10-7), IncHI1A (mean 2.27x10-7), IncHI1B 
(1.85x10-7) and IncHI1A-IncHI1B (8.7x10-8) (Table 5.1). 
 
 
 
Fig.5.5 Alignment of 26 mcr-1-complete plasmids and visualized using BLAST Ring Image 
Generator (BRIG v0.9555). First inner ring is the plasmid obtained from PN105, used as reference for 
the alignment, name and size of the reference plasmid indicated in the middle of rings.  
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Fig.5.6 Alignment of 29 mcr-1-complete plasmids and visualized using BLAST Ring Image 
Generator (BRIG v0.9555). First inner ring is the plasmid used as reference for the alignment, 
GenBank accession number and size of the reference plasmid indicated in the middle of rings. These 
mcr-1-carrying plasmids are recovered from different sources, namely, companion animals (PN10 and 
PN11), poultry (PN23, 24, 25 and 29), human feces (PN45, 42, 57, 41, 46, 51, 58, 60, 47, 49 and 71), 
excepting 10 from blowflies (PN78, 83, 86, 88, 91, 93, 112, 117, 109 and 124). Besides those strains 
from blowflies fully described in Table 1, the rest of strains showed in this figure were also obtained 
from Thailand (Appendix II Table 2.1). 
 
5.2.4 Virulence factors in MCRPKP strains and virulence loss in G. mellonella models 
K. pneumoniae is now recognized as an urgent threat to human health because of the 
emergence of MDR strains associated with hospital outbreaks, a number of virulence factors 
of K. pneumoniae are significantly associated with bacterial pathogenicity. Our database 
includes a set of virulence genes: capsular biosynthesis genes (wzy/magA, K2A) (Yu et al., 
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2008, Lin et al., 2012); mucoid factor regulator (rmpA, rmpA2) (Cheng et al., 2010); allantoin 
metabolism operons (allABCDRS, gcl and glxRK) (Chou et al., 2004); an iron-uptake system 
(kfuABC) (Ma et al., 2005); two-component operon (kvgAS) (Lai et al., 2003); gene clusters 
for siderophores dependent iron acquisition (aerobactin iucBCD-iutA, yersiniabactin 
ybtAEPQSTUX-irp1-irp2-fyuA, colibactin clbBCDEFGHHIJKLMNOPQR, salmochellin 
iroBCDN, enterobactin entABCDEF) (Hsieh et al., 2008); gene clusters of type I and type III 
fimbriae (fimABCDEFGH and mrkABCDFHIJ, respectively) (Di Martino et al., 2003, Struve 
et al., 2008); outer membrane lipoprotein (ycfM); serum resistance factor (traT) (El Fertas-
Aissani et al., 2013); hemolysin transport protein (hlyABCD) (Thomas et al., 2014); urease 
operon (ureABCDEFG)   (Liu & Bender, 2007)and type IV secretory system gene cluster 
(virB1 to B11) (Juhas et al., 2008). Annotation of genes with 75% identity to reference 
sequences was performed by Geneious (10.2; Biomatters Ltd.). Capsular (KL) loci were 
evaluated using Kaptive platform (http://kaptive.holtlab.net/jobs) (Wyres et al., 2016). The 
detailed of this dataset are available in method 2.21 in Chapter 2. 
    There are at least five groups of pathogenicity factors found in the 17 MCRPKP isolates, 
these include gene clusters associated with serum resistance (traT); adhesins (type I firmbrial 
operon fimABCDEFGH, and type III firmbrial operon mrkBCDEF); lipopolysaccharide 
(wabGHN); siderophore systems (enterobactin-encoding entABCDEFS, and aerobactin-
encoding iucABCD, iutA) and capsular synthesis loci (wzi/wzc typing, 412/K16). Similarly, 
the iron acquisition operons kfuABC, and iroE, urease-synthesis operon ureABCDEFG 
associated with gastric ulceration and urinary stone formation, and gene ycfM encoding 
surface protein are identified in all MCRPKP isolates (Table 5.2). 
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Table 5.2 Virulence determinants in 17 MCRPKP strains obtained from blowflies in Thailand 
virulence factors virulence genes 
MCRPKP strains  
PN 
120 
PN 
118 
PN 
110 
PN 
114 
PN 
107 
PN 
106 
PN 
105 
PN 
104 
PN 
100 
PN 
98 
PN 
97 
PN 
96 
PN 
95 
PN 
84 
PN 
81 
PN 
79 
PN 
77 
PN 
38* 
Fimbria type I fimABCDEFGH + + + + + + + + + + + + + + + + + + 
Fimbria type III mrkBCDEF + + + + + + + + + + + + + + + + + + 
iron acquisition 
systems iroE + + + + + + + + + + + + + + + + + + 
kfu iron uptake 
system kfuABC + + + + + + + + + + + + + + + + + - 
Aerobactin  iucABCD iutA + + + + + + + + + + + + + + + + + - 
Enterobactin entABCDEFS + + + + + + + + + + + + + + + + + + 
salmochellin  iroB - - - - - - - - - - - - - - - - - - 
yersiniabactin   - - - - - - - - - - - - - - - - - - 
colibactin  clb - - - - - - - - - - - - - - - - - - 
serum resistance traT + + + + + + + + + + + + + + + - + - 
urease ureABCDEFG + + + + + + + + + + + + + + + + + + 
LPS synthesis wabGHN + + + + + + + + + + + + + + + + + + 
surface protein ycfM + + + + + + + + + + + + + + + + + + 
allantoinase   - - - - - - - - - - - - - - - - - - 
rmpA / rmpA2   - - - - - - - - - - - - - - - - - - 
two-component 
system KvgAS  - - - - - - - - - - - - - - - - - - 
Wzi/K-typing  wzi/wzc 
412/
K61 
412/
K61 
412/
K61 
412/
K61 
412/
K61 
412/
K61 
412/
K61 
412/
K61 
412/
K61 
412/
K61 
412/
K61 
412/
L61 
412/
K61 
412/
K61 
412/
K61 
412/
K61 
412/
K61 
385 / 
K22 
 
*PN38 strain serves a control strain, is a clinical strain from human feces in Thailand. 
('+', positive; ' -', negative) 
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     As shown in Table 5.2, at least 10 different virulence factors were found in all 17 ST43 
MCRPKP strains, which prompted us to investigate the virulent potential of these isolates by 
using a G. mellonella model. The effect of different inoculum of 10 randomly selected ST43 
MCRPKP strains was assessed in the Galleria mellonella. As a reference isolate, K. 
pneumoniae K1 is known as a hypervirulent strain. As shown in Fig. 5.7 (after 12 hour post-
infection), with an inoculum of approx. 1x106 CFU, 100% of mortality was observed on both 
K1 strain and 10 ST43 MCRPKP strains. With an inoculum of 1x105 CFU survival was 70% 
with K1 strain and 0% with 10 ST43 MCRPKP strains. Finally, with an the inoculum of 
1x104 CFU resulted in 100% survival by K1 strain and approx. 20% by ST43 MCRPKP 
strains. The consistency between genotypic virulence factors and G. mellonella infection 
model data suggest that the ST43 MCRPKP strains recovered from blowflies are highly 
virulent clones. 
    Based on our previous study, the acquisition of a mcr-1-carrying plasmid leads to virulence 
loss in E. coli strain.  In this study, three mcr-1-carrying plasmids were transferred into a 
clinical susceptible K. pneumoniae strain ff101 and a KPC-positive K. pneumoniae strain p35, 
followed by infection of G. mellonella larvae with an inoculum of ~1x105 CFU. As shown in 
Fig. 5.8 two K. pneumoniae strains ff101 and p35 caused more than 80% and 90% of 
mortality after 72h infection, respectively. After acquiring of IncX4-mcr-1 plasmid, the 
survival rates of larvae increased to 40% - 80% with strain ff101, and survival rates of five-
fold higher from ~10% to ~50% with strain IncX4-mcr-1-carrying p35 strain at 72h after 
infection. These data suggest that IncX4-mcr-1 plasmid are responsible to reduce bacterial 
virulence. 
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Fig.5.7 A. The image of G. mellonella over 12 h post-infection with ST43 MCRPKP strains and a 
clinical reference strain K1. B and C, Kaplan-Meier plots showing the percent survival of G. 
mellonella over 24 h post-infection with the 104 CFU/ml (B) and 105 CFU/ml (C) inoculum of 
MCRPKP and strain K1. Survival curves were plotted using the Kaplan-Meier method (GraphPad 
Software).  
 
 
 
Fig. 5.8 A and B, Kaplan-Meier plots showing the percent survival of G. mellonella over 72 h post-
infection with the 105 CFU/ml inoculum of clinical susceptible K. pneumoniae ff101 and clinical 
KPC-positive K. pneumoniae p35, with or without mcr-1-carrying plasmid. Survival curves were 
plotted using the Kaplan-Meier method (GraphPad Software). 
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5.3. Discussion   
The mcr-1 gene first discovered in E. coli, which has become the major host of mcr-1, and 
has been found in most continents crossing more than 40 countries. So far, MCRPE isolates 
have been mainly recovered from animal samples compared to environmental and human 
clinical samples, there is a dearth of evidence linking blowflies to the transmission of mcr-1 
in Thailand. Widely considered as important epidemiologic factors for the spread of 
antibiotic resistance bacteria in different environments, blowflies involved in the mechanical 
transmission of mcr-1 is an immense public health concern. In our study, 16% of blowflies 
possessed mcr-1, predominantly located on IncX4 plasmids (29/48, 60.42%) with high 
conjugant frequency (up to 5.93x10-3 in this study). These data suggest that flies serve as an 
important transport host for mcr-1.  
To date, no less than 14 different plasmid incompatibility types have been identified, and 
approximately 35.2% of mcr-1-carrying plasmids belong to IncX4 plasmids found from E. 
coli isolates from humans, animals and the environment (Matamoros et al., 2017). 
Interestingly, identical nucleotide sequences of 27 mcr-1-carrying IncX4 plasmids in our 
study, share a similar plasmid backbone to that obtained from human and animal samples in 
Thailand, suggesting that this IncX4-type plasmid serves as a common mcr-1 carrier and 
responsible for the dissemination of mcr-1 gene in Thailand. 
WGS analysis provided comprehensive information about the mcr-1-carrying bacteria and 
their phylogenetic relationship.  Twelve different STs were identified in 31 MCRPEC strains, 
which is consistent with other studies affirming that MCRPEC isolates are highly diverse, but 
E. coli ST10 being the most dominant clade linked to mcr-1 (n=7, 22.58%).  E. coli ST10 has 
been frequently recovered from meat products (Cohen Stuart et al., 2012), food-borne 
animals (Cortes et al., 2010) and human clinical samples (Oteo et al., 2010), has been 
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strongly associated with human infections and ESBL-production (Manges & Johnson, 2012). 
ESBL-producing E. coli ST10 has also been shown to be the most predominant lineage 
obtained from a military medical center in America (Manges et al., 2017). E. coli ST10 is 
highly represented among MCRPEC isolates (Matamoros et al., 2017), recovered from 
human (Bernasconi et al., 2016), animals (Xavier et al., 2016) and environmental sectors 
worldwide (Sun et al., 2017). Apart from mcr-1, a variety of other acquired resistance genes 
was detected in the MCRPE isolates (mean 8.05, ranging from 4 to 15), including plasmid-
mediated quinolone resistance genes (qnrS, oqxA and oqxB) and ESBL genes, blaSHV and 
blaCTX-M. Furthermore, a higher number of acquired resistance genes has been found in E. 
coli ST10 isolates (mean 12, ranging from 9 to 15), compared to other STs. Therefore, E. coli, 
notably that related to ST10, may act as mcr-1 gene pool, facilitating the spread of mcr-1 in 
clinical and environmental settings. 
Comparison with highly reported MCRPEC isolates, the prevalence of MCRPKP is rare. 
In a recent study, mcr-1-positive E.coli, Providencia spp and Enterobacter cloacae strains 
were recovered from houseflies and blowflies in China, but no mcr-1-carrying K. 
pneumoniae strain was reported (Zhang et al., 2018). Sporadic mcr-1-positive isolates of K. 
pneumoniae have been identified mainly from patients (Li et al., 2016, Rolain et al., 2016), 
animal samples (Kieffer et al., 2017) and environmental sectors (sewage water) (Ovejero et 
al., 2017). The fact that 17 MCRPKP isolates (35.42%, 17/48) recovered from blowflies is of 
particular concern, as K. pneumoniae is widely considered as a leading cause of hospital-
acquired infections. Most interestingly, all 17 MCRPKP isolates belonged to ST43, K. 
pneumoniae ST43 has been widely reported in clinical sectors, and associated with epidemic 
ß-lactamases CTX-M-15 and OXA-181 (Lascols et al., 2013, Kayama et al., 2015). The 
highly identical PFGE patterns and phylogenetic tree (SNP<10) further proves the clonal 
relationship of ST43 MCRPKP among these blowflies. This scenario is worrying, because 
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there is evidence that blowflies acting as one of environmental dispersals of bacterial 
pathogens to human and animals, are strongly associated with outbreak of enteric pathogens 
in rural area in developing countries (Echeverria et al., 1983, Olsen, 1998).  
It has been proposed that antibiotic resistance in pathogenic bacteria poses a growing threat 
to human health, by increasing the mortality rate and economic burden associated with 
bacterial infections (Shankar, 2016). These ST43 MCRPKP isolates also contain at least four 
major virulence determinants responsible for disease progression: capsular synthesis loci 
(wzi/wzc typing, 412/KL16); lipopolysaccharide; siderophores (Enterobactin and aerobactin) 
that are responsible for binding ferric iron in the host cell; and adherence factors (fimbria 
type I and III) that allow bacteria to attach to the host cell surface (Podschun & Ullmann, 
1998, Paczosa & Mecsas, 2016). The virulence potential of these isolates, as evidenced in a G. 
mellonella model, suggest that ST43 MCRPKP are virulent clones circulating via blowflies in 
Thailand. Taken together, apart from the acquisition of IncX4-mcr-1 plasmids, these ST43 
MCRPKP strains are virulent, multidrug resistant and transmissible, providing evidence of 
their threat to public health. 
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Chapter 6  
Genomic insights into MCR-1 and MCR-3-producing Escherichia coli isolates, an 
urgent threat to public health 
 
 
6.1 Brief introduction 
The recently reported mcr-conferring colistin resistance in Enterobacteriaceae, frequently 
associated with multiple resistance genes including blaNDM-1 and blaKPC-2 (Li et al., 2018), has 
been described as a global crisis and an impending return to the pre-antibiotics era. mcr 
genes, especially mcr-1 and mcr-3 genes are mainly found in Escherichia coli, which is not 
only ubiquitous in the environment, but also can cause a range of infections in humans such 
as most community acquired urinary tract infections, asymptomatic bacteriuria, intra-
abdominal and soft tissue infections (Rodriguez-Bano et al., 2004). Multiple resistance to 
currently available antimicrobials in E. coli poses considerable therapeutic challenges, and 
resistance to colistin, considered as a last-resort therapeutic option, is even more worrying. 
So far, there is a lack of knowledge regarding mcr-positive E. coli (MCRPEC), regarding 
transmission, pathogenicity, resistance evolution and the global spread of MCRPEC clones. 
The drivers and maintenance of antimicrobial resistance was hitherto, thought to be 
antimicrobials themselves; however, increasingly we are becoming aware that antimicrobial 
resistance is as much to do with genetic maintenance systems e.g. toxin-antitoxin systems 
(TAs), as it is to do with the presence of the drug (Yang & Walsh, 2017). TAs are remarkable 
systems that parasitize the bacteria and hold it hostage. TAs are also extremely varied and are 
a testimony to the dexterity and plasticity of genetic systems to adapt and evolve (Yang & 
Walsh, 2017). Although yet to be fully established, TAs are becoming increasingly numerous 
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and associated with antimicrobial genes present on the same plasmid; thereby, providing 
maintenance of the antimicrobial resistance mechanism in the absence of the drug. Apart 
from antibiotic resistance genes and TAs, other genetic factors, like virulence factors and 
heavy metal resistance, are closely linked to bacterial survival and pathogenicity.  
Therefore, it is important to improve our understanding of the increasing development of 
colistin resistance, and whole genome analysis is a necessary step to unveil the genetic basis 
of mcr-carrying isolates. In this study, we sequence the genome of over 210 human, 
environment and animal isolates carrying mcr-genes, from Vietnam and Thailand, which 
divide into three distinct groups, mcr-1-bearing E. coli, mcr-3-postive E.coli and mcr-1/3-
positive E.coli. Herein, I provide a detailed genomic framework for MCRPEC, for example, 
characteristics of phylogenetic group of mcr-harboring clones, distinct sets of accessory 
genes including TAs, heavy metal resistance and virulence traits, and diversity of antibiotic 
resistance genes. These data show that the main host of mcr-genes, E.coli, are highly diverse, 
this is partially due to a population structure of conserved/dominant lineages associated with 
unique combinations of genes encoding virulence factors, host adaptation and mobile genetic 
elements. 
 
6.2. Results 
6.2.1. Dataset 
    A total of 219 MCRPEC isolates, isolated from a variety of samples, were contributed by 
our collaborators in Thailand and Vietnam. All isolates are given in Appendix II. All isolates 
from Vietnam are isolated from patient faeces (n=136). Samples from Thailand were 
collected from different sources (n=83), including human (n=22), blow flies (n=40), 
environmental water (n=9), poultry feces (n=7), pet feces (n=3), cattle feces (n=1) and 
poultry meat (n=1). Genomic DNA was extracted and sequenced via Illuminia HiSeq (See 
! 147!
methods in 2.20 in Chapter 2). The wgMLST, PlasmidFinder, ResFinder and 
VirulenceFinder tools from the Center for Genomic Epidemiology were used for WGS data 
analysis, full details of all analyses are provide in methods 2.21 in Chapter 2. 
 
 
Fig. 6.1 database structure and workflow of sample collections from various sources in Vietnam and 
Thailand. MCRPEC represents mcr-positive E. coli and the list of samples were shown in Appendix II. 
 
6.2.2. Multi-locus sequence typing of MCRPEC isolates 
As E. coli is the most frequent host for mcr genes, especially for mcr-1 and mcr-3, I sought 
to determine the clonal diversity of the accumulation of MCRPEC from South Asia. Diverse 
sequence types (74 STs in total) have been found among 219 MCRPEC isolates, while 19 
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isolates are belonged to unknown ST clones. The most common ST clone is ST10 (n=24, 
24/219), which includes 13 from Vietnam and 11 from Thailand; followed by ST48 (n=11). 
The number and diversity of strains from Thailand were greater than those from Vietnam, for 
example, Vietnam have 54 ST clones from 141 strains (38.3%), compared with 31 STs found 
in 75 isolates from Thailand (41.3%). There are only 11 STs shared from both Vietnam and 
Thailand; namely, ST10, ST34, ST48, ST58, ST101, ST206, ST218, ST410, ST617, ST685, 
ST746 and ST2705, furthermore, they are linked to both mcr-1 and mcr-3 isolates, excepting 
ST746 and ST2705 associated with mcr-1 isolates only. Importantly, a total of 57 isolates 
bearing both mcr-1- and mcr-3-plasmids share 26 different ST clones, including the two most 
frequent ST groups ST359 (n=7) and ST10 (n=6). ST10-like E. coli, globally distributed in 
human and animals, particularly for ESBL- and AmpC-producing isolates (Ewers et al., 
2012), is closely associated with MCRPEC strains. As shown in Fig.6.2, the majority of 
MCRPEC strains recovered from Vietnam and Thailand, belong to ST10-like group, which is 
consistent with other studies (Matamoros et al., 2017). It is noted that partial several mcr-
carrying isolates from human (n=13), blowfly (n=9) and animals (n=1), shared the identical 
sequence type, ST10, suggesting interspecies transmission of plasmid-borne mcr-genes 
among different habitats, but more clear evidence is needed. Core-genome-based 
phylogenetic analysis was employed in all MCRPEC strains (Fig.6.3 and Fig.6.4). The 
MCRPEC strains from Thailand were divided into four lineages and mainly fell into yellow 
lineage (n=54/83) shown in Fig.6.3. Similarly, five lineages were found in MCRPEC strains 
from Vietnam, and the main lineages are indicated in blue (n=40/81) and green (n=24/81) 
(Fig.6.4). Taken together, the highly diverse clones of MCRPEC as observed above, suggest 
that the acquisition and spread of mcr-genes is not only dependent on strain background.  
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Fig. 6.2 Minimum spanning tree calculated with Bionumerics 6.6 (Applied Math, Sint-Martens-
Laterm, Belgium) shows the population structure (MLST grouping) of mcr-positive E. coli 
(MCRPEC) strains from Vietnam (top, n=136) and Thailand (bottom, n=83), based on allele sequence 
combinations of seven housekeeping genes adk, fumC, purA, recA, gyrB, icd and mdh. The size of the 
nodes is proportional to the number of isolates. Length of branches between each node represents the 
number of different alleles (out of seven housekeeping genes) that differ between two linked 
nodes/ST. Selected nodes are labelled with corresponding ST, phylogenetic group, and number of 
isolates represented. MLST, multi-locus sequence typing. ST, sequence type. NK, unknown. 
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Fig.6.3 phylogenetic tree of 83 MCRPEC isolates from Thailand. represents maximum-likelihood 
tree based on their core genome sequences, which was determined by Parsnp-harvest and visualized 
by iTOL, and four distinct lineages were indicated in different colors. The presence of mcr- genes , 
Bacterial MLST , bacteria sources  and the information of AMR genes , which are all analyzed 
by CGE website (http://www.genomicepidemiology.org/), are presented in this tree. Legends of each 
data set are also indicated in the left of this tree. The average number of AMR genes is indicated by a 
red line in . 
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Fig. 6.4 phylogenetic tree of 81 mcr-1-carrying E. coli isolates from human stools in Vietnam. Circles 
from inside to outside are represented:   maximum-likelihood tree was determined by Parsnp-
harvest and visualized by iTOL using their core-genome sequences, five distinct lineages were 
indicated in different colors; the presence of mcr- genes , bacterial MLST , bacterial sources  
and the number of AMR genes  , which are all analyzed by CGE website 
(http://www.genomicepidemiology.org/). Legends of each data set are also indicated in this tree. The 
average number of AMR genes is indicated by a grey line in . 
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6.2.3 Virulence factors in MCRPEC 
    Virulence genes were determined using the whole genomic sequence deposited in the 
Center for Genomic Epidemiology (http://www.genomicepidemiology.org) as part of their 
VirulenceFinder Web-based tool (https://cge.cbs.dtu.dk/services/VirulenceFinder). A total 
of 18 different virulence genes were detected in MCRPEC from Vietnam and Thailand. 
These genes encode E. coli virulence factors (VFs) including chaperone-usher fimbriae, 
autotransporter proteins, siderophore receptors, colicin and toxins: gad (glutamate 
decarboxylase), iss (increased serum survival), lpfA (long polar fimbriae), astA (heat-stable 
enterotoxin 1), iroN (enterobactin siderophore receptor protein), mchF (ABC transporter 
protein MchF), cma (colicin M), eilA (Salmonella HilA homolog), air (enteroaggregative 
immunoglobulin repeat protein), mumA (microcin M part of colicin H), mchB (microcin H47 
part of colicin H), mchC (microcin C protein), tsh (serine protease autotransporters of 
Enterobacteriaceae), capU (hexosyltransferase homolog), stb (heat-stabile enterotoxin II), 
katP (plasmid-encoded catalase peroxidase), celb (endonuclease colicin E2) and aaiC (AraC 
transcriptional activator). Microcin-encoding mchABC and stb genes that didn’t found in 
MCRPEC from Thailand, are only detected in one and three isolates from Vietnam, 
respectively. katP, celb and aaiC, which are absent in the isolates from Vietnam, have been 
found in three, five and four isolates from Thailand, respectively. In general, the majority of 
virulence genes detected in the present study are found in MCRPEC isolates from Thailand, 
which exhibit a higher virulence score (mean number of virulence genes 2.93 from Thai 
strains vs 1.65 from Vietnamese strains). For example, approximately 46.0% and 37.8% of 
MCRPEC strains from Thailand contains a serum-tolerance gene (iss) and an enterotoxin 
gene (astA), compared with 15.2% and 23.9% Vietnam (Fig.6.5). Furthermore, the gad is 
strongly associated with MCRPEC in both countries Vietnam (81.2%) and Thailand (62.2%), 
as is lptA encoding long polar fimbriae (23.9% in Vietnam and 51.3% in Thailand). 
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Interestingly, when compared to different groups of MCRPEC, the mean numbers of 
virulence genes are higher in mcr-1- group than those in mcr-3 groups with isolates carrying 
mcr-3-only or co-existed mcr-1 and mcr-3 plasmids. 
 
 
Fig. 6.5 The prevalence of virulence genes identified in MCRPEC strains from Thailand and Vietnam 
(A). In B, the average numbers of virulence genes were identified in each group of MCRPEC strains, 
p value was calculated using one-way ANOVA and p < 0.05 indicates means among group are 
significant different (B). 
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6.2.4 Antibiotic resistance genes are associated with MCRPEC isolates 
   In this study, there are several variations in the nucleotide sequence of mcr-1 gene were 
identified, and most of them are only contain single amino acid substitution (Fig 6.6). Given 
the clinical importance of AMR genes, targeted analysis of all known AMR genes in MCRPE 
genomes using ResFinder (https://cge.cbs.dtu.dk/services/ResFinder/) was performed. Fifteen 
different antibiotics classes are available in this database, which include aminoglycosides, β-
lactams, fosfomycin, fluoroquinolones, glycopeptides, macrolide-lincosamide-streptogramin 
(MLS), phenicols, rifampicin, sulfonamides, tetracyclines and trimethoprim. As showed in 
Fig.6.7, the abundance and diversity of resistance genotypes are observed in most of 
MCRPEC isolates, with 34 and 36 in total of different AMR genes detected in Thailand and 
Vietnam, respectively. Furthermore, the genetic characteristics of MCRPEC vary between 
Thailand and Vietnam; for example, β-lactamase genes are significantly higher in Thai 
MCRPEC than those from Vietnam (mean numbers of AMR genes 4.41 vs 1.79), while 
aminoglycocides resistance were mainly associated with MCRPEC in Vietnam (3.15 
copies/strain). These data confirm that AmpC, AmpH and CTX-M are responsible for β-
lactam resistance in Thailand, while AmpC and TEM are the major causes for β-lactams 
resistance in Vietnam. This probably reflects that the distribution of these AMR genes in 
particular countries or regions but not in lineages. It is evident that MDR genotypes are 
commonly found in MCRPEC strains obtained from both Vietnam and Thailand with 
approximately 1.2 copies of resistance mechanism/isolate, the average number of AMR genes 
for phenicol (1.04~1.07), tetracycline (0.99~1.14), sulphonamine (0.88~1.35), 
animoglycocide (1.88~4.41) and β-lactams (2.28~3.15) suggesting that mcr is often co-
existing with resistance to other antibiotic classes resulting in very limited therapeutic options. 
Less commonly, three plasmid-borne genes qnrS, oxqA and oqxB, which contribute to 
horizontally transmission of low-level fluoroquiolone resistance, were also found in the 
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MCRPEC dataset with an average number of  0.57 in Vietnam and 0.77 in Thailand. 
Meanwhile, approximately 53.7% and 67.6% of MCRPEC isolates from Vietnam and 
Thailand contain a qnrS gene, respectively. 
 
 
 
Fig.6.6 Phylogenetic trees of mcr-like genes. All the nucleotide sequences of mcr-like gene used for 
the phylogenetic tree were belonged to the PEA lipidA transferase family. Multiple sequence 
alignment was conducted using Geneious 10.0.7, and resultant output was generated with Tree View. 
The variants of mcr-1 and mcr-3 squared in red, respectively, are derived from our MCRPEC 
collection. mcr-2, mcr-4, mcr-5, mcr-6 and mcr-7 are collected from NCBI with Genbank Number 
indicated on the branches. 
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Fig. 6.7 average numbers of different classes of antimicrobial resistance (AMR) genes in our 
MCRPEC strains from Vietnam and Thailand. MLS indicates macrolide-lincosamide-streptogramin, 
and AmGly indicates aminoglycocide. 
 
 
Most interestingly, the mcr-3-linked groups of MCRPEC from Vietnam (mcr-3 alone or 
co-existence of mcr-1 and mcr-3 isolates), have markedly higher copies of AMR genes, 
compared to mcr-1 alone group (mean 14.5~15.9 vs 10.4 copies per isolate, p<0.0001). 
Similarly, in Thailand, isolates co-harboring mcr-1 and mcr-3 plasmids are also strongly 
associated with more antibiotic resistance genes than mcr-1-only isolates (mean 17.88 vs 
11.02, p<0.0001) (Fig. 6.8). Overall the average copy number of AMR genes in mcr-3-
linked- and co-existed mcr-1 and mcr-3- MCRPEC isolates are 15.87 and 15.51, respectively, 
which is significant higher than that in mcr-1 MCRPEC isolates (mean 10.55 copies per 
strain, p<0.0001). Furthermore, significantly lower numbers of AMR genes in MCRPEC 
from Thailand are observed in Fig.6.8, with mean 8.1 copies of AMR genes per strain (p 
<0.0001), compared to mcr-1-only MCRPEC isolates. In combination with the results of 
0 1 2 3 4 5
β-lactams
AmGly
colistin
tetracycline
fluroquinolone
phenicol
sulphonamine
trimethoprim
MLS
rifampicin
fosfomycin
Vietnam
Thailand
average copies of AMR genes per strain
cla
ss
es
 o
f A
M
R 
ge
ne
s
157!
!
virulence genes described above, it indicates that mcr-1-linked MCRPEC strains harbor more 
virulence genes and less AMR genes, which is contrast to that in mcr-3 and co-existed of 
mcr-1 and mcr-3 groups with less virulence genes and more AMR genes. 
 
 
 
 
Fig. 6.8 The distribution of AMR genes in three subpopulations of MCRPEC isolates, namely, mcr-1-
positive strains, mcr-1-positive strains and co-existed mcr-1 and mcr-3 strains. Figure A, B and C, 
reprent the abundance of AMR genes in MCRPEC isolates from Vietnam, Thailand and both 
countries, respectively. p values were calculated using student t-test. Numbers in the boxplots indicate 
average copies of AMR genes within each group.   
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6.2.5. Diverse plasmid patterns of mcr-gene acquisition 
Screening against the PlasmidFinder database 
(https://cge.cbs.dtu.dk/services/PlasmidFinder/) (Carattoli et al., 2014), 77 isolates from 
Vietnam were selected for plasmid replicons analysis and 32 different of known plasmid 
replicons were detected (Appendix IV Table 6.2). These include 78 from IncF-related 
plasmids, i.e., 26 IncFIA (HI1), 3 IncFIA, 26 IncFIB (K), 11 IncFIB (AP001918), 2 IncFIC 
(FII) and 3 IncFII (pSEI1).  The number of plasmids found in per MCRPEC isolate are 
ranging from 1 to 9, further providing evidence of the genetic plasticity of these MCRPEC 
isolates. However, linking mcr genes to specific plasmids was not determined as whole 
genomic assemblies were generated using Illumina short-reads and the repetition of mobile 
elements complicates assembly of full-length plasmid sequences. Fortunately, some contigs 
containing both plasmid replicon sequences and mcr were found, thus incompatibility groups 
for some mcr-bearing plasmid could be determined (Table 6.1 and Appendix Table 6.1). In 
this study, Inc types could definitively be determined for a total of 78 MCRPEC but not for 
the rest of MCRPEC isolates. At least seven different Inc groups of mcr-bearing plasmids 
were found, including IncX4, IncX1, IncP1, p0111, IncFII, IncHIB and IncHIA. Plasmids 
belonging to IncX4 group are strongly associated with mcr-1-gene and detected in 33 
MCRPEC. Moreover, mcr-1-IncHIB (R27) and mcr-1-IncHIA plasmids have also been 
identified in 5 and 2 MCRPEC strains from Thailand, respectively. In Vietnam, where all 
MCRPEC strains are collected from patient faeces, more diverse mcr-linked plasmid types 
have been found. In Hanoi, mcr-identified plasmids belong to five incompatibility groups: 
IncP1 plasmids associated with both mcr-1 (n=10) and mcr-3 genes (n=9); 7 IncX plasmids 
(6 IncX4 plasmids with mcr-1 gene and one IncX1 with mcr-3 gene); 2 IncFII plasmids 
related to mcr-3 gene; 2 IncHI1 plasmids with mcr-1 gene only (IncHI1A and IncHI1B) and 
one p0111 plasmid with mcr-1 gene.  
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Table 6.1 Incompatibility types of mcr- carrying plasmids  
Plasmid types  IncX4 IncX1 IncFII IncHIB IncHIA IncHIA 
/HIB 
IncP1 repB 
(p0111) 
colE 
Vietnam* 
(n=28) 
mcr-1 5 0 0 1 1 0 10 1 0 
mcr-3 0 1 2 0 0 0 9 0 0 
Thailand* 
(n=51) 
mcr-1 33 0 0 4 2 1 0 0 0 
mcr-3 0 0 6 0 0 0 1 0 1 
Total No. 78 38 1 8 5 3 1 20 1 1 
*only list the isolates where mcr-carrying contigs also contain plasmid replicon sequences. 
 
 
6.2.6 Accessory functions associated with MCRPE isolates 
6.2.6.1 Coexistence of heavy metal resistance genes 
   Metal compounds such as mercury, arsenic, copper and silver also have been used in 
veterinary and clinical settings as therapeutic purposes for decades. The prevalence and 
linkage of metal resistance genes to other antibiotic resistance genes was examined; in 
particular, the genetic operons bearing metal resistance genes by whole genomic sequencing 
analysis. Firstly, I created a database for four most commonly detected operons responsible to 
metal resistances and searched in MCRPEC strains using megaBLAST in Geneious 10.0.7; 
namely, i) mercuric resistance operon, mer, commonly consisting of six genes merRTPCAD, 
where merA is mercuric reductase, reducing mercuric ions Hg2+ to non-toxic Hg0 in the 
cytoplasm. ii) plasmid-mediated copper resistance system, Pco, containing four membrane 
protein PcoABCD. PcoA is a copper oxidase, contributing to oxidize Cu (I) to less toxic Cu 
(II). iii) silver efflux system, sil, originally found on plasmid pMG101. The sil system forms 
a silCBA complex, attributing to efllux Ag+ directly to the outside of the cell. iv) arsenic 
resistance operon, ars, which consists of several genes arsA, arsB, arsC and arsD. It has been 
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proposed that ArsA, and ArsB can form an ATP-energized effluxer, conferring to arsenic 
resistance (Hobman & Crossman, 2015). As showed in Fig.6.9, there are similar genotypic 
characteristics of metal resistance in MCRPEC strains from Thailand and Vietnam. Most of 
MCRPEC strains contain a number of genes associated with arsenic resistance (0.96.3-
105.41%) and silver resistance system (71.85-78.38%). Less commonly, approximately 43% 
of MCRPEC strains carriy genes encoding copper resistance such as pcoA and pcoB. Of note, 
mercuric resistance genes, merA and merC, were also found 31.85-36.49% and 13.51-32.59% 
MCRPEC strains, respectively.  
 
 
 
Fig. 6.9 The prevalence of most commonly heavy metal resistance genes in MCRPEC 
     
6.2.6.2. The abundance of TAs on MCRPEC and non-MCRPEC isolates 
To determine the MCRPE genome for toxin-antitoxin systems (TAs), I have generated a 
TAs database containing 22 pairs of TAs belonged to type I-V groups, then searched in 
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MCRPE strains using megaBLAST in Geneious 10.0.7. As showed in Fig. 6.11, aside parDE, 
the other 21 TAs present in MCRPEC strains had frequencies ranging from 0.36 to 3.79. 
Multiple copies of toxin YeeV were observed in most of the isolates, with a mean number of 
2.1 in Vietnam and 3.79 in Thailand, which are usually higher than in cognate yeeU (mean 
copies are 1.2 and 2.1 in Vietnam and Thailand, respectively). Significantly high prevalence 
(94.2-100.0%) of TAs ghoST, hipAB, hicAB, tisAB and mazEF were found in our collection, 
followed by yafQ-dinJ, higAB and yefM-yoeB ranging from 72.2% to 86.9%. As showed in 
the hierarchical bar chart (Fig. 6.11), detection rates (3.6%-28.0%) for vapB, pemKI, ccdAB, 
hok, relBE and yacAB, are relatively low. The average number of TAs detected in MCRPEC 
from Thailand is 17.24, which is higher than in Vietnamese MCRPEC (p<0.0001, average 
number 14.39 ranging from 7 to 29). Moreover, there is no significant difference the average 
number of TAs in mcr-1 only, mcr-3 only or co-harboring mcr-1 and mcr-3 isolates, with 
mean 15.52, 14.62 and 15.41 per strain, respectively. 
 
 
 
 
Fig. 6.10 Prevalence of TAs systems in MCRPEC isolates from Thailand (A) and Vietnam (B) 
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Fig. 6.11 Distribution of 22 TAs groups in mcr-3-positive isolates (heat-map) 
 
 
Less frequent linkages between mcr and TAs identified in this study:  
    (i) yeeU-yeeV is the most popular TAs in all groups of isolates, and multiple copies of 
yeeU and yeeV are identified in the majority bacteria, especially in those from Thailand 
isolates (see Fig. 6.11). yeeUV  belonging to type IV TAs, in which the protein antitoxin 
YeeU directly binds to both MreB and FtsZ, rather than forming a complex with the toxin 
YeeV (previously designated as CbtA) via direct toxin-antitoxin binding (Masuda et al., 
2012). YeeV is the first toxin of the TA systems that affects cellular morphology (Tan et al., 
2011). YeeV binds and inhibits the polymerization of bacterial cytoskeletal proteins, MreB 
and FtsZ, which are responsible for maintaining the cell shape and cell homeostasis. The 
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antitoxin, YeeU, suppresses the YeeV toxicity by promoting the activity of MreB and FtsZ, 
which are inhibited by YeeV (Masuda et al., 2012).  
(ii) As shown in Fig. 6.11, the genes for five TAs are particular popular with high 
percentage in MCRPEC strains; namely, mazEF (86.7-96.2%), ghost (85-96.2%), hicAB 
(86.7-98.1%), hipAB (83.3-96.2%) and tisAB (88.9-100%). Except tisAB belonging to type I 
TAs and ghoST belonging to type V TAs, the resting TAs are all belonged to type II TAs.  
These TAs are involved in a variety of essential cellular processes, for instance, TisB, 
produces clusters of narrow anion-selective pores in lipid bilayers that significantly disturbs 
the cytoplasmic membrane (Wagner & Unoson, 2012). GhoT is a membrane-damaging 
protein, and its production can lyse the cell membrane and change its morphologies. 
Ultimately, this causes the formation of ghost cells, a group of dead or dying cells in which 
cell outline is still visible but the cytoplasmic area are transparent (Wang et al., 2012). 
(iii) Interestingly, several TAs (mqsAR, stbDE, vagCD and relBE), seem to be linked with 
mcr-3-positive isolates with clearly high detection rate than the other two groups. Specifically, 
mqsAR is the first TAs shown to be involved in biofilm formation was mqsAR (motility 
quorum sensing regulator), a typical type II TAs in which the toxicity of protein MqsR is 
neutralized by its conjugate antitoxin MqsA (Gonzalez Barrios et al., 2005, Brown et al., 
2009, Wang & Wood, 2011). Andres et al. demonstrated that toxin MqsR is significantly 
stimulated by biofilm formation and enhanced cell motility (Gonzalez Barrios et al., 2005). 
    (iv) Lastly, one of SOS response inducer, TisB, is commonly found in MCRPEC strains. It 
has been proposed that once activated, the toxin TisB gradually accumulates and rapidly 
binds to the cytoplasmic membrane, leading to membrane damage and the proton motive 
force (pmf) and ATP levels are decreased. This causes the rates of DNA, RNA and protein 
synthesis to decrease, and the intake of drugs to the cells are blocked. As a result, growth 
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slows down and a multidrug resistant persister is formed (Vogel et al., 2004, Darfeuille et al., 
2007, Unoson & Wagner, 2008, Dorr et al., 2010).  
 
 6.3. Discussion 
It has been reported that MCRPEC isolates from China are genetically and phenotypically 
diverse (Wang et al., 2017). Here I show a detailed genomic framework for MCRPEC 
isolates based on WGS of over 210 isolates from Thailand and Vietnam. My results show the 
existence of highly diverse MCRPEC clones that have access to a diverse pool of AMR/metal 
resistance genes and plasmid maintenance systems (TAs), suggests that there is potential for 
the emergence of mcr-linked extended drug-resistance (XDR) clones in hospitals setting. 
ST10 and ST48 are prominent among MCRPEC isolates. It has been reported that E. coli 
ST10 is associated with carbapenem resistance and an XDR nosocomial outbreak (Zhang et 
al., 2017). ST10-MCRPEC clone has been reported globally including China, South America 
(Monte et al., 2017), Belgium (Xavier et al., 2016), Netherlands (Veldman et al., 2016), 
Switzerland (Bernasconi et al., 2016), France and Italy (El Garch et al., 2017). However, 
given the diversity of ST groups and unknown epidemic clones detected in all MCRPEC 
strains, it suggests that the acquisition of mcr-bearing plasmids is not attributed to the E. coli 
genetic background, making the emergence of MCPREC complicated and unpredictable. A 
wider population framework of MCRPE need to be undertaken before determining any mcr-
linked clonal background and identifying new and emerging clones. 
mcr-linked plasmids have been found in at least 10 different Inc groups including IncX4, 
IncX3, IncX1, IncP1, IncFII, IncHI2, IncI2, IncHIB and IncFIB (Li et al., 2017, Matamoros 
et al., 2017). Among which, the major type of mcr-1-bearing plasmids is IncX4 plasmids, 
which belongs to the subgroup IncX family consisting of six subgroups, IncX1-X6 (Lo et al., 
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2014). IncX is a self-transmissible plasmid with high frequencies (10-1 ~ 10-4), which is 
significantly higher than the epidemic IncFII plasmids (by 102 ~ 105 fold) (Lo et al., 2014). 
IncX plasmids are proposed to be responsible for promoting worldwide-spread of antibiotic 
resistance genes including genes encoding ESBLs, i.e. blaCTX-M (Lo et al., 2014, Dobiasova 
& Dolejska, 2016), plasmid-mediated quinololone resistance genes (i.e., oqxAB and qnrS1) 
(Dobiasova & Dolejska, 2016) and carbapenemase genes (blaNDM-5) (Li et al., 2018). mcr-1-
linked IncX4 plasmids have globally spread to various species including E. coli, K. 
pneumoniae and Salmonella spp. from human and animals from Denmark  (Hasman et al., 
2015), Germany (Falgenhauer et al., 2016), China (Li et al., 2017), South American (Monte 
et al., 2017), South Africa (Li et al., 2017) and United Kingdom (Doumith et al., 2016). In 
this study, short-read sequence contigs did not fully facilitate the identification of the genetic 
location of all mcr genes. Fortunately, mcr-1-IncX plasmids were definitively determined 
from 40 isolates, consisting of two subgroups, 39 IncX4 and 1 IncX1, also linked to mcr-
genes. Of interest is the co-existence of IncX3-blaNDM-5 and IncX4-mcr-1 plasmids 
(Mediavilla et al., 2016, Sun et al., 2016). Collectively, these findings highlight that IncX 
plasmids play a quintessential role in promoting the spread of mcr-medicated colistin 
resistance. The second major mcr-carrying plasmid type is IncP, mainly found from our 
Vietnam samples, 10 linked to mcr-1 gene and 9 linked to mcr-3 gene. Unlike IncX plasmids 
that are normally narrow-spectrum plasmids, IncP1 is a broad host range plasmid, which can 
spread genetic information across taxonomic barriers (Schluter et al., 2007). Therefore, the 
link between mcr-gene and IncP1 plasmids has drawn considerable attention, as IncP1 will, 
theoretically, facilitate the rapid spread of mcr genes across various bacterial populations in 
natural and clinical environments. It is known that one of mobile genetic elements, IS family, 
including IS3, IS30, IS110, IS26 and ISCR type elements, play an important role in resistance 
gene translocations. ISApl1 is a type of IS surrounded by a pair of left and right inverted 
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repeats (IRL and IRR), which was first identified in Actinobacillus pleuropneumoniae. The 
fact that the mcr-1 gene is consistently associated with ISApl1 and that the ISApl1-mcr-
1 cassette may be inserted into different genetic loci in different plasmids. 
    WGS analysis identified well-established antibiotic resistance-conferring genes (Fig.6.5). 
The presence of co-resistance to clinical importance antibiotics, such as β-lactams and 
fluoroquiolones in MCRPE isolates is worrying, because our data shows that mcr-depended 
colistin resistance is strongly associated with diverse β-lactamases, thus eventually limiting 
therapeutic options to treat infections. These include ESBLs (CTX-M groups); AmpC β-
lactamases (AmpC and CMY-2) hydrolyzing broad-spectrum cephalosporins, i.e., cefotaxime, 
ceftazidime and ceftriaxone (Jacoby, 2009). When comparing mcr-1-positive isolates that are 
associated with other AMR genes (mean number 10.4 per isolate), mcr-3-related E.coli are 
MDR and have a greater number of AMR genes (approx. 15.7 per isolate). These findings 
suggest that the accumulation of AMR genes in mcr-3-linked MCRPEC strains is the 
consequence of the successful spread of such clone with better fitness than those in mcr-1-
only MCRPEC as described in Chapter 4. It is noteworthy that, in addition to emerging 
multiple patterns of antibiotic resistance, heavy metals represent another major sources of 
environmental and clinical contamination that may, fortuitously, select for antibiotic 
resistance (Silver & Phung, 1996, Gullberg et al., 2014). Heavy metal compounds are use in 
animal growth feeds and therapeutic treatment, including commonly used metal compounds 
such as mercury, silver, arsenic and cooper. These compounds are common place in pig and 
poultry production and unlike antibiotic food additives, can accumulate in soil, water, 
aquaculture and marine antifouling treatments or industrial effluent (Wales & Davies, 2015). 
It has been proposed that antibiotic-resistant bacteria are enriched at locations contaminated 
with metals, and genes conferring co-selection to heavy metal and antibiotic are often found 
together in many clinical isolates (Dhakephalkar & Chopade, 1994, Baker-Austin et al., 2006, 
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Fard et al., 2011, Ji et al., 2012, Seiler & Berendonk, 2012). Furthermore, genes conferring 
heavy metal tolerance may coexist on the same genetic element (e.g. plasmid), which could 
further promote co-dissemination and resistance (Akinbowale et al., 2007, Seiler & 
Berendonk, 2012). In this study, genomic analysis show that metal resistance operons are 
widely identified in MCRPEC strains, with high detection rates 13.51-105.41%. Most 
interesting, a mercuric resistance operon consisting of eight ORFs, merRTPCADE , and a 
gene cluster terABCDEW contributing to tellurium resistance, were found on a mcr-1-IncP 
plasmid pKH457-3-BE isolated from bovine strain in Belgium (Malhotra-Kumar et al., 2016). 
 
   Another interesting genetic feature is the abundance of TAs in MCRPEC strains. Because 
of their ubiquity and crucial intracellular targets, the study of bacterial TAs will help us to 
better understand their role in the dissemination and evolution of bacterial antibiotic 
resistance. TAs, originally linked to plasmid maintenance systems (Ogura & Hiraga, 1983), 
exert important activities in the context of bacterial resistance (Wen et al., 2014, Harms et al., 
2016, Patel, 2016). TAs are small modules consisting of a stable toxin and its unstable 
cognate antitoxin. Antitoxins are more labile than toxins and readily degraded under stress 
conditions, this allow the toxins to exert their detrimental effects, promoting plasmid 
maintenance, slow growth and dormancy, which is rather linked with chromosomally 
encoded TAs  (Page & Peti, 2016). Besides, TAs like hok-sok and ccdAB, are responsible for 
the plasmids stabilization, thus TAs also have been viewed as “addiction 
modules”(Engelberg-Kulka et al., 2006). Beside plasmids, TAs appear to play a stabilizing 
role in genomic islands, for instance, SXT, an integrative and conjugative element (ICE) that 
mediates tolerance to multiple antibiotics in Vibrio cholera (Wozniak & Waldor, 2009). One 
novel TA pair (designated mosAT) within SXT has been identified to promote SXT stability. 
Ectopic expression of mosT causes growth inhibition and MosA can neutralize the toxic 
effect of overexpressed MosT. Similar to plasmid-borne toxins, when SXT is vulnerable to 
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loss, MosT expression is activated to minimize the SXT-free cells. Therefore, the activity of 
mosAT may contribute to the maintenance of SXT in bacterial populations (Wozniak & 
Waldor, 2009).  In this study, high prevalence of hicAB (96.0-97.1%) and higAB (72.0-86.9%) 
were identified in MCRPEC strains, in addition, they are associated with mcr-carrying 
plasmids: hicAB found in most of mcr-1-linked IncX4 plasmid described in Fig.5.5 in 
Chapter 4; and higAB identified in a mcr-3-harboring IncP1 plasmid shown in Fig.4.2 in 
Chapter 5. However, their physiological roles connected to mcr-plasmids have not yet been 
elucidated. Besides regulated by its cognate antitoxin HigA, it has been reported that HigB 
toxin is also regulated by the DNA damage (SOS response) inhibitor LexA, thereby 
promoting bacterial growth arrest when bacteria is under amino acid starvation (Christensen-
Dalsgaard & Gerdes, 2006, Kirkpatrick et al., 2016). More importantly, both higAB loci can 
significantly enhance the stability of the test plasmid, up to 600-fold increase in genetic 
stability (Christensen-Dalsgaard & Gerdes, 2006). The effect of toxin HicA seems to be 
bacteriostatic and its overexpression cause E. coli growth inhibitation (Li et al., 2016). 
Therefore, it would be interesting to further study the genetic roles of these TA loci in the 
maintenance and dissemination of mcr-harboring plasmids. 
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Chapter 7  
General Discussion 
 
7.1 Multifaceted aspects of mcr-like genes conferring colistin resistance 
    Today, antibiotic resistance has become a global crisis, evidenced by the increasing 
conflict between rapid emergence and dissemination of antibiotic resistance genes and the 
marked decline in the discovery and pipeline development of novel antibiotic agents. The 
global dissemination of CREs capable of lysing nearly all β-lactams, are also frequently 
associated with multiple resistance to aminoglycosides and fluoroquinolones- historically, 
both have been effective treatment options for Gram-negative infections. XDR or pan-drug 
resistant phenotypes leave very few therapeutic options and force clinicians to re-consider 
older antibiotics, such as colistin, discovered in 1947. For the past decade, colistin has been 
considered as the last-line antibiotics against CRE pathogens. The discovery of the plasmid-
borne mcr-1 gene conferring colistin resistance in the late 2015 is therefore deeply disturbing. 
Plasmid-mediated horizontal transmission of mcr-genes exacerbates this predicament of 
global colistin resistance and makes it more unpredictable and complex. There are several 
features of mcr-mediated colistin resistance in my study summarized as follow:   
    (i) Multiple reservoirs of mcr-conferring colistin resistance, a concerned threat in both 
human and animal health. An established but increasingly challenged paradigm, is the 
antibiotic resistance is associated with the volume of antibiotic use. Colistin has been used in 
food-producing animals since 1950s, either as a growth promoter, metaphylaxis or treatment 
of individual animals or flocks/herds and thereby can facilitate the emergence and spread of 
colistin resistance. It is therefore not surprise that the rate of mcr-1-mediated resistance is 
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much higher in the veterinary sector than in clinical settings (Skov & Monnet, 2016). In this 
thesis, over 219 MCRPEC strains originating from human, animals and environmental 
samples from Vietnam and Thailand, were characterized using WGS. A vast diversity of 
MCRPEC clones were observed, reflected by the variety in sequencing types (ST) and 
distinct sets of accessory genes including TAs, heavy metal resistance determinants, 
virulence factors and other antibiotic resistance genes. Worryingly, the ST10-like MCRPEC 
were identified from all sources including patients, food-producing animals, blowflies and 
environmental sectors (e.g. water and soil), indicating widespread distribution and therefore, 
the possibility of further transmission of MCRPEC strains. There is an increasing perception 
that flies can spread antibiotic resistant bacteria from the environment to humans, and vice 
versa. In Chapter 5, the high prevalence of mcr-1-carrying isolates (16%, 48/300) were 
recovered from blowflies trapped from Northern Thailand, consisting of 17 MCRPKP and 31 
MCRPEC. The clonal relationship among 17 MCRPKP strains was affirmed by all isolates 
belonging to ST43, indistinguishable PFGE patterns and an identical phylogenetic tree. The 
presence of numerous virulence factors and virulence potential in the Galleria mellonella 
model, also suggests that the ST43 MCRPKP clone is hypervirulent. WGS-based analysis of 
MCRPE isolates from blow flies show that mcr-1 is predominantly located on IncX4 
plasmids (n=29/48), which are similar to our previously described IncX4-mcr-1 plasmids 
obtained from human and animals. This suggests that the IncX4-mcr-1 plasmid has been 
circulated in various environments in Thailand, particularly in the clonal and virulent 
MCRPKP isolates, which would cause a serious threat for public health.  
     (ii) The expanding groups of mcr-like PEtN transferases family. To date, a total of eight 
mcr-like genes (mcr-1, -2, -3, -4, -5, -6, -7 and mcr-8) have been identified. These mcr-like 
genes share similar functions - modifying the bacterial LPS with PEtN additions, and share 
35-78% nucleotide identity. mcr-2, mcr-4, mcr-5 and mcr-6 have been identified from animal 
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origins in Europe (AbuOun et al., 2017, Borowiak et al., 2017, Carattoli et al., 2017); in 
contrast, mcr-1-gene has been globally disseminated and based on my dataset from South 
Asia, mcr-3 appears to exist be noticeably present in both humans and animals. A large 
dataset of mcr-1- and/or mcr-3-positve Enterobacteriaceae (MCRPE) were studied in this 
thesis. In Chapter 4, co-occurrence of mcr-1 and mcr-3 genes are identified in 34 out of 52 
isolates (61.5%) from humans in Vietnam.  Two variants of MCR-3 with three amino acid 
substitutions, have been further studied. A number of mcr-harboring plasmids were 
characterized and plasmid IncX4 was strongly associated with mcr-1 and mcr-3 genes, and 
the broad-host rang plasmid, IncP1 was also found to carry mcr-1 and mcr-3. These plasmids 
are transferable at high frequency (up to 6 x10-3). These data provide an important milestone 
in our understanding of mcr movement and dissemination.  
    (iii) The expression of mcr-1 and mcr-3 gene causes bacterial fitness burden. Fitness is an 
important factor to predict the spread and development of antibiotic resistance. In Chapter 3, 
our data shows that over-producing MCR-1 in E.coli imposes a substantial fitness loss, 
observed by slow growth rates, impaired membrane integrity, reduced bacterial survival and 
decreased competitiveness (Yang et al., 2017). The fitness burden imposed by mcr-3 seems 
to be lower than that of mcr-1, and mcr-3 is more stable and competitive, compared to mcr-1-
expressing isolates. Further comparisons between mcr-1 and mcr-3 have also been explored 
in Chapter 4 and discussed below. 
(iv) The impact of MCRPE isolates on bacterial virulence. The activity of MCR-enzyme is 
to catalyze the transfer of PEtN to the phosphate groups of lipid A, the endotoxin portion in 
GNB outer-membranes. It has been proposed that modified lipid A provides bacteria with 
protection from innate immune systems in host tissues. In chapter 3, mcr-1-modified lipid A 
decreased the production of pro-inflammatory cytokines TNF-α and IL-6. Furthermore, after 
the acquisition of a mcr-1-producing natural plasmid, the bacteria become less virulent and 
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with reduced Galleria mortality. These data suggest that the activity of MCR-1 may aid 
bacteria in evading host immune systems.  
 
7.2 The links between fitness and the future of colistin resistance: would the mcr-
conferring fitness cost lead to the reversion of colistin resistance in E. coli? 
    The emergence and development of antibiotic resistance is a complex biological process 
driven by many factors, including the volume of antibiotic use, the resistance-conferred 
fitness burden and the frequency of compensatory mutations (Andersson & Hughes, 2010, 
Hughes & Andersson, 2015). Factors effecting fitness cost of antibiotic resistance have been 
reviewed in my introduction. Briefly, antibiotic resistances conferred by chromosomal 
mutations and plasmid-carrying genes are initially associated with a fitness loss evidenced by 
low growth rates and less competitiveness. Fitness cost conferred by colistin resistance plays 
a role in limiting the emergence and development of resistance to colistin; for example, in A. 
baumannii. According to SENTRY Antimicrobial Surveillance Program (2006-2009), 
analyzing a large number of A.baumannii (4686 isolates), the reported rates of resistance was 
0.8% for polymyxin B and 0.9% for colistin, and most of MDR A. baumannii were 
susceptible to colistin (Gales et al., 2011). In another recent large population study, the 
colistin resistance of A. baumannii was also very low level with resistant rates of 2.1% (9/401) 
from Turkey (Aydin et al., 2017). These data suggest that colistin is still active against A. 
baumannii. This phenomenon is probably due to the fitness costs imposed by non-silent 
mutations in the LPS synthesis genes (lpxACD) and pmrAB systems (Adams et al., 2009, 
Beceiro et al., 2014, Pournaras et al., 2014). It has also been reported that the in vitro growth 
rates of lpx-mutants were dramatically diminished; furthermore, both in vitro and in vivo 
competition experiments revealed a significant reduction of fitness - as low as less than 0.01 
(Beceiro et al., 2014). Similarly, pmrB-mutants also failed to reach the same growth rate as 
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their parental strains, and pmrB-mediated colistin resistance is associated with a fitness loss 
in vivo. Both colistin- resistance mechanisms have been shown to cause a noticeable fitness 
cost, with a greater reduction associated with mutations in lpxACD resulting in complete loss 
of LPS, than with pmrB mutants mediating PEtN addition to lipid A (Beceiro et al., 2014). To 
date, no mcr-gene has been identified in A. baumannii. 
Given the above, an obvious question to ask is: does plasmid-mediated colistin resistance, 
mcr-genes, firstly discovered in late 2015, have a fitness cost too? Apparently, fitness costs of 
resistance alone are not a good predictor of subsequent clinical resistance development. The 
dissemination of plasmid-encoded colistin resistance also depends on the following three 
factors: First, efficiency of transfer versus genetic barriers; second, the genetic 
contexts/background of the resistance genes, and third, the ecological opportunity for 
plasmid-encoded resistance genes to enter a pathogen (Hughes & Andersson, 2015). All of 
these factors are key to understanding and predicting the development of this novel colistin 
resistance mechanism, but currently, we have very limited data of these factors. The main 
host of mcr-1 and mcr-3 genes is E. coli, and mcr-genes, located on transferable plasmids, 
confer low-moderate resistance to colistin (MICs 2-8 mg/l) (Liu et al., 2015), when compared 
to chromosomal-mediated resistance (MICs 8-256 mg/l). In Chapter 3, the biological costs on 
the expression of mcr-1, including in vitro growth rate, competiveness, cell morphological 
changes and cell viability, have been determined. The decrease in growth rates of mcr-1-
producing E .coli induced by different concentrations of L-arabinose, were clearly evident. In 
the competition assay, over-expression of mcr-1 causes a high fitness loss, suggesting that the 
level of mcr-1 expression in E. coli is responsible for bacterial fitness cost; similar 
observations have been made in K. pneumoniae (Tietgen et al., 2017). More importantly, 
pleiotropic effects of mcr-1 expression on E. coli physiology also have been observed. Firstly, 
MCR-1 is an outer membrane protein consisting of five-helix hydrophobic domain and a 
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soluble form, the expression of mcr-1 has profound effects on the outer membrane topology, 
the multi-layer cell envelope has been significantly compromised. Furthermore, the over-
production of MCR-1 is toxic to the bacterial cell, observed by a decreasing cell populations 
during bacterial growth cycles and a significantly higher ratio between dead- and alive- cells. 
These data may explain why expression of mcr-1 has been tightly controlled resulting in only 
low-moderate colistin resistance (Yang et al., 2017). However, the carriage of a natural 
occurring plasmid encoding mcr-1 also causes only negligible effects on growth rates of 
clinical isolates, which is consistent with Tietgen’s results (Tietgen et al., 2017, Yang et al., 
2017). Moreover, bacterial architecture is intact and cell viability are not affected after the 
acquisition of a mcr-1 positive plasmid (Yang et al., 2017). This is possible because these 
clinical isolates can moderate the acquisition of mcr-1 by compensatory adaptations, 
facilitating the expression of mcr-1. Tietgen et al. examined the mcr-1-imposed fitness costs 
by a competition growth experiment in K. pneumoniae and E. coli and showed that the 
acquisition of a natural mcr-1-positive plasmid impaired fitness in K. pneumoniae but not in 
E.coli, this may, in part, explain the high prevalence of mcr-1 in E.coli, but less present in 
other species like K. pneumoniae (Tietgen et al., 2017). Most recently, a deactivated mcr-1 
gene by the insertion of an IS1294b element has been found in an uropathogenic E.coli 
ECO3357 (Zhou et al., 2018), this inactive form of mcr-1 gene can be induced under colistin 
pressure by the removal of IS1294b element. Furthermore, the acquiring of this inducible 
mcr-1-plasmid did not impair bacterial fitness. This finding provides a novel insight into the 
fluidity and plasticity of genetic elements augmenting gene expression in response to external 
stimuli such as colistin challenge. 
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7.3 Are compensatory mutations in mcr-1 responsible for the amelioration of bacterial 
fitness loss?  
    It maybe be too naïve to imagine that the high fitness cost imposed by mcr-1 expression, 
will limit the spread and maintenance of mcr-mediated colistin resistance in pathogen 
population. It has been identified that some clinical strains carrying acquired-resistance genes 
can compensate the fitness cost, thereby producing a selective advantage and raising the 
potential spread of antibiotic resistance (MacLean et al., 2010). The amelioration of the high 
cost imposed by antibiotic resistance plasmid provides a good illustrative example of how 
high fitness costs can be negated by compensatory mutations, which is crucial for the 
maintenance and dissemination of antibiotic resistance in clinical and natural environments   
(Loftie-Eaton et al., 2017). Plasmids R1 and RP4 both carrying multidrug resistance genes 
imposing an initial fitness burden on bacteria (Dahlberg & Chao, 2003), but the cost was 
reduced through changes in both the plasmids and the bacteria. The altered plasmids no 
longer impose a cost on the hosts when transferred to a plasmid-free recipient; additionally, 
the recipient showed enhanced plasmid maintenance, thereby enhancing plasmid persistence 
(Loftie-Eaton et al., 2017). The evolution trajectories of costly multi-drug resistance are more 
interesting. There are several factors influencing the trajectory of compensatory mutations 
associated with fitness cost: i) selective pressure by antibiotics; ii) level of resistance; iii) 
frequency of mutation rates; iv) impact of each mutation on fitness burden (Toprak et al., 
2011, Lesho et al., 2013, Hughes & Andersson, 2017, Wong, 2017). It has been reported that 
mutations in pmrB can be induced by high concentration of colistin, leading to an increase in 
resistance to colistin and imposing a fitness cost (Phan et al., 2017). Due to the global spread 
of mcr-1 mediating moderate levels of colistin resistance, in Chapter 3, I developed a 
selective passage that continuously monitor bacterial growth, colistin sensitivity and fitness 
cost. The data shows that wild-type MCRPEC (4-8 mg/l) also can be readily induced to high-
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level of colistin resistance (16-256 mg/l) by multi-step passage in the increasing 
concentrations of colistin (Yang et al., 2017). Most of these HLCRMs initially confer huge 
fitness costs with slow growth rates comparing their respectively parental strains, except 
PN16. However, their fitness costs can be subsequently compensated by serial passages in the 
absence of colistin, reflected by their increasing growth rates (Fig.7.1). This observation 
supports the fact that clinical strains with high levels of colistin resistance, leading to large 
fitness costs, possibly evolve alternative pathways for rapid compensatory mutations, thereby 
potentially stabilizing the costly HLCRMs in colistin-free condition. However, little is known 
about the genetic adaptations of these HLCRMs, deeper sequencing is currently being 
determined to better understand the evolution of HLCRMs. 
 
 
Fig.7.1. Growth curves of ancestral MCRPEC strains (referred as _D0) and their respective 
HLCRMs (referred as _D14) and revertants (referred as _D14r). The means of three independent 
replicates were shown and the error bars represent the S.D (n=3). 
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    The fitness measurements of mcr-1 expression have also been employed in mcr-3-carrying 
strains. Interestingly, in comparison with the high fitness burden imposed by mcr-1 
expression, mcr-3 gene seems to confer colistin resistance with low fitness costs, evidenced 
by higher growth rates, less cell toxicity and higher fitness (described in Chapter 4). Most 
importantly, the abundance and stability of mcr-3-plasmids is higher that of mcr-1-plasmid in 
both competition models in laboratory strains J53 and wild-type clinical strains containing 
both mcr-1 and mcr-3 plasmids (Fig.4.9 and Fig.4.10 in Chapter 4). Based on these 
observations the expression of mcr-3 is less toxic to the cell, and bacteria carrying mcr-3 
seems to be fitter and more stable even in the colistin-free environments, when compared to 
that of mcr-1-carrying strains. Although it is prudent to be circumspect, mcr-3 gene confers 
colistin resistance with a lower fitness and thus it is tempting to predict that mcr-3 may 
become globally dominant. However, our results also indicate the limitations of strategies 
predicting the development of colistin resistance based only on growth competition 
measurement in vitro. If laboratory assays of relative growth together with epidemiological 
studies on the prevalence of targeted resistance genes in clinical isolates, the fitness measures 
made in-vitro can have better clinical relevance (Hughes & Andersson, 2015). Thus, it is 
necessary to conduct an international systematic surveillance of mcr carried with biological 
cost studies to better predict which genotypes may globally dominate. 
 
7.4 What is the impact of mcr-mediated lipid A modification on the interations between 
bacteria and its hosts?  
    All mammals possess innate immune mechanisms which are induced during the invasion 
of pathogens into the host. The immune responses involves the synthesis of cytokine and 
chemokine, killing microbes with membrane-bound vacuoles, or secretion of molecules with 
antimicrobial activities (Ernst et al., 2001). Currently, one of the best characterized stimuli of 
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the mammalian immune system is lipid A, the endotoxic component of LPS from GNB. Lipid 
A comprises of fatty acid chains and two-phosphate substitutents bound to 1’- and 4-position 
of a glucosamine dimer. In response to lipid A, host cells synthesize and secrete a number of 
cytokines and adhesion molecules that result in initiating a wide range of immune responses, 
including enhanced killing by phagocytes, activation of potent mediators (such as IL-1β and 
TNF-α) of inflammation, thereby eventually eliminating the invaded bacteria (Ernst et al., 
2001, Raetz et al., 2007). Such immune responses can clear bacterial infections but can over-
produce inflammatory factors resulting in sepsis, for example, damaging of blood vessels and 
causing septic shock.  
In mammalian cells, at least ten members of toll-like receptors (TLRs) are responsible for 
the recognition of microbes. TLR4 complexed with an accessary protein MD-2, is primarily 
responsible for the response to bacterial lipid A (Beutler, 2000, Scott et al., 2017). The 
special structural features of lipid A, particularly its two phosphate groups, are essential to 
activate TLR4/MD2 in human cells (Beutler, 2000, Raetz et al., 2007). The LPS response 
pathway involves a series of interactions with several signaling molecules, contributing to the 
early detection and engagement of bacteria after they invade the host (Beutler, 2000, Lu et al., 
2008, Rosadini & Kagan, 2017). Briefly, LPS initially binds to the LPS-binding protein, LBP, 
which in turn facilitates its interaction with CD14 on the surface of mononuclear cells. 
Protein CD14 acts as a co-receptor together with TLR4 and transfers LPS to a TLR4/MD2 
complex on the cell surface; thereby, stimulating macrophages to produce pro-inflammatory 
cytokines including interleukin-1 (IL-1), IL-6 and tumor necrosis factor (TNF-α). As a result, 
LPS-TLR4/MD2 activated innate immune systems can effectively eliminate invading 
microbes; however, high-level of LPS may trigger the overproduction of cytokines, which 
can drive the immune system into “overload” resulting in clinical presentations such as septic 
shock (Ernst et al., 2001).  
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According to above description, alterations of the Gram-negative outer-membrane; 
particularly LPS, may present an evasive mechanism by Gram-negative bacteria disguising 
them from host immune surveillance and defense systems (Ernst et al., 2001, Raetz et al., 
2007, Needham & Trent, 2013). It has been widely studied that the chromosomal two-
component systems, pmrAB and phoPQ, control expression of LPS modification genes in 
GNB, including E. coli, Salmonella Typhimurium, K. pneumoniae and A. baumannii. In 
addition to promoting resistance to polymyxins, PmrA- or PhoP- modified lipid A has been 
shown to reduce host inflammatory response and confer resistance to serum, thereby resulting 
in the persistence of colistin-resistance bacteria in host tissues. Because lipid A is the key 
signal for host recognition of invading microbes, and the modified lipid A may result in 
reduced TLR4/MD2 and LPS interactions, in addition to reduced innate immune responses, 
persistence may facilitate survival and dissemination. The following is the brief descriptions 
of pathogenic impacts of colistin resistance-mediated LPS modifications mediating on two 
commonest GNB, Salmonella spp and K. pneumoniae, where mcr genes have been found. 
(i) Salmonella spp.: This phenomenon in Salmonellh spp. has been extensively reviewed 
(Guo et al., 1997, Ernst et al., 2001, Gunn, 2008, Kawasaki, 2012, Dalebroux & Miller, 
2014). It also has been found that the protein PmrA-dependent anti-virulence of S. 
Thyphimurium is associated with down-regulation of the type III secretion system Spi/Ssa, 
which is necessary for bacterial survival within macrophages by delivering effectors into the 
phagosomal surface (Choi & Groisman, 2013). In S. Thyphimurium, phoP/phoQ system 
regulates a number of unique genes including pagL, pagQ and pagP, of these contributing to 
the specific structural changes in lipid A, thereby promoting survival and persistence in host 
tissues (Ernst et al., 2001, Kawasaki et al., 2004). Additionally, PhoP-dependent 
modifications of lipid A has been shown to affect host innate inflammatory response (Loftie-
Eaton et al., 2017). LPS extracted from PhoP-null bacteria induces higher level of E-selection 
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expression from human endothelial cells and higher TNF-α expression from human 
monocyte-derived macrophage, comparing to wild-type LPS (Guo et al., 1997). This 
probably because the inability of LPS modifications in phoP-null bacteria, and complete 
structural LPS enhance the host recognition of invading bacteria, thereby promoting the 
activation of inflammatory system for clearance of bacteria (Gunn, 2008). The altered 
inflammatory responses to environmentally modified lipid A suggest that Salmonella can 
gain survival advantage within host tissues. Unsurprisingly, in the mouse model, virulence of 
Salmonella strains with pmrA-activated Ara4N addition to lipid A are highly attenuated when 
the strains were administered orally, but not by intraperitoneally (Guo et al., 1997, Gunn et 
al., 2000). This result includes that when mice orally inoculated with the same dose of 
bacteria, the survival rates of mice with pmrF::Tn10d mutants has seven-fold higher (63% vs 
9%) than that with wild-type strains. Additionally, the extended survivals with more than 20 
days was observed in some mice infected with the pmrF::Tn10d mutants, while the mice 
inoculated with wild-type Salmonella strains only have the average 12 days survival (Gunn et 
al., 2000). However, in some studies, PEtN modification mediated by pmrC and cptA shown 
a modest virulence defect in the mouse model (Tamayo et al., 2005). 
    (ii) K. pneumoniae: the inactivation of MgrB, the repressor of PhoQ/PhoP signal system, 
is a common mechanism of colistin resistance in K.pneumoniae, via up-regulation of phoP 
and pmrK genes responsible for LPS decorations (Cannatelli et al., 2014, Giani et al., 2015). 
However, in contrast to the above findings that colistin resistance is commonly associated 
with fitness loss and impaired virulence, mgrB mutation not only confers colistin resistance 
by inducing phoP-activated multiple lipid A remodeling, but also enhances K.pneumoniae 
virulence in a G.mellonella model (Kidd et al., 2017). Furthermore, infection with mgrB 
mutant was not attenuated in a C57BL/6 mice model with similar bacterial load in murine 
lung and spleen to those of wild type K. pneumoniae. However, the mgrB mutation also 
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results in reduced the secretion of proinflammatory cytokine TNF-α in macrophage upon 
infection. This scenario in K. pneumoniae whereby mgrB-dependent colistin resistance 
mechanism enhances bacterial virulence, may provide some insight into the high rate of 
clinical mortality associated with colistin resistance K. pneumoniae (Kidd et al., 2017). 
comparing to their isogenic strains, the bacterial loads of pagP and pmrF mutants were lower 
in both trachea and lung (Llobet et al., 2011), suggesting pagP- and pmrF-activated lipid A 
modifications in K.pneumoniae play a role in immune-evasion strategies in the mouse model. 
    In conclusion, the variety of modifications of GNB lipid A have multifaceted effects on 
innate immune responses. However, whilst much is known of PhoQ/PhoP in, for example, 
Klebsiella and Pseudomonas, there are no similar studies in E. coli. Therefore, we sought to 
determine the impact of MCR-1 modification(s) mcr-1) on lipid A and the subsequent 
response of the human immune system. Results described in Chapter 3 showed that mcr-1-
dependent PEA lipid A modification has an effect on the production of TNF-α and IL-6 in 
human macrophage differentiated by human monocytic cell lines (THP-1 cells). LPS 
extracted from MCR-1-producing bacteria produces lower levels of TNF-α and IL-6 
expression from human macrophage, relative to wild-type LPS (Fig.3.10 in Chapter 3). Thus, 
mcr-1-mediated PEA modification of lipid A in E. coli plays a dual role in protecting bacteria 
from colistin activity and enhancing survival advantages against host innate defenses. 
Additionally, MCRPEC also reduces virulence in the G. mellonella model, compared to non-
MCRPEC. In vitro growth rate is not significantly different between the mcr-harboring 
transconjugants and their respective recipients, demonstrating that the killing rates or 
pathogenic potential is not due to a growth deficiency. These data are further supported by 
two recent studies examining the fitness of E. coli harboring mcr-1 plasmid (Tietgen et al., 
2017, Zhang et al., 2017). Both studies (Zhang et al., 2017 and Tietgen et al., 2017) 
demonstrated that acquisition of a natural mcr-1 plasmid had no significant fitness cost in E. 
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coli. In the Zhang et al. study, it also shown that E. coli carrying both mcr-1 and blaNDM-5 
plasmids possess a slower growth rate and reduced fitness than that with the blaNDM-5 plasmid 
alone (Zhang et al., 2017). Impaired virulence was observed in E. coli harboring both mcr-1 
and blaNDM-5 plasmids: the time to murine death was over 14 days, while mice injected with E. 
coli carrying the blaNDM-5 plasmid alone died within one day (Zhang et al., 2017). Tietgen and 
colleagues also examined the impact of mcr-1 cytotoxicity in A549 lung epithelial cells and 
virulence in the G. mellonella model, and shown that it has no significant impact in both 
models (Tietgen et al., 2017).  
 
7.5 WGS analysis of MCRPEC strains: what factors facilitate the global spread of mcr 
genes?  
Since its discovery in November 2015, the global spread of mcr genes have been 
extensively reported. Aside from mediating resistance to colistin, MCRPE are frequently 
associated with phenotypic and genotypic resistance to multiple classes of antibiotics 
including carbapenems, fluoroquinolones and aminoglycosides. MCRPE isolates are 
genetically diverse and previous efforts to identify specific features that can distinguish 
human clinical isolates from animal or environmental isolates have yet to yield meaningful 
data. (Matamoros et al., 2017, Wang et al., 2018). According to a recent study that included 
over 400 MCRPEC isolates from the literature, their genetic relatedness based on highly 
diverse MLST profiles suggest that no specific host-linkage is responsible for its global 
transmission. Among them, a higher prevalence of mcr-1-carring E.coli ST10 has been 
identified (40/312, 12.8%) from Africa, Asia, Europe and South-America, compared to other 
STs (Wang et al., 2018).  So far, at least 14 incompatibility groups of mcr-1-linked plasmids 
have been found, including IncF, IncFI, IncFII, IncFIB, IncHI1, IncHI1A (FIA), IncHI1B, 
IncHI2, IncI2, IncP, IncX4, IncX3/X4, IncY, repB (p0111) (Matamoros et al., 2017).  
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Unlike mcr-1 that has been widely studied, mcr-3, which was first reported in late 2017, 
are still relatively unknown. To better understand the dynamics of mcr genes, especially mcr-
1 and mcr-3, in this study, I have combined the power of WGS with a genome-data-base 
analysis, encompassing a total of 236 clinical, animal and environmental MCRPE isolates 
from Thailand and Vietnam, consisting of 219 MCRPEC (see the detail in Chapter 6) and 17 
MCRPKP (see the detail in Chapter 5). A variety of MLST profiles was found in 219 
MCRPEC isolates, consisting of 54 STs in 136 isolates from Vietnam and 31 STs in 83 
isolates from Thailand. In comparison with other STs, a higher prevalence of ST10 has been 
observed in MCRPEC strains (23/219, 10.50%), including 18 ST10 carrying mcr-1 only and 
5 ST10 carrying both mcr-1 and mcr-3 plasmids from human, environmental and animal 
isolates. E. coli ST10 is also linked to mcr-2  identified in porcine isolates from Belgium 
(Xavier et al., 2016). Therefore, we hypothesize that several E. coli strains, notably those 
related to ST10, may play a crucial role as a reservoir of mcr genes. Interestingly, ST43 K. 
pneumoniae has been identified in 17 MCRPKP isolates obtained from blowflies from 
difference places in Thailand. Many possess the same size mcr-1-plasmid belonging to IncX4 
isolated from blowflies, companion animals, food-producing animals and human faeces 
(described in Chapter 5). These findings suggest that ST43 K. pneumoniae from blow flies 
may act as an efficient vector for disseminating mcr-1 genes between environments and 
humans. IncX4 plasmid is the most prevalent mcr-linked plasmid type, which have found in 
human feces, animals, environmental water and blow flies in MCRPE collection. In addition, 
26 of IncX4 plasmids share an identical plasmid background, further suggesting widespread 
dissemination of IncX4 in the Thai environment (Fig.5.5 in Chapter 5). Furthermore, broad-
host range plasmid IncP, the second biggest group of mcr-associated plasmids, are mainly 
found in clinical isolates from Vietnam (n=19), in which nine IncP plasmids contain mcr-3, 
and ten with mcr-1 (Table 6.1 in Chapter 6).  
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7.6 Future Perspectives 
Unlike the high detection rates of MCRPE in animals, with mcr-1 gene in particular, in 
human population and environmental factors have been reported to be substantially low (0.2-
1.7%) (described in 1.3.2.1 in Chapter 1). Based on ‘one health’ perspective, what roles have 
animal-originated Enterobacteriaceae played in the subsequent spread of mcr-genes? In order 
to better understand the possible interspecies transmission of mcr- genes, the most obvious 
follow-up work is to do a comprehensive sampling and testing of animal-, environmental- 
and human-pathogenic bacteria for the presence of mcr-like genes. This project is 
collaborated with our current collaborators in Thailand, Vietnam, Combodia and China. 
Besides epidemiological surveillance, there is an urgent need to develop novel tools for 
predicting and preventing the evolution of mcr-conferring colistin resistance. Whole-genome 
sequence data has highlighted the significant genetic diversity of MCRPE isolates, but the 
impact of this diversity on the evolution and dissemination of mcr-linked colistin resistance 
remains poorly understood. Deeper WGS-based analysis and comprehensive epidemiological 
data, combined with the ‘game’ between acquiring and loss of mcr-like genes will provide 
insights for mathematical modellings, to scale up mcr-fitness landscape, and predict the 
global spread trend of MCRPE isolates. This project is on-going. 
    Another follow-up research interest is to ascertain the exact mechanisms behind the 
HLCRMs. Phenotypic characteristics of these HLCRMs have been determined, such as high-
level MICs of colistin (32-256 mg/L), reduced fitness and highly attenuated virulence in a 
Galleria mellonella model (Yang et al., 2017). However, there is a missing link between 
genetic alterations and phenotypic changes. Therefore, in the future research woek, I am 
interested in understanding how genomic background change the rate and evolution of 
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colistin resistance in these HLCRMs, using combination of high-quality genomic and 
functional analysis. 
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Appendice 
Appendix I   Culture media and Stock solutions 
 
Appendix 1.1 list of culture media 
(1) Luria Bertani (LB) Agar, Miller (Thermo Fisher Scientific, Waltham, USA): 
Supplemented with specific antimicrobials for subculture and passage experiments. 
(2) LB Broth, Miller (Thermo Fisher Scientific, Waltham, USA): Used for subculture, 
conjugation and passage experiments. 
(3) Mueller Hinton (MH) Agar (E&O Laboratories Ltd): Used for susceptibility testing of 
antimicrobials. 
(4) BrillianceTM UTI Clarity Agar (Oxoid Ltd, Basingstoke, UK): Used for selective 
isolation in mating experiments by adding different antibiotics. 
 
Appendix 1.2 list of stock solutions for PFGE and Southern blotting 
Cell suspension buffer 
1M Tris (pH8.0) 100 ml 
0.5 Na2EDTA(pH8.0) 200 ml 
Dilute to 1000 ml with sterial distilled water. 
Cell lysis buffer 
1 M Tris (pH8.0) 50 ml 
0.5 M Na2EDTA(pH8.0) 100 ml 
10% Sarcosyl 100 ml 
Make up to 1000 ml with sterial distilled water, 10% sarcosyl was added after autoclaved. 
 
220!
!
1X TE buffer 
1 M Tris-HCl (pH8.0) 10 ml 
0.5 M Na2EDTA (pH8.0) 2 ml 
Dilute to 1000 ml with sterile water. 
 
10X S1 buffer 
Sodium acetate (Fisher) 12.3 g 
Zinc acetate (Fisher) 0.92 g 
Dissolve both in 200 ml of water, followed by adding 250 ml of glycerol and adjust pH to 4.6. 
Then add sterile distilled water to 500 ml. Keep 10X S1 buffer at -20 oC. 
10X TBE buffer  
Tris base (Fisher) 108 g 
boric acid (Sigma) 55 g 
0.5 M EDTA (pH 8) 40 ml 
Adjust pH to 8 with concentrated HCl and make up to 1000 ml with sterile distilled water.  
Denaturing solution 
NaCl 87.66 g 
NaOH 20 g 
Dissolve them in 1000 ml of sterile distilled water. 
Neutralising solution 
Tris base (Fisher) 78.5 g 
NaCl 87.6 g 
Dissolve both in 800 ml of sterile water, adjust pH to 7.5 with concentrated HCl, and then 
make up to 1000 ml with sterile distilled water. 
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Pre-hybridisation stock solutions  
5% Polyvinylpyrrolidone (Sigma) 0.4 ml 
5% ficoll (Sigma) 0.4 ml 
10% SDS 1 ml 
20X SSC 6ml 
full cream UHT milk 1 ml 
10mg/ml herring testes DNA (Sigma) 0.3 ml 
Make up to 20 ml with Sterile distilled water. 
20X Saline-sodium citrate solution (SSC) 
Nacl (Fisher) 17.5 g 
Na3citrate.H2O(Fisher) 8.8 g 
Concentrated HCl adjust pH to 7.0 
Make up to 100 ml with sterile distilled water. 
 
Note: all solutions need to be autoclaved before use. 
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Appendix II List of studied isolates from Thailand and Vietnam 
 
Appendix Table 2.1 list of 100 MCRPE isolates from Thailand used in the study 
Isolate species Sources mcr-genes Year 
PN101 E.coli Blow fly mcr-1 2015 
PN102 E.coli Blow fly mcr-1 2015 
PN103 E.coli Blow fly mcr-1 2015 
PN108 E.coli Blow fly mcr-1 2015 
PN109 E.coli Blow fly mcr-1 2015 
PN111 E.coli Blow fly mcr-1 2015 
PN112 E.coli Blow fly mcr-1 2015 
PN116 E.coli Blow fly mcr-1 2015 
PN117 E.coli Blow fly mcr-1 2015 
PN119 E.coli Blow fly mcr-1 2015 
PN121 E.coli Blow fly mcr-1 2015 
PN122 E.coli Blow fly mcr-1 2015 
PN123 E.coli Blow fly mcr-1 2015 
PN124 E.coli Blow fly mcr-1 2015 
PN126 E.coli Blow fly mcr-1 2015 
PN127 E.coli Blow fly mcr-1 2015 
PN33 E.coli Blow fly mcr-1 2015 
PN73 E.coli Blow fly mcr-1 2015 
PN74 E.coli Blow fly mcr-1 2015 
PN75 E.coli Blow fly mcr-1 2015 
PN76 E.coli Blow fly mcr-1 2015 
PN78 E.coli Blow fly mcr-1 2015 
PN80 E.coli Blow fly mcr-1 2015 
PN83 E.coli Blow fly mcr-1 2015 
PN85 E.coli Blow fly mcr-1 2015 
PN86 E.coli Blow fly mcr-1 2015 
PN87 E.coli Blow fly mcr-1 2015 
PN88 E.coli Blow fly mcr-1 2015 
PN91 E.coli Blow fly mcr-1 2015 
PN92 E.coli Blow fly mcr-1 2015 
PN93 E.coli Blow fly mcr-1 2015 
PN94 E.coli Blow fly mcr-1 2015 
PN203 E.coli Blow fly mcr-3 2015 
PN207 E.coli Blow fly mcr-3 2015 
PB215 E.coli Blow fly mcr-3 2015 
PN218 E.coli Blow fly mcr-3 2015 
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Isolate species Sources mcr-genes Year 
PN313 E.coli Blow fly mcr-3 2015 
PN326 E.coli Blow fly mcr-3 2015 
PN328 E.coli Blow fly mcr-3 2015 
PN107 K. pneumoniae Blow fly mcr-1 2015 
PN114 K. pneumoniae Blow fly mcr-1 2015 
PN118 K. pneumoniae Blow fly mcr-1 2015 
PN120 K. pneumoniae Blow fly mcr-1 2015 
PN77 K. pneumoniae Blow fly mcr-1 2015 
PN79 K. pneumoniae Blow fly mcr-1 2015 
PN81 K. pneumoniae Blow fly mcr-1 2015 
PN84 K. pneumoniae Blow fly mcr-1 2015 
PN95 K. pneumoniae Blow fly mcr-1 2015 
PN96 K. pneumoniae Blow fly mcr-1 2015 
PN97 K. pneumoniae Blow fly mcr-1 2015 
PN98 K. pneumoniae Blow fly mcr-1 2015 
PN104 K. pneumoniae Blow fly mcr-1 2015 
PN105 K. pneumoniae Blow fly mcr-1 2015 
PN106 K. pneumoniae Blow fly mcr-1 2015 
PN110 K. pneumoniae Blow fly mcr-1 2015 
PN100 K. pneumoniae Blow fly mcr-1 2015 
Tha30 E.coli Cattle (feces) mcr-1,mcr-3 2015 
PN1 E.coli Environmental water mcr-1,mcr-3 2015 
PN2 E.coli Environmental water mcr-1,mcr-3 2015 
PN3 E.coli Environmental water mcr-1,mcr-3 2015 
PN4 E.coli Environmental water mcr-1,mcr-3 2015 
PN5 E.coli Environmental water mcr-1,mcr-3 2015 
PN6 E.coli Environmental water mcr-1,mcr-3 2015 
PN7 E.coli Environmental water mcr-1 2015 
PN8 E.coli Environmental water mcr-1,mcr-3 2015 
PN9 E.coli Environmental water mcr-1 2015 
PN41 E.coli feces from healthy human  mcr-1,mcr-3 2015 
PN42 E.coli feces from healthy human mcr-1,mcr-3 2015 
PN43 E.coli feces from healthy human mcr-1 2015 
PN44 E.coli feces from healthy human mcr-1 2015 
PN45 E.coli feces from healthy human mcr-1, mcr-3 2015 
PN46 E.coli feces from healthy human mcr-1 2015 
PN47 E.coli feces from healthy human mcr-1,mcr-3 2015 
PN49 E.coli feces from healthy human mcr-1 2015 
PN51 E.coli rectal swab from patient mcr-1 2015 
PN52 E.coli rectal swab from patient mcr-1 2015 
PN54 E.coli rectal swab from patient mcr-1 2015 
PN55 E.coli rectal swab from patient mcr-1 2015 
224!
!
Isolate species Sources mcr-genes Year 
PN56 E.coli rectal swab from patient mcr-1,mcr-3 2015 
PN57 E.coli rectal swab from patient mcr-1 2015 
PN58 E.coli rectal swab from patient mcr-1 2015 
PN59 E.coli rectal swab from patient mcr-1,mcr-3 2015 
PN60 E.coli rectal swab from patient mcr-1 2015 
PN67 E.coli rectal swab from patient mcr-1 2015 
PN68 E.coli rectal swab from patient mcr-1 2015 
PN69 E.coli rectal swab from patient mcr-1 2015 
PN70 E.coli rectal swab from patient mcr-1 2015 
PN71 E.coli rectal swab from patient mcr-1,mcr-3 2015 
PN38 K. pneumoniae rectal swab from patient mcr-1 2015 
PN10 E.coli Pet (cat) mcr-1 2015 
PN11 E.coli Pet (cat) mcr-1 2015 
PN12 E.coli Pet (cat) mcr-1 2015 
PN21 E.coli Poultry (feces) mcr-1 2015 
PN23 E.coli Poultry (feces) mcr-1 2015 
PN24 E.coli Poultry (feces) mcr-1,mcr-3 2015 
PN25 E.coli Poultry (feces) mcr-1 2015 
PN28 E.coli Poultry (feces) mcr-1 2015 
PN29 E.coli Poultry (feces) mcr-1 2015 
PN32 E.coli Poultry (feces) mcr-1,mcr-3 2015 
PN16 E.coli Poultry meat  mcr-1 2015 
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Appendix Table 2.2 list of 136 MCPREC isolates from Vietnam used in this study 
Isolate Species Sources Geno Year  
1407.4 E.coli Human Stool mcr-1 2015 
1460.1 E.coli Human Stool mcr-1 2015 
1440.1 E.coli Human Stool mcr-1 2015 
1439.2P E.coli Human Stool mcr-1 2015 
1509.1 E.coli Human Stool mcr-1 2015 
1516.1 E.coli Human Stool mcr-1 2015 
1519.1 E.coli Human Stool mcr-1 2015 
1438.1 E.coli Human Stool mcr-1 2015 
1467.2 E.coli Human Stool mcr-1 2015 
1470.1 E.coli Human Stool mcr-1 2015 
1529.2 E.coli Human Stool mcr-1 2015 
1526.2 E.coli Human Stool mcr-1 2015 
1450.3 E.coli Human Stool mcr-1 2015 
1463.4 E.coli Human Stool mcr-1 2015 
1461.1 E.coli Human Stool mcr-1 2015 
1474.1 E.coli Human Stool mcr-1,mcr-3 2015 
1394.1 E.coli Human Stool mcr-1 2015 
1481.1 E.coli Human Stool mcr-1 2015 
1497.1 E.coli Human Stool mcr-1 2015 
1405.1 E.coli Human Stool mcr-1 2015 
1400.3 E.coli Human Stool mcr-1 2015 
1484.1 E.coli Human Stool mcr-1 2015 
1492.2 E.coli Human Stool mcr-1,mcr-3 2015 
1490.1 E.coli Human Stool mcr-1 2015 
1392.1 E.coli Human Stool mcr-1 2015 
1482.1 E.coli Human Stool mcr-1 2015 
1483.1 E.coli Human Stool mcr-1 2015 
1386.1 E.coli Human Stool mcr-1 2015 
13845.1 E.coli Human Stool mcr-1 2015 
1475.1 E.coli Human Stool mcr-1 2015 
1487.1 E.coli Human Stool mcr-1 2015 
1489.1 E.coli Human Stool mcr-1 2015 
1432.1B E.coli Human Stool mcr-1 2015 
1412.1 E.coli Human Stool mcr-1,mcr-3 2015 
1388.1 E.coli Human Stool mcr-1 2015 
1393.1 E.coli Human Stool mcr-1 2015 
1442P E.coli Human Stool mcr-1 2015 
1446.1 E.coli Human Stool mcr-1 2015 
1472.1 E.coli Human Stool mcr-1,mcr-3 2015 
1471.1 E.coli Human Stool mcr-1 2015 
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Isolate Species Sources Geno Year  
1500.1 E.coli Human Stool mcr-1 2015 
1540.1 E.coli Human Stool mcr-1 2015 
1541.1 E.coli Human Stool mcr-1 2015 
1422.1 E.coli Human Stool mcr-1 2015 
1421.1 E.coli Human Stool mcr-1 2015 
1485.1 E.coli Human Stool mcr-1 2015 
1435.1B E.coli Human Stool mcr-1 2015 
1543.1 E.coli Human Stool mcr-1 2015 
1542.1 E.coli Human Stool mcr-1 2015 
1502.1 E.coli Human Stool mcr-1 2015 
1503.1 E.coli Human Stool mcr-1 2015 
1397.2 E.coli Human Stool mcr-1 2015 
1436.1 E.coli Human Stool mcr-1 2015 
1433.1 E.coli Human Stool mcr-1 2015 
1432.1 E.coli Human Stool mcr-1 2015 
1431.2 E.coli Human Stool mcr-1 2015 
1419.2 E.coli Human Stool mcr-1 2015 
1480.1 E.coli Human Stool mcr-1 2015 
1479.1 E.coli Human Stool mcr-1,mcr-3 2015 
1435.1 E.coli Human Stool mcr-1 2015 
1518.1 E.coli Human Stool mcr-1,mcr-3 2015 
1507.3 E.coli Human Stool mcr-1 2015 
1466.1 E.coli Human Stool mcr-1,mcr-3 2015 
1533.2 E.coli Human Stool mcr-1 2015 
1535.1 E.coli Human Stool mcr-1,mcr-3 2015 
1532.2 E.coli Human Stool mcr-1 2015 
1539.1 E.coli Human Stool mcr-1 2015 
1537.1 E.coli Human Stool mcr-1,mcr-3 2015 
1536.2 E.coli Human Stool mcr-1 2015 
1453.1 E.coli Human Stool mcr-1 2015 
1403.2 E.coli Human Stool mcr-1 2015 
1404.2 E.coli Human Stool mcr-1,mcr-3 2015 
1522.1 E.coli Human Stool mcr-1 2015 
1309 E.coli Human Stool mcr-1 2015 
1310 E.coli Human Stool mcr-1 2015 
1311 E.coli Human Stool mcr-1 2015 
1304 E.coli Human Stool mcr-1 2015 
1306.1 E.coli Human Stool mcr-1 2015 
1308 E.coli Human Stool mcr-1 2015 
1334.1 E.coli Human Stool mcr-1 2015 
1313.1P E.coli Human Stool mcr-1 2015 
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Isolate Species Sources Geno Year  
1314.1 E.coli Human Stool mcr-1 2015 
1317.1 E.coli Human Stool mcr-1 2015 
1327.1 E.coli Human Stool mcr-1 2015 
1326.1 E.coli Human Stool mcr-1 2015 
HN1402.1 E.coli Human Stool mcr-3 2015 
HN1272.2 E.coli Human Stool mcr-3,mcr-1 2015 
HN1271.3 E.coli Human Stool mcr-3,mcr-1 2015 
HN1271.2 E.coli Human Stool mcr-3,mcr-1 2015 
HN1456.5 E.coli Human Stool mcr-3,mcr-1 2015 
HN1409.2 E.coli Human Stool mcr-3 2015 
HN1404.2 E.coli Human Stool mcr-3,mcr-1 2015 
HN1050.3 E.coli Human Stool mcr-3,mcr-1 2015 
HN1398.5 E.coli Human Stool mcr-3 2015 
HN964.4 E.coli Human Stool mcr-3 2015 
HN961.3a E.coli Human Stool mcr-3,mcr-1 2015 
HN961.3b E.coli Human Stool mcr-3,mcr-1 2015 
HN763.3 E.coli Human Stool mcr-3,mcr-1 2015 
HN943.3 E.coli Human Stool mcr-3 2015 
HN514.1 E.coli Human Stool mcr-3 2015 
HN596.5 E.coli Human Stool mcr-3 2015 
HN657.1 E.coli Human Stool mcr-3,mcr-1 2015 
HN657.4 E.coli Human Stool mcr-3,mcr-1 2015 
HN657.5 E.coli Human Stool mcr-3,mcr-1 2015 
HN621.1 E.coli Human Stool mcr-3,mcr-1 2015 
HN1142.2a E.coli Human Stool mcr-3 2015 
HN1142.2b E.coli Human Stool mcr-3 2015 
HN1142.5 E.coli Human Stool mcr-3 2015 
HN1142.4 E.coli Human Stool mcr-3 2015 
HN1142.3a E.coli Human Stool mcr-3 2015 
HN1142.3b E.coli Human Stool mcr-3 2015 
HN1380.4 E.coli Human Stool mcr-3 2015 
HN1364.4 E.coli Human Stool mcr-3,mcr-1 2015 
HN1545.1 E.coli Human Stool mcr-3 2015 
HN1335.2 E.coli Human Stool mcr-3,mcr-1 2015 
HN1335.1 E.coli Human Stool mcr-3,mcr-1 2015 
HN40.5 E.coli Human Stool mcr-3,mcr-1 2015 
HN75.5 E.coli Human Stool mcr-3,mcr-1 2015 
HN75.3 E.coli Human Stool mcr-3,mcr-1 2015 
HN2.5 E.coli Human Stool mcr-3,mcr-1 2015 
HN367.4 E.coli Human Stool mcr-3 2015 
HN367.2 E.coli Human Stool mcr-3 2015 
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HN1410.4 E.coli Human Stool mcr-3 2015 
HN225.5 E.coli Human Stool mcr-3,mcr-1 2015 
HN225.4 E.coli Human Stool mcr-3,mcr-1 2015 
HN225.2 E.coli Human Stool mcr-3,mcr-1 2015 
HN225.1 E.coli Human Stool mcr-3,mcr-1 2015 
HN83.5 E.coli Human Stool mcr-3,mcr-1 2015 
HN83.2 E.coli Human Stool mcr-3,mcr-1 2015 
HN269.2 E.coli Human Stool mcr-3,mcr-1 2015 
HN269.3 E.coli Human Stool mcr-3,mcr-1 2015 
HN1270.5 E.coli Human Stool mcr-3,mcr-1 2015 
HN1466.5 E.coli Human Stool mcr-3 2015 
HN1466.4 E.coli Human Stool mcr-3 2015 
HN1570.3a E.coli Human Stool mcr-3 2015 
HN1570.3b E.coli Human Stool mcr-3 2015 
HN1499.1 E.coli Human Stool mcr-3 2015 
HN1272.5 E.coli Human Stool mcr-3 2015 
AV106.1 E.coli Human Stool mcr-3,mcr-1 2015 
AV28.1 E.coli Human Stool mcr-3,mcr-1 2015 
1305.1 E.coli Human Stool mcr-3,mcr-1 2015 
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Appendix III supplementary data in Chapter 3 
 
 
 
 
 
 
Appendix Fig.3.1 ESI-QTOF/MS revealed the PEA modification of bacterial lipid A 
mediated by MCR-1 gene.  
A, ESI-MS/MS spectrum of the negative ion of the lipid A extracted from the constructed 
control strains E. coli W3110+ pUC19. The lipid A has a prominent peak at m/z 1797.10 and 
no PEA modification existed at m/z 1920.  B, ESI-MS/MS spectrum visualization of the 
negative ion of the lipid A extracted from the constructed positive strains E. coli W3110 
+pUC19-mcr-1. A PEA (123u) is added into the bis-phosphorylated hexaacylated lipid A 
(m/z 1920).  
Note: In this study, the bacterial lipid A was analyzed using Waters Synapt HR mass 
spectrometry under two different ion channels (m/z 1797 and m/z 1920). TOF MSMS 
1920.10ES-: Selected ion monitoring of the product of lipid A modification at m/z 1920.10 
with negative ion scan. TOF MSMS 1797.20ES-: Selected ion monitoring of the bacterial 
lipid A at m/z 1797.20 with negative ion scan 
(This figure is contributed by co-authors from China Agriculture University)(Yang et al., 
2017) 
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Appendix Table 3.1 Laboratory strains and plasmids used in this study 
 
Plasmid name Host strain Plasmid (size) Colistin 
MIC 
(mg/L) 
Reference 
mcr-1/pBAD  E.coli TOP10 ~6000bp 2 This study 
pBAD alone  E.coli TOP10 ~4100bp 0.25 Thermo Fisher, UK 
E.coli TOP10   - - 0.25 Thermo Fisher, UK 
mcr-1/pSU18  E.coli TOP10 ~4000bp 4 (Hinchliffe et al., 
2017) 
GFP-pHT315  DH5 alpha  - 0.5 (Daou et al., 2009) 
blaTEM-1b/pBAD E.coli TOP10 ~5000bp 0.25 This study 
E246A/pBAD E.coli TOP10 ~6000bp 0.25 This study 
mcr-1 soluble 
domain /pBAD 
E.coli TOP10 ~5400bp 0.25 This study 
 
 
Appendix Table 3.2 Relative Fitness (RF) using Flow cytometer 
 
RF(compared to the mcr-1/pBAD D0 
Strain) 
repeats mean SD propagated 
errors 
p-value 
E.coli TOP10 6 1.0960 0.0129 0.0171 0.132 
E.coli TOP10 pBAD 6 1.0955 0.0054 0.0134 0.0649 
E.coli TOP10 mcr-1/pBAD D3 6 1.0080 0.0062 0.0140 0.041* 
E.coli TOP10 mcr-1/pBAD D4 6 1.0132 0.0257 0.0283 0.3095 
E.coli TOP10 mcr-1/pBAD D8 6 0.8258 0.0088 0.0165 0.0022** 
E.coli TOP10 mcr-1/pBAD D14 6 0.7922 0.0084 0.0164 0.0022** 
RF(compared to mcr-1/pBAD uninduced strain – 0%#) 
E.coli TOP10 6 1.0000 0.0147 0.0177 0.8182 
E.coli TOP10 mcr-1/pBAD +0.0002% 6 0.9992 0.0088 0.0132 0.6991 
E.coli TOP10 mcr-1/pBAD +0.002% 6 0.9991 0.0153 0.0182 1 
E.coli TOP10 mcr-1/pBAD +0.02% 6 0.7278 0.0031 0.0108 0.0022** 
E.coli TOP10 mcr-1/pBAD +0.2% 6 0.4272 0.0074 0.0262 0.0022** 
 
# indicates the concentration of L-arabinose (w/v).  * indicates 0.01< p value <0.05 and ** 
indicates p value <0.01 
 
 
 
231!
!
Appendix Table 3.3 MICs of colistin for mcr-1/pBAD after 14-day serial passage 
 
Passage MICs of Colistin (mg/L) 
days mcr-1(1)* mcr-1(2)* pBAD-1 pBAD-2 TOP10 
1 0.5 0.5 0.125 0.125 0.125 
2 2 1 0.125 0.125 0.25 
3 4 2 0.125 0.125 0.25 
4 4 4 0.125 0.125 0.25 
5 4 4 0.125 0.125 0.25 
6 8 4 0.125 0.125 0.25 
7 8 4 0.125 0.125 0.25 
8 8 16 0.125 0.125 0.25 
9 16 16 0.125 0.125 0.25 
10 16 16 0.125 0.125 0.25 
11 32 16 0.06 0.06 0.125 
12 32 16 0.06 0.06 0.125 
13 32 16 0.06 0.06 0.25 
14 32 32 0.06 0.125 0.25 
 
* indicate duplicates were performed.  
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Appendix IV supplementary data in Chapter 6  
Appendix Table 6.1 Inc types of mcr-linked plasmids  
 
  
Isolate ID 
mcr-3-linked Inc types mcr-1-linked Inc types 
P1 FII X1 colE X4 P0111 P1 HI1A HI1B 
(R27) 
HI1A/HI1B 
(R27) 
1335-1 1                   
1456-5 1                   
657-5 1                   
AV106-1 1                   
AV28-1 1                   
1272-2 1                   
269-2 1                   
1364-4 1                   
1398-5 1                   
83-5     1               
943-3   1                 
1410-4   1                 
1309             1       
1422.1             1       
1460.1         1           
1471.1         1           
1479.1             1       
1475.1             1       
1481.1               1     
1482.1                 1   
1497.1           1         
1509.1             1       
1516.1             1       
1529.2         1           
1535.1             1       
1537.1             1       
1540             1       
1543.1         1           
1435.1             1       
1442p         1           
PN47 1                   
PN111         1           
PN112         1           
PN116         1           
PN117         1           
PN119         1           
PN12         1           
PN121         1           
PN122         1           
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Isolate ID 
mcr-3-linked Inc types mcr-1-linked Inc types 
P1 FII X1 colE X4 P0111 P1 HI1A HI1B 
(R27) 
HI1A/HI1B 
(R27) 
PN123         1           
PN124         1           
PN126         1           
PN127         1           
PN16         1           
PN21         1           
PN23         1           
PN25         1           
PN28         1           
PN29         1           
PN33         1           
PN41         1           
PN43         1           
PN44         1           
PN46         1           
PN49         1           
PN51         1           
PN52         1           
PN54         1           
PN55         1           
PN57         1           
PN58         1           
PN60         1           
PN67         1           
PN68         1           
PN7               1     
PN78               1     
PN80                 1   
PN83                 1   
PN87                 1   
PN88                 1   
PN9                   1 
F203   1                 
F207   1                 
F215       1             
F218   1                 
F326   1                 
F328   1                 
F313   1                 
Total No. 10 8 1 1 39 1 10 3 5 1 
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Appendix Table 6.2 plasmid types found in randomly selected 77 MCRPEC strains from Vietnam 
 
strains I
1 
I
2 
FI
A1 
FI
A 
FI
A2 
FI
I1 
FI
IK 
FI
C 
 
FI
B3 
 
FI
V4 
FI
I5 
FI
B6 
F
II 
FI
C 
 
FI
BK 
HI
1A 
HI
1B7 
H
I2 
HI
2A 
P
1 
Q
1 
X
1 
X
2 
X
4 N R Y 
C
ol8 
 
Col
E10 
Colp
VC 
p01
11 
Total 
No. 
1386-
1 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 
1388-
1 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 
1393-
1 0 0 1 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 5 
1394-
1 0 0 1 0 1 0 0 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 0 1 9 
1397-
2 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 4 
1403-
2 
0 0 1 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 1 1 0 6 
1404-
2 
0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 1 4 
1407-
4 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 3 
1419-
2 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 3 
1431-
2 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 1 5 
1432-
1 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 0 0 0 0 0 0 0 0 1 4 
1432-
1-b 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 0 0 0 0 0 0 0 0 1 4 
1439-
2B 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 4 
1442 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 4 
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strains I
1 
I
2 
FI
A1 
FI
A 
FI
A2 
FI
I1 
FI
IK 
FI
C 
 
FI
B3 
 
FI
V4 
FI
I5 
FI
B6 
F
II 
FI
C 
 
FI
BK 
HI
1A 
HI
1B7 
H
I2 
HI
2A 
P
1 
Q
1 
X
1 
X
2 
X
4 N R Y 
C
ol8 
 
Col
E10 
Colp
VC 
p01
11 
Total 
No. 
B 
1442
P 
0 0 1 0 0 0 0 1 0 0 0 1 0 0 0 1 1 0 0 0 0 0 0 1 0 0 0 1 0 0 0 7 
1446-
1 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 
1450-
3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 
1453-
1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 4 
1460-
1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 1 0 0 0 0 0 5 
1463-
4 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 1 0 0 0 0 0 0 3 
1467-
2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 
1470-
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 2 
1472-
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 1 0 0 0 0 0 1 4 
1475-
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 
1479-
1 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 2 
1481-
1 0 0 1 0 0 0 0 1 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 
1483-
1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 4 
1484-
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 1 3 
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strains I
1 
I
2 
FI
A1 
FI
A 
FI
A2 
FI
I1 
FI
IK 
FI
C 
 
FI
B3 
 
FI
V4 
FI
I5 
FI
B6 
F
II 
FI
C 
 
FI
BK 
HI
1A 
HI
1B7 
H
I2 
HI
2A 
P
1 
Q
1 
X
1 
X
2 
X
4 N R Y 
C
ol8 
 
Col
E10 
Colp
VC 
p01
11 
Total 
No. 
1489-
1 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 
1490-
1 
0 1 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 
1492-
2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 2 
1497-
1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 
1500-
1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 4 
1507-
3 
0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 1 4 
1519-
1 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 
1532-
2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 2 
1533-
2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 1 0 0 0 0 0 0 0 1 5 
1535-
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 
1537-
1 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 2 
1540-
1 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 2 
1542-
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 3 
1543-
1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 1 5 
1392- 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 5 
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strains I
1 
I
2 
FI
A1 
FI
A 
FI
A2 
FI
I1 
FI
IK 
FI
C 
 
FI
B3 
 
FI
V4 
FI
I5 
FI
B6 
F
II 
FI
C 
 
FI
BK 
HI
1A 
HI
1B7 
H
I2 
HI
2A 
P
1 
Q
1 
X
1 
X
2 
X
4 N R Y 
C
ol8 
 
Col
E10 
Colp
VC 
p01
11 
Total 
No. 
1 
1400-
3 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 1 0 0 0 0 0 1 4 
1405-
1 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 2 
1412-
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 2 
1421-
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 
1422-
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 1 4 
1433-
1 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 0 0 1 0 0 0 0 0 0 4 
1435-
1B 0 0 1 1 0 0 0 0 0 0 1 1 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 1 8 
1435-
1 0 0 1 1 0 0 0 0 0 0 1 1 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 1 8 
1436-
1 0 0 1 1 0 0 0 0 0 0 1 1 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 1 8 
1438-
1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 
1439-
2P 
0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 4 
1502-
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 2 
1440-
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 2 
1466-
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 2 
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strains I
1 
I
2 
FI
A1 
FI
A 
FI
A2 
FI
I1 
FI
IK 
FI
C 
 
FI
B3 
 
FI
V4 
FI
I5 
FI
B6 
F
II 
FI
C 
 
FI
BK 
HI
1A 
HI
1B7 
H
I2 
HI
2A 
P
1 
Q
1 
X
1 
X
2 
X
4 N R Y 
C
ol8 
 
Col
E10 
Colp
VC 
p01
11 
Total 
No. 
1471-
1 
0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 
1461-
1 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 1 0 0 0 0 0 1 4 
1474-
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 1 0 0 0 0 0 0 1 4 
1480-
1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 3 
1482-
1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 1 0 1 0 0 0 0 7 
1485-
1 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 1 3 
1485-
1 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 1 3 
1487-
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 1 0 0 0 0 0 1 4 
1503-
1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 
1509-
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 2 
1516-
1 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 2 
1518-
1 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 2 
1522-
1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 
1526-
2 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 
1529- 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 
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strains I
1 
I
2 
FI
A1 
FI
A 
FI
A2 
FI
I1 
FI
IK 
FI
C 
 
FI
B3 
 
FI
V4 
FI
I5 
FI
B6 
F
II 
FI
C 
 
FI
BK 
HI
1A 
HI
1B7 
H
I2 
HI
2A 
P
1 
Q
1 
X
1 
X
2 
X
4 N R Y 
C
ol8 
 
Col
E10 
Colp
VC 
p01
11 
Total 
No. 
2 
1536-
2 
0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 
1539-
1 
0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 3 
1539-
1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 3 
1541-
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 2 
1384
5-1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 1 4 
Total 
No. 2 2 23 3 2 1 1 2 2 1 3 11 2 1 26 10 7 
1
2 12 
1
6 1 
2
5 1 8 
1
9 4 4 3 4 1 42   
 
* The ori variants in from FIA1(HI1), FIA2 (pBK30683); FII3 (pHN7A8), FIV4 (pB171), FII5 (pSEI1); FIB6(pB171), HI1B7(R27), Col8 (BS512)
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ARTICLE
Balancing mcr-1 expression and bacterial survival is
a delicate equilibrium between essential cellular
defence mechanisms
Qiue Yang1, Mei Li1, Owen B. Spiller1, Diego O. Andrey 1,2, Philip Hinchliffe3, Hui Li4, Craig MacLean 5,
Pannika Niumsup6, Lydia Powell7, Manon Pritchard7, Andrei Papkou5, Yingbo Shen8, Edward Portal1,
Kirsty Sands1, James Spencer3, Uttapoln Tansawai6, David Thomas7, Shaolin Wang8, Yang Wang8,
Jianzhong Shen8 & Timothy Walsh1
MCR-1 is a lipid A modifying enzyme that confers resistance to the antibiotic colistin. Here,
we analyse the impact of MCR-1 expression on E. coli morphology, ﬁtness, competitiveness,
immune stimulation and virulence. Increased expression of mcr-1 results in decreased growth
rate, cell viability, competitive ability and signiﬁcant degradation in cell membrane and
cytoplasmic structures, compared to expression of catalytically inactive MCR-1 (E246A) or
MCR-1 soluble component. Lipopolysaccharide (LPS) extracted from mcr-1 strains induces
lower production of IL-6 and TNF, when compared to control LPS. Compared to their parent
strains, high-level colistin resistance mutants (HLCRMs) show reduced ﬁtness (relative ﬁt-
ness is 0.41–0.78) and highly attenuated virulence in a Galleria mellonella infection model.
Furthermore, HLCRMs are more susceptible to most antibiotics than their respective parent
strains. Our results show that the bacterium is challenged to ﬁnd a delicate equilibrium
between expression of MCR-1-mediated colistin resistance and minimalizing toxicity and thus
ensuring cell survival.
DOI: 10.1038/s41467-017-02149-0 OPEN
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Heavy Metal Resistance Genes Are Associated with blaNDM-1-
and blaCTX-M-15-Carrying Enterobacteriaceae
Qiu E. Yang,a Siham Rajab Agouri,a Jonathan Mark Tyrrell,a Timothy Rutland Walsha
aDepartment of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff
University, Cardiff, United Kingdom
ABSTRACT The occurrence of heavy metal resistance genes in multiresistant Entero-
bacteriaceae possessing blaNDM-1 or blaCTX-M-15 genes was examined by PCR and
pulsed-field gel electrophoresis with S1 nuclease. Compared with clinical susceptible
isolates (10.0% to 30.0%), the pcoA, merA, silC, and arsA genes occurred with higher
frequencies in blaNDM-1-positive (48.8% to 71.8%) and blaCTX-M-15-positive (19.4% to
52.8%) isolates, and they were mostly located on plasmids. Given the high associa-
tion of metal resistance genes with multidrug-resistant Enterobacteriaceae, increased
vigilance needs to be taken with the use of heavy metals in hospitals and the envi-
ronment.
KEYWORDS heavy metal resistance, blaNDM-1, blaCTX-M-15, plasmids, coresistance
The increasing spread of multidrug-resistant superbugs in clinical environmentshas prompted worldwide concern, because antibiotic resistance genes, such as
blaNDM-1 and blaCTX-M-15, limit treatment options to combat bacterial infections (1–4).
Note that in addition to emerging antibiotic resistance, heavy metals represent another
major source of environmental contamination that may select for antibiotic resistance
(5). Heavy metal compounds for growth promotion and therapeutic treatment, like zinc
and copper, have been used in pig and poultry production; and unlike antibiotic food
additives, metals can accumulate in soil, water, aquacultural and marine antifouling
treatments, and industrial effluent (6). It has been proposed that antibiotic-resistant
bacteria are enriched at locations contaminated with metals, and genes conferring
coselection to heavy metals and antibiotics are often found together in many clinical
isolates (7–11). Furthermore, genes conferring heavy metal tolerance may coexist on
the same genetic element (e.g., plasmid), which may further promote codissemination
and resistance (10, 12). Here, we characterize the phenotype and genotype of heavy
metal resistance in a collection of clinical Gram-negative isolates, including Klebsiella
pneumoniae, Escherichia coli, Enterobacter cloacae, Klebsiella oxytoca, and Providencia
stuanti, isolated from the United Kingdom and India.
A total of 95 nonduplicate isolates were tested in this study (Table 1): 39 blaNDM-1-
positive isolates originated from human lower respiratory and urinary tract samples
from the United Kingdom and Chennai and Haryana, India, as previously described (13);
36 blaCTX-M-15-carrying isolates originated from patients with burns, bacteremia, and
urinary tract infections (UTIs) from various Indian hospitals (Haryana, Mumbai, Kolkata,
Kerala, Delhi, and Vellore); and 20 control E. coli and K. pneumoniae isolates susceptible
to all known antibiotic classes as control samples were provided by Specialist Antimi-
crobial Chemotherapy Unit (SACU), Public Health Wales. MICs of four heavy metal ions,
i.e., CuSO4.5H2O for copper (Cu2!), HgCl2 for mercury (Hg2!), AgNO3 for silver (Ag!),
and AsNaO2 for arsenic (As3!), were measured by agar dilution using Mueller-Hinton
agar (Becton Dickinson, USA). E. coli (ATCC 25922) was used as a negative control. MIC
levels of!10 mM for Cu2!,!2 mM for As3!,!32 "M for Hg2!, and! for 128 "M Ag!
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